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General Introduction 
1.1 Brief biological mNonale for hyperthermia 
Hyperthemlia is defined as a temperature elevation by several degrees (3-7 °C) above the 
normal physiological level. In vitro and ill vivo experiments have shown that a cell kill 
response to hyperthcnnia in conjunction with radiotherapy exists (Harisiadis et al. (1975); 
Alfieri and Hahn, (1978); Dewey e/ ai, (1977); Bhuyan, (1979)), Harisiadis e/ ai, also report 
on the increased sensitivity to hyperthermia of tumour pmis that arc nOlmally less sensitive to 
radiation alone. 
Tumour tissue differs from 1101111a1 tissue in that it has a chaotic stmcture of the 
vascularisation. Due to this inferior vasculature stmcture, areas exist in the tumour with 
insufficient blood perfusion, which, in tum, causes local hypoxia and a low pH. Tumour cells 
in these hypoxic areas are relatively insensitive to radiation and because of the poor blood 
perfusion, a systemic chemotherapeutic approach for these areas has also less effect. One 
approach used to attack the cells in insufficiently perfused areas is hyperthenllia in 
combination with radiotherapy or chemotherapy since hypoxic areas are relatively sensitive to 
hyperthenllia. This makes hypelihermia an ideal complementalY treatment modality to both 
radiotherapy and/or chemotherapy, taking into account that nom131 tissue in general tolerates a 
hypelihennic treatment of one hour with temperatures of up to 44°C without relevant clinical 
damage, i.e. 110 negative side-effects. 
1.2 Clinical e.'perience 'with hyperthermia 
The combination of radiotherapy and hypelthennia has proven its clinical efficacy 
providing that the combined therapy is applied adequately. The relative value ofhypelihennia 
as an adjunct to either radiotherapy or chemotherapy has been investigated in a number of 
2 Chapler 1 
phase I-II and phase III studies. Without providing a complete overview of all (recently) 
published clinical studies including hyperthermia, I will summarise and comment on a few 
studies, which have had an impact on the credibility of hyperthennia in the last decade. 
Perez el al. (1991) published a devastating report on the efficacy of hyperthermia in the 
treatment of superficially measurable tUIllOurS. They found 110 significant difference in overall 
complete response (CR) between radiotherapy alone and radiotherapy plus hyperthennia (307 
pts.). The authors concluded that the most important reason that the CR rate did not improve 
with hyperthenllia was because of the poor quality of the hyperthennia treatments. Emami et 
al. (1996) came to the same conclusion in their evaluation of interstitial hyperthermia added 
to interstitial radiotherapy (184 pts.): no gain in CR due to poor hyperthennic quality. 
Although these two studies found no beneficial effect due to hyperthenllia, neither did they 
show any negative effects of the addition of hyperthennia. 
A more recent study by Vernon ef al. (1996) showed in a combined analysis of five 
randomised phase III studies that the addition of hyperthennia to radiotherapy was beneficial 
for the treatment of advanced primary and reClilTent breast cancer (CR rate radiotherapy alone 
41 % versus 59% for radiotherapy plus hyperthernlia (306 pts.)), which difference in local 
control lasted throughout the 3 years follow-up. Overgaard el al. (1995) reported fi'om a phase 
III study on the addition of hyperthenl1ia to radiotherapy in the treatment of reCUlTent or 
metastatic malignant melanoma a significantly improved local tumour control (CR rate 
radiotherapy alone: 35% versus 62% for radiotherapy plus hyperthermia (68 pts.); 2-year 
control (SE) 28 (6)% versus 46 (8)%). In the treatment of glioblastoma, Sneed el al. (1998) 
showed in their prospective randomised trial that the addition of interstitial hypelihenl1ia to 
radiotherapy improved the time to progression and 2-years survival (15% radiotherapy alone 
versus 31 % radiotherapy plus interstitial hyperthermia (79 pts.)). In a multi-centre randomised 
phase III trial comparing radiotherapy alone with radiotherapy plus hyperthennia in the 
treatment of primary cervical cancer (stage 2b lateral, 3b and 4a). Van der Zee el al. (2000) 
proved that the combined treatment was significantly more effective than radiotherapy alone: 
in CR 57% for radiotherapy alone versus 83% radiotherapy plus hyperthennia (114 pts.). This 
study also showed an improved 3-years survival: 27% versus 51%. Based on the results of the 
phase III trials for the combined modality of radiotherapy plus hypeI1hermia in the palliative 
treatment of cancer (Van der Zee el al. (1988); Overgaard el al. (1995); Valdagni and 
Amichetti, (1994)) and curative treatment of primary cervical cancer (Van der Zee el al. 
(2000)), the Dutch minister of Health, Welfare and Sport has decided to acknowledge the 
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addition of hyperthem1ia to radiotherapy as standard in the palliative treatment of superficial 
tumours and curative treatment of primary cervical cancer (stage 2b lateral, 3b and 4a). 
The data used by Perez ef al. (1991) and Emami ef al. (1996) was obtained in the period of 
February 1981 till June 1992 while the data analysed by Vernon ef al. (1996), Overgaard ef al. 
(1995), Sneed ef al. (1998) and Van der Zee ef al. (2000) was obtained between January 1986 
and September 1996. Although there is a large overlap in time, general insight in the 
hyperthennic mechanisms and continuous technical progress in hyperthetmia equipment will 
have contributed to the different outcome in these studies, indicating strongly that the 
teclmical quality of the hyperthem1ia equipment is of cmcial importance to clinical efficacy 
(and acceptance). 
1.3 Quality ill hyperthermia 
Quality in hyperthenllia is defined by the ESHO Quality Assurance (QA) guidelines (I-Iand 
ef al. (1989)) and RTOG QA guidelines (Dewhirst ef al. (1990)). These guidelines cover basic 
technical properties of hyperthermia equipment. However, the effectiveness of hyperthermia, 
i.e. clinical quality, especially in a combined treatment modality, can only be investigated in a 
phase III study. This often requires large numbers of patients and can be a lengthy process. 
The effectiveness of combining radiotherapy or chemotherapy with hyperthermia is 
defined by a broad spectnnn of (prognostic) factors of which the radiotherapy !chcmotherapy 
dose and thennal dose (based on the minimum temperatures) are known entities. Besides 
these parameters, other (confounding) factors like tumour histology, thennotolerance, volume 
or location, timing of hyperthermia in relation to radiotherapy or chemotherapy and further 
treatment-related factors like SAR coverage and the number of hyperthennia treatments play 
an important role in the effectiveness of the combined treatment (Raaphorst ef al. (1998); 
Sakurai ef al. (1998); Engin ef al. (1995); Kapp and Cox (1995); Hand ef al. (1997); Lee ef al. 
(1998». The complexity of these factors and their (non-linear) interactions make the 
assessment of the clinical quality of hyperthennia treatments (for each specific tUIllour group) 
in the combined treatment modality a cumbersome and difficult subject. 
If the effectiveness of two concurrent hyperthenllia tcclmiques have to be investigated, a 
relatively quick way to demonstrate their difference can be an intra-patient comparison. In this 
set-up, both hyperthennic applications are used aitemately during one treatment series of a 
patient and with the well-defined and technically measurable temperature, a more limited 
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assessment i.e. technical assessment of hyperthennia quality can be achieved for both types of 
applications under otherwise constant circumstances. 
A major drawback in the use of invasive thellllometry is the relatively poor quality of 
spatial resolution as the measurement of a true 3D~representative temperature data set is 
clinically not feasible, Only recently is 3D-treatment plmming stat1ing to emerge on a more 
routine basis (for deep and interstitial hypelthennia) in which a full 3D-SAR distribution is 
generated. From this, a 3D-temperature distribution can he calculated given a static blood 
perfilsion. However, there are no guidelines conceming the evaluation of a patient-based SAR 
distribution obtained from antennae in alTay configurations. Neither is it possible to obtain 
and correlate an invasively measured SAR distribution to the calculated SAR values. It is also 
not possible to correlate a coarse-measured temperature distribution to a fine-meshed 
treatment-model-calculated temperature distribution in a patient due to large variations in 
blood flO\v and strong dynamic changes in blood flow during a hyperthermia treatment. In 
conclusion, a full assessment of the technical quality of a hyperthenllia treatment can not be 
obtained from clinical data yet. 
Although full assessment of the tec1mical quality is not feasible, the ESHO Quality 
Assurance guidelines (Hand et al. (1989» on the basic technical qualities of an antenna can 
be used: the effective field size (EFS). i.e. surface at I cm depth in muscle-equivalent tissue 
with a SAR of more than 50% with the SAR normalised to the absolute maximum at that 
depth, and penetration depth (PD, defined as the depth under I cm with 50% SAR level). 
Evaluation of SAR data in a muscle-equivalent tissue phantom is the best altemative for 
technical hypelihellllic quality assessment. These measurements andlor calculations can be 
performed with either one antenna or multiple antennae in a clinically relevant anay 
application. 
For evaluation of superficial hyperthenllia antennae, the development of a thennographical 
measuring device existing of an Infra Red camera interfaced to a PC made it possible to 
obtain (coarse) 3D-SAR infonnation using a flat multi-layered phantom (Van Deursen and 
Van Rhoon, (1987». However, the time-interval between measurements to reinstate the 
phantom properties slows down the process of measurements. Also, the heat conduction in the 
phantom during the power pulse (60 to 90 seconds) causes extra inaccuracy. Another 
drawback of measuring SAR distributions from muscle-equivalent phantoms this way, is the 
initial variation in the stmcture of the phantom and the varying electro-magnetic properties in 
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time of the phantom. Only with computer planning models, a better-controlled method of 
generating SAR distributions have become available. 
The efficacy of these computer generated SAR distributions depends on the accuracy of the 
models used and experimental verification was used to validate the models. The Gaussian 
beam model as introduced by Bach Andersen (1987) and further developed Lumori ef al. 
(1990a) has proven to be reliable to predict SAR distributions in layered water-fat-muscle 
phantoms from Cunent Sheet Applicators (CSA) in an array application (Lumori ef al. 
(1990b)). The experimental verification oHhe model showed an error less than 3% (Lumori et 
al. (1990a)). This model played an important role in the technical evaluation and comparison 
of superficial hyperthermia antennae under development in the University Hospital 
Rotterdam-Daniel. Presently, other, 1110re sophisticated, models have proven their reliability in 
predicting SAR distributions from antennae especially in the application of deep regional 
hyperthellllia (Sullivan (1991); Sullivan ef al. (1993); Wust ef al. (1996); Wust ef al. (1999». 
They either used a FDTD algoritlull or IE algorithm to calculatc SAR distributions in 3D 
patient representations. Basis for these 'clinical' calculus techniques was provided by Van den 
Berg ef al. (1983) and Zwambom (1991). 
Through the use of the same FDTD algorithm, the first preliminary results of modelling a 
superficial Lucite Conc Applicator have become available (Samaras ef al. (2000)). 
1.4 Aim of this study 
The main object of this thesis is to address the problem of technical quality in superficial 
hyperthermia. Since 1978, the clinical application of hype11hermia has been the subject of 
various research projects in Rotterdam. Initially, research was done into the application of 
whole body hyperthellllia (Van der Zee, (1987)) and since 1983 research has been 
concentrated on the application of local superficial hyperthenllia and (loco-) regional deep 
hyperthennia as an adjuvant to radiotherapy. This research has resulted in the development of 
a 433 MHz waterfilled waveguide antelUla, used in an incoherent multi-element array for 
superficial hypcI1hermia applications, a 27 MHz capacitive coupling system for interstitial 
hyperthennia (Kaatee, (2000)) and a 27 MHz ring capacitor applicator for deep regional 
hyperthelmia (Van Rhoon, (1995». 
In general, CR rates in the treatment of reCUlTcnt breast cancer by radiotherapy plus 
hypcrthem1ia are found to be lower in the case of large tumours than in small tumours. 
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Through clinical evaluation, we found that technical improvement (Le. changing the 
frequency fi'om 2450 MHz to 433 MHz and designing the waterfilled waveguide applicator 
(\VGA),) resulted in an increase of CR for tumours with a diameter larger than 3 ern from 
31 % to 65% (Van der Zee et a1. (1999)), chapter 2. However, a difference between CR rates 
of large tumours and in small tumours « 3 em) remained, 65% respectively 87%. To further 
improve the teclmical quality of the superficial hyperthennia treatment, research concentrated 
on the development of an antenna capable of adequately heating a large tumour volume. To 
clinically verify the technical quality of a hyperthennia treatment, the temperature distribution 
must be monitored throughout the treatment. The use of interstitial thenllometry in clinical 
practice and for research putposes is discussed in chapter 3. 
Since the 433 MHz driven WGA has a limited effective field size (EFS, 33% of the 
aperture), it is not suitable for the heating of a large tumour volume. Therefore, an antenna 
had to be developed with an EFS that covered the entire aperture of the antenna. The new 
antenna, the Lucite Cone Applicator (LCA) is based on the WGA and has an EFS that is 
about three times larger than that of the WGA. The basic properties of, this antelUla are 
reported in chapter 4. 
In clinical application, an an'ay of antennae is often needed to cover the entire tumour area, 
To study the basic technical properties of the newly developed LCA, a simple 2D beam 
profile model (Gaussian beam (GB) model) was tested on its usability to predict SAR 
distribution from a 2* I array of LCA (chaptc!· 5). Finally, in chapter 6, more clinically 
relevant 2*2 array applications of the LeA were quantitatively evaluated using the GB model 
and verified by thermographically obtained SAR images. 
In theory, arrays of antennae with individual power control of each element are capable of 
heating a treatment volume if two conditions are fulfilled: a) the overall treatment volume 
needs a certain minimum dose and b) nonnal tissue in the treatment volume must not be 
damaged, Since the tissue properties in the treatment volume can vary greatly either initially 
or during the treatment, individual power adjustments are essential in optimising the 
hyperthennia treatment. An an'ay constructed from small antennae provides a high spatial 
resolution of power deposition, which can counteract small unwanted hot spots in the 
treatment volume adequately. Hmvever, major drawbacks of a small aperture anteIUla array 
are a) the (potential) loss of penetration depth and thus a decrease in CR and b) a strict 
demand of spatial resolution of thermometty to exploit the feasibility of power steering, In 
contrast, arrays of large aperture antennae are more difficult to confonn to the body contours, 
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A small hot spot (in normal tissue) causes the reduction of local power output in the whole 
area under the aperture with the risk of local underdosage in that part of the treatment volume, 
and thus may decrease the CR. Both systems therefore have their specific technical 
advantages and disadvantages. To investigate the pros and cons of large and small aperture 
antellllae, a theoretical comparison of the SAR distribution from arrays of large LeA and 
small C,ment Sheet Applicators (CSAs) using the GB model was perfonned (chapter 7). In 
this study, an attempt has been made to find a quantitative measure to evaluate arrays of 
antennae to be used for superficial hyperthenllic treatments. The currently available QA 
guidelines do not provide any such measure for these purposes. 
The remaining (and perhaps the most burning) question to be answered, having 
acknowledged technical progress made in the laboratory, is: 
Does teellllical Improvemellt ill a hyperthermic app/ic)tIOIl actllally result III a 
qualltifiable Improl'emellt ill the clillical hyperthermia t\eatmellt? 
Only a clinically orientated study will make clear which tebhnical improvement is most 
significant under which clinical circumstances. Therefore, we set up a paired comparison of 
the temperature distributions achieved by either \VGA or LeA alTays within several patient 
treatment series (cha}ltcl' 8). From this comparison, we calculated to what extent laboratory-
obtained improved SAR distributions resulted in an improved temperature distribution under 
clinical conditions. 
Since the Gaussian beam model is a simple 2D model that does not take into account 
mutual interaction between antennae and 3D tissue load properties, the more complex FDTD-
modelling was tested on its capability to predict SAR distributions from an LCA. FDTD-
modelling has proven its efficacy as 3D SAR distribution calculator in regional and interstitial 
hyperthermia. In chapter 9 we show the first results of basic FDTD-modelled SAR 
distributions from the LeA, which are conelated with thennographically obtained data. 
Chapter 10 concludes this study with a general discussion. Furthennore, some directives 
are fonnulated for future research. 
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Summary Bolh experimental and clinical research have shown thaI hyperthermia (Hn gives valuable additional effects when applied In 
combination with radiotherapy {AT}. The purpose of this study was evaluation of results in patients with recurrenl breast cancer. trealed at the 
Daniel den Hoed Cancer Center (DHCC) with reirradialion (re-RT; eightlfactions of 4 Gy twice weekly) combined with HT. All 134 patients lor 
whom such treatment was planned were included in the analysis. The complete response rate in 119 patients with macroscopic tumour was 
71 %. Including the 15 patients with microscopic disease, the local conlrol rate was 73%. The median duration of local conlrol was 32 months, 
and toxicity was acceptable. The complete response (CR) rate was higher, and the toxicity was less with the later developed 433-MHz HT 
technique compared w'tth Ihe 2450-MHz technique used initially. With this relatively well-tolerated treatment, palliation by locattumour control 
of a worth • .,.hile duration is achieved In the majority of patients. The technIque used for hyperthermia appeared to influence the achieved 
results. The value 01 HT in addilion to this re-RT schedule has been confirmed by a prospective randomized trial in a similar patient group. In 
The Netherlands, this combined treatment is offered as standard to patients with breast cancer recurring in previously irradiated areas. 
Keywords: breast cancer; reirradiation; hyperthermia; local tumour control; palliation 
The clinical problem 
Ltlt'al regional reo.::llrr"nccs of brea.\t cancer may be Ihe cau~e of 
severe ~ufkring when uncontrolled, without being life-threalening 
at ~hort teml. Symploms ~uch as ulceration, hleeding and ~e\'ere 
pain ha\'e he~n ~c('n in 62<;l. of the pa1i~nls with recurrent hrea\t 
cancer referred for fiJdiotherapy (RT) (Bedwinek et aI, 198111). 
FurthcmlOle. wato.::hing a growing tumour at lhe ~urface of the 
body i~ a ~tR'~~ful e,~perience 10 the p~t!ienl. TIle survival of 
patil.'nts with a ]ocoregional recurrence appears nntlo be rdated to 
any local IrealnlCnI; in the majority of p~ltiL'nts, distant meta\t'his 
i~ idL'lltificd after a median folluw-up time of les~ than 12-30 
months. Ne\'erlhdL',,~, the median .~ur\'i\'nl time in this patient 
group 11m}' vary from 12 to 53 munths, depending mainly un 
tumour l"haracleri~tiL"~ al the lime of first diagno~is, with as-year 
~urviv'll ratL' of 22-sm'0 (Bedwinek d aI, 1981/1; Toonkd et nl, 
1983; Patanaphan et aI, 1%4; Abcrizk et aI, 19R6; DI.'Ubch et aI, 
19X6; Hielanen d al, It)X6; Stadler and Kogdnik, 19X7; Blanco et 
ai, 1990; Schwaihold et nl, lY91; Halver~on et aI, 1<192). The 
finanL"ial CO\t of tll.'ating patients with local regional brc'l,t cancer 
recurrenc~~ has been estimated to be around Australian $533 p"r 
month by HurleY et al (1992). 'Tllerefore, appliL"ation of a treat-
ment whiL"h can n::~ult in long-term locallul11our control would be 
worthwhile from the pe~p~di\'6 of both the pati~1\t nnd tilL' health 
care system. 
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In the (·a.~e of a recurrent tumour within a previously irradiated 
area, the dlanl'c of achieving local control hy eilher RT or 
chemotherapy is reduced (Okunidf d ai, 1991). The radiation 
dose that can b~ giv~n without a high risk of unacceptable toxicity 
i~ lower than considered adequale (BedwinL'k el aI, 19~1a; 
Halverson et aI, 1990; Withers el ai, 1995). TIli~ poor progno\i~ 
led to lhc cvaluation of combining re-RT and local hyperthermia 
(HT) in this patient group at till' DHCC. 
Experim~ntal rc~earch ha.~ .~hown that HT is nil ~ffeo.::ti\'e cd!-
killing agent especially to celh in a hypoxio.::, nutrient deprived and 
low pH ellviwllllll'nt, (onditions which are specifically found in 
malignallt tumours. The combination of RT with HT ~hould result 
in at lea~t a complellll.'ntary tumoriddal effect, if not a SUllr,\-addi-
live dfl'd (Field, 1l)l)O; RaapllOr~t. 1990). The existing clinical 
data appear to confinll till' finding~ from e1\perimental re~eall.'h. 
Recently, thl' therapeutic gain by HT in ndditiun to In~ h~l~ bcen 
durumented by landomiled comparativc studie, in \'adou'i tumour 
type'i (Valdagni 1'1 al, 19XX; Owrgaard el a!. 1995; InlL'matiunal 
Collaburativc Hyperlhennia Group, 1996; van JerZee et aI, 191)0). 
At the DHCC, both treatml.'nt lIl(ldalitie~ lHltkrwent l'hangL's 
during thl' paiod since the combination \\"~l, first applied rHnkall}'. 
"be total re-RT do~~ gradually increa'ed fmm about 20 to 32 Gy, 
The freatment whcdule of eight fntL'lions of4 Gy, twicc \\'eekly, \\"l'i 
fin! 'Jpplied in 1981. ~lnd, aftL'r apP'Jrenl eff<:,di\'t'n~s, ;lmilokr,lIll'e 
(\'an der Zl'l' cl ai, J9XX). fhi\ b~L'amL' the protocol in IY,'{X. 
lIypl'rthennia techni(IUe was gradually improved oVer the y~aTh, 
MATERIALS AND METHODS 
Patients and tumours 
All lJ4 p;lticnts with reCurrent Htl\.'nocarcinoma of thl' brca~1, lilr 
whom reirradiation with l'jght fraction<; of 4 Gy combined \\'ith HT 
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Table 1 PaUent and tumour characterisUcs in relaUofl to treatment te<:hnique 
433MHln",,107 2450 MHz n "" 27 
Median (range) s.d.' 
Disease·frea intervat from start of first 
treatment to firs! relapse (months) 23(1-158)27 
Number 01 previousty given kinds 01 chemotherapy 
0 
1 
20r3 
Number of previously given kinds of hormonal therapy 
0 
1 
" 
Number 01 previous surg:cal procedures at the same 
localion 
0 
1 
" 
Dose of radiotherapy given previously (Gy) 45 (20--66) 6 
Macroscop:o tumour 
",3cm 
>3cm 
Ulcerating tumour 
Tumour histology: grade of d<fferenUaUon 
Good 
Moderate 
Poor 
Undlfferentiate-cl 
Unkno'~ln 
Number 01 lesions 
Single 
2 
3--9 or more 
Haemoglobin at time 01 !reatment (mmol j-') 8.30.7 
Tumour outside treatment VOlume 
Macroseop!o tumours only: 
Tumour volume (cm;) II (1-868) 166 
Tumour maximum diameter (em) 4.9 (5-300) 6.0 
Maximum depth (em) 2.0 (t-9) 1.6 
Continuation 01 hormonal therapy during local 
treatment 
's.d., standard deviation 
wa, plnnned between January 19~1 and May 1992 for a total 
number of 143 fields, nre included in thi, evaluation. Only the fir,t 
treated field in each patient wa~ inchHled, leaving a total number 
of 134 fields in 134 patients to he analy~ed. Six of Ihe,e p~lien" 
hnd heen included in the mndomiled ,tudy reported by the 
Inkmationlll Collabomtive Hyperthemlia Group (1~9fi). 
Patients were ~elected for re-RT plu~ HT on the folll)wing 
nikria: flx'urn::nl tumour, inopemble (/1 -:=: 119) or after micrmcopi-
enlly incomplete exci~ioll (n = 15); and sptemic therapy \Va, either 
inatietlUilh: to control the local regional tumour, or wa, deemed 
inappropriate, in the ah,ence of (symptomatic) sy~temic db"'il,"'. 
At Ihe lime oftr"'iltm"'llt, pati",nb were aged 28· .. 82 yenr~, with a 
median of 5~ years. Performance status wa.s generally good, with 
WHO .,cores 0 or I in 132 patients and 2-4 in two patient,. Distant 
Patients Median (range) s.d.' Patients 
15(2-168)25 
57 9 
33 13 
17 
54 10 
23 0 
30 9 
49 16 
51 10 
45 (15-58) 10 
38 11 
57 13 
24 
0 
18 
53 12 
14 7 
21 7 
42 9 
19 B 
46 10 
8.30.7 
41 10 
6 (1-777) 39 
4.7 (6-175) 4.8 
2.0 (1-5) 0.7 
15 5 
mcta~ta\b \\'il, pre~enl at Ihe start of treatnwn! in 38<'-;, of the 
patients. Seventy per cenl of Ihe patients had been tn'all·d wilh 
hOnll!lnal amI/or chemotherapy in the pa~!. Previous RT to the 
~ame area had been given 4 Ilwnth, to 17 year:-. (median 41 
monlh,) hefore the re-RT plus HT treatment. TUl1lour loealizatiun 
wa., on the (he,\ wall in 130 palients. Patient and tumour chamc-
teri'>lic, known tn have prognmtic vallie are given in Table I, in 
relation to the fiT techni4ue u~ed for treatment. In ca,c of mUltiple 
Ie,ion" the maximum diameter and Ihe volume of the large\t 
Ie~ion Wll, u,cd ill the evaluation. Tumour volume wa, calculated 
according to the formula l/fi!rr("iH\', in which II and II lire the 
largc,t diamete~ mea,ured hy "."aliper~ and c is !he max.imum 
e.\telhiol1 in depth e,timated by p;i1pation and, in ~ume ca~e". 
e~tabli,hcd by llitril'lllllHI or computerized !omognlphy (CT) scan. 
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Tabla 2 Treatment characteristics 
To!;]\ fe-RT dose 
<32 (12-28) Gy 
=32 Gy 
=36Gy 
Sj~e 01 rad,ation "aid (em") 
Size 01 hyperthermia field {cm'J 
Number 01 HI applicator sel·ups 
1 
2 
3 
4 
Received eighll-fT treatments 
Total duration of all HT treatments (m'ln) 
Number of thermometry points {median (raoge)]-
In tumour Vssue 
In norrnallissue 
HT dose parametors {median (s d,')] 
Tmaxmax,"""" in tumour Cc) 
T90" _, in tumour I'C) 
Tmaxmax,.-=, in normal tissue {'c) 
T90"" in normal tissue CC) 
Tumour ,issue T90 >40-C (min) 
Normal tissue TeO >40-C (min) 
'S.d., standard doviation 
Treatment 
All pJtienls were treated with the ~ame radiation ~chedu!e of 4 Gy 
twice wed";!y, each fraction fol!owetl hy [ hIlT. 1l1e time interval 
between \wo re~RT + lIT treatment~ Wll~ .1---4 days, that between 
the re-RT fraction and HT ~e,,~ion \\'a'i an average of 40 min. A 
~ummary of tR'atment chameteri~tic~ is given in Tahle 2. 
Radiotherapy 
The planned treatment of eight fractions of 4 Gy wa~ applied to 
129 patienb. FI1\1r patienh rereived a lowl'[ tolal dn~e, of [2-
2g Gy, a\ thl'ir treatment was terminated berause of gl'nem[ deteri-
oration by mpid prugres~inn of "y~temk di~l'<lw. [n nne patient, 
the treatnH:nt W;L\ intemrpled beciiu~e of development of a urinary 
tract intl'ction, wnd a ninth frac!ion Wll'i given to rompen",ne for 
the delay. Radiation terhniques includcd eledroll" (/I;;;: 107), 
photons (/I ;;;: 15), a t'ombina!lon (/I '" I}) or nrthovoltage (11 = 2) 
(unknown ill one) depending on the tumour locatinn and depth, 
The radiation field was ehosen with a margin of at lea<.\ "2 rm 
arollnd the macro~copk tumour. 
Hyperthermia 
Seven patients received less HT Ireatments than RT fml'lion,. Four 
patients received ~e\"en in,te,ld of eight HT trcatments be<:au~e of 
logistics. In two patients, the treated HR'a needed four HT appJi-
t'atof ~et-ups to cover the whole field, thert'fore only half of the 
field W:L~ !re<lted during each se,~ion. In the one patk'nt receiving 
nine fraclions of Rl~ ~ix HT treatments were applied. Standard 
treatment duration wa~ 60 min with power on. For delivery of HT, 
the 2450-MHz technique wa~ u,ed in 27 patients (ll}gl-86) and 
the 4.13-MHz technique in !O7 patients (~incc [986). The aim of 
the treatment wa~ to achieve the highest tumour temperatures. 
Chapter 2 
n Range Median (s,d.') 
129 
30-875 248 (184) 
64-800 300 (155) 
101 
2 
2 
123 
480 (55) 
433 MHz 2450MHz 
5.4 (1-20) 2.6 (1-10) 
13.9 (1--44) 2.9 (1-11) 
433 MHz 2450 MHz 
43.4 (1.3) 42.2{1.4) 
40.1 (\.2) 40.6 (1.7) 
43,S (I.O) 422(1.2) 
39,2 (1.1) 39,9 (t.2) 
6t (118) 118 (137) 
0(55) 48 (101) 
Power input wa~ limited by the tempemttrfes mea'iUl'ed within the 
tumour periphery (minimum 44"'C wa~ allowed at .,;1 t'm distance 
fWIIl norllla[ tis~ue) and the nomla[ thsue (nnximum 43"C during 
the first 30 min, 44°C during the second 30 min), and by powef~ 
related pain expres~ed by the patient at u site without thermometry. 
The hyperthennia field size is defined as the sum of the aperture 
area~ of the applicators used. 
2450 MHz technique 
Cu<;\om-built air-filled w;lveguide applicators, with aperture sizes of 
S x 4 and g x 6 cm!, \\"('[1.' used in various (()mbination~. Up to fOllr 
applicators \WR' coupled to one power supply, without tile po~~ibility 
to cOnlrol power supply to the individual npplirators. A nU1>imutll (If 
cight applicators rou[d be u'ied al the ~a!lle time, Surface cooling, 
when ne~'6~ilfy, \\'a, perfomlcd by directing air l'urrent~ under the 
upplicators. Inlcr!>titial tilennoJl1etry Wil'i perfonned by them1ll---
couples, llsing either ~ingle ~en~or prohe..; within a needle or muJti~ 
~cn~or pf\ll1e"; within u catheter. Temp.::rJtures were mea'iured evcr), 
5 min Wilh the power ~hut off. 
433 MHz technique 
A dipole antenna wa~ used in three patient~. Custnm-built water-
fillcd waveguide applirators (Van Rhnon el at, }INS) were used 
since February 19S5. The maximum number of applicators med 
simullancously increa..;ed, over time, from two to five. Each appli-
cator wa~ ~upplied with independent power rontrol. Until July 
[987, the aim of the treatment was to heat the macroscopic tumour 
but, after experiencing tumour regrowth within the radiation Held, 
outside the margin of the HT field (van der Zee et a!, [992); the 
applicator set-up wa..; dlO,cn such that the radiation field lI'a, 
widely covered. Surface temperature control wa, perfonned by 
u,ing a perfused water bolus. Since May [987, tempenllures have 
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Table 3 Parameters included in the e~aluation of prognostic factors 
Chemotherapy 
Hormonal therapy 
Former local Irealmenl 
Former chemotherapy: yes or no 
Former hormonal therapy: yes or no 
RTdose 
Number 01le5ions 
Two crasses: either a maximum of one surglcal treatmenl pius RT, or two or more surgical !malmenls plus RT 
Total (Cllmu!ative) dose 01 previously applied RT; continuous variable, or classes $42, >42-46 and <:46 Gy 
Number of lumour lesions within the trealment volume; classes I, 2 and ~3 
Log tumour volume 
Tumour max;mum diameter 
Logarithm of volume of (Iargesl) lumour leSion in mml; continuous variabte, or classes 52, 2-4 and ~4 
Maximum diameter 01 (largest) lumour lesion; In Iwo classes s3 and >3 em 
Tmaxmax~_." in tumour 
T90"", in tumour 
Tmaxmax~~ In normal tissue 
T90,. _, In normal tissue 
Conlinuous variable, or classes .":42 5, >42.5-43.5 and <:43.5'C 
Continuous variable, or classes s39.6, >39.6----40.6, end >40.6-C 
Conlinuous variabie, or classes .":43.3, >43.3-44.3, and >44.3'C 
Continuous variable, or classes s38.8, >38.8----39.5 and >39.5 C 
KT technique Two classes: 433 MHz and 2450 MHz 
been l11ea~urt'd continuously during trealments by a 24-channel 
~L',mning fihre-optic system (F1'121O, Takaoka Japan), wilh which 
five lllultisell50r probe~ (up 10 four .~enwrs) ami four ~ingle-semor 
probes were available, 
Two patients, both with 11 tumour extending to a deplh of more 
th~n 5 em, who werc treated with other equipment (13.5 MHz 
eapacative and SO MHz mdiative, respectively) were included in 
the 433-MHz teehniquc group, 
HyperthermIa dose parameters 
For both nomlal tis'iue ami tumour ti~~ue, 20 parameters repre~en­
tati\'\~ of HT do,e were calculated from the temperatures me(.l'iured 
during heating. A full lbcription of allthe,e do~e parameters is 
beyond the ,cope of Ihis report, but will be puhJi,hed ebewhere, 
The'>e parameters, however, appeared highly correlated, Factor 
analy\i~ wa" used to ,eicct the two parameters, within tumour :L~ 
well a~ normal ti,~ue, that coll1;lin the mo\t infomllltion. The,e 
parameter'> were TmaXm,L'\_, _, and T90k " TmlLWI/H' is defined a, 
the highe,t temperature mea'>ured for each heat ~e"illn ,tnd, for thi~ 
an<J.Jy'ih, the average of the,>c highe,t temperatures was ~eleeted. 
TYO i, cakulateu frum the Gau\\ian di,tribution of aft tempaature 
mea,uremelll\ during e~~'h heat treatment, ,In~'r the heating-up 
pha,e of 10 min, and n!prc'ent\ the value above which 90'J. of all 
rnL'a,urement\ were oh'en'ed. The T90,." i\ the TYO from the treat-
ment \e ... ,ion during \~hich the highe,\ \,;tluc \\'(.l\ achieved. 
End points 
Re,pon,e WiI, c,tablhhed ill the time of Ilw.\imum fegre,~ion which 
wa~ ob>efwd 1-14 (median 2) rlwnth, after ~tart of tn:,tlment. A 
complete n;,'pllmc (CR) i\ defined uccording to WHO nileda: dill-
ically a complete tumOllr rernh\illn, ob"rvcd twice wilh a time 
interval of at lea,t 4 week\, The dUfiltion of local control, in patient-. 
treated for mkrO'icopk tumour and in p"tient~ in whom il CR Wll, 
adlie\'ed, \\'a\ defined from the ~tmt of treatment till the first oh<,er~ 
valion of rfllgre~.,ion within the treated volum(', which i\ defiut'd a~ 
the volume to whkh mdiation wa\ applied. 
Acute toxidty ob'ierved can he di~tingui ... hcJ to re\ult from 
either RT or HT. Radiation-induccd acute toxicity include'i 
er),lhcrn:J (none, mild, nwtkrate or ~evere) and moi,t desquama-
tion, TIlemlal bum, include second and third degree hllm, in the 
Table 4 Complete tumour response and acute toxicity in relation 10 
trealmenl technique 
Complete response (macroscopic disease onlyl 
Max. tumour diameter 53 cm 
Max. tumour d;ameter >3 cm 
Local control (microscopic disease Included) 
Burns 
No or first degree 
Secood degree 
Third degree 
Subcutaneous 
Erythema 
None-mid 
rl.oderate---maf~ed 
Moist desquamation 
433 MHz 
technique 
n= 107{%) 
74 
87 
65 
76 
71 
19 
7 
3 
65 
35 
12 
2450 MHz 
technIque 
n" 27(%) 
58 
91 
31 
63 
33 
56 
11 
0 
59 
41 
7 
For bolh techniques, the dJlerence if) CR rate between sma!1 and larger 
tumours Is significant (p= 0.017 for the 433-MHz techn:que and P" 0.003 
for the 2450-MHz technlquo). The difference in CR rilte behHlen tile 11'10 
techniques is slgnif,cant for the large tumours (P= 0,024), 
,kin, and suhcut;!neou, bums. L;Jte raui;Jtioll to.\idty was ~l:orl:d 
for pigmentation, telangieet;J\is, ~ub<:uttm<:\)us fibrosis anu ulcera-
lion. Only ulceration\ ob,t'fvcd without per~i\tent or progr6sive 
tumour, and not nc,ulting from a thim degree Ihermal hurn, were 
a"l',\Cd :L'i re-RT toxicity. 
Statistical methods 
TIle p;tWI1lL'ters included in the cvaluation of jlft)gnmtil..' flll'ltlfs arc' 
li,tet! in Tallie 3. Thc I..'vulU;Jtion offactllr" a,~()ciated with CR wa'i 
re\trkted to the 111) patient-; with macroscopic tumour. Palients 
trl..';ttcd after irradical re,'><x:tion of recurrent tumour wen' included 
in the analy,,>i~ of local tumour eontn)!. Pearson's di~.~quared te~t 
wa~ u,l'd to determine which pammeters were il\sociated with CR 
rate nr acute toxicity I..'au,ed hy the treatment. Cox regres,ion, 
univariate tl~ well a\ multivariate, was med to inve,tigate which 
variahles were n~,ol..'iatcd with duration of ItK'al control. 
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Figure 1 Duration 01 local control In relation to technique used fOf delivery 
of hyperthermia: 2450 MHz or 433 MHz, Actuarial local control rates at 1 and 
2 yaMS are 44~~ and 33% for 2450 MHz and 54~:' and 47~~ for 433 MHz 
respectively (Iog·rank test p= 0,05) 
RESULTS 
Complete response and dUration of local control 
The follOW-lip time for all patients varied from I In 76 months 
with a fill'uian nr 21 monlh~, Five patiL'llb died within 4 weeks 
aner the 11I'i! treatment, :mu three patients were 1m! to follow-up of 
the locally Ir..caleu area becau~e of tumour progIT~~ion outside the 
treatment volume for which Ihey wcrc treated in another ho~pital. 
111e,e eight formally non-evaluable IXltienls were included as non-
complete re~ponder.~. A CR IVa\ ob~em:d in 84 out of 119 (71'}.) 
of p<Jtients with a macro~d.:opil: tumour. The prohahility to w.:hieve 
a CR appeared higher for patients treated with the 433~11Hz tech-
nique (74~O than {or those treatl'd with the 2450-l\fHz technitlUe 
(5S~}) (Tahle 4). 
In 2M~ (1/ = 35) of all patienh, locul tumour control wa~ not 
achieved. Within the group of l}9 patients with CR, or treated llftl.'r 
micn).\copil'ully incomplete re'iection, in-field tumour regro\\1h 
was ob ... eTved in 36. after a follow-up time of 2 month" to 5 years 
(median II month,), The mcdian overall .'iurvival in thl.',e patients 
1\',)\ 20 month~. TIlirty-~ix patienh have dil'd with local tumour 
control after a Jlh'tHan ~ur\'i\'al of 15 months, wherea' 27 patients 
are ~till alive with local tumour control after a follow~up period of 
5-76 months (median J I mOll1h,). Overall, the median duration of 
local control, censored for Jeath, is 32 month". 
Thl.' Tlll.'dian overall sun'ival time for thl.' whok group of patient, 
i~ 21 Illonth,. In the 99 patient~ in wholll local cnntm] WllS 
achieved, thl' median overall sun' ivaI is J I months. 
Local tumour control In patients with microscopIc 
disease 
Fitieen patient~ with mil'ro,copic di,ea,e after in..:omplete e1(cision 
\\W~' <til trcated with the planned re-Rr of eight f!action, of 4 Gy. 
Three ofthe~e patienb wac treated with the 2450-l\Ulz technique. 
Tn all three patients, in-field tumour regrowth W,L, oh<;en'etl 10--12 
months ufter the ~tart of trl'atment. In the 12 patienh treated with 
the 43J-l\IHL te~'hnique, in-field tumollr regrowth wa~ ob\er\'ed 
only twice, 10-13 months after the start of treatment. Thrl.'l.' patients 
have died with local tumourcontml after 4--1 6 (median 10) month, 
and ~even patients are still alive with local tumour control after 
16--70 (median 42) month,. TIle differen..:1.' in lora! control proba-
hility bctween the two tel'hnique~ is signitkant (P < OJl1). 
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Figure 2 Duration 01 local tumour control in relation to tumour Sizo: 
maximum tumour diameter.'03 cm compared \\ith >3 em. Actuariat tocal 
control rates all and 2 years are 69~;' and 57~:' for smaller tumours and 
36% and 33~;' for larger tumours respectively (log-rank test P", O.OOOt) 
Acute and late toxicity 
The skin reaction re,ulting from re-RT was moderate to marked 
erythema in 48 patient~, ..:ombined with moist desquamation in 15 
patients. In g6 patients, the skin reaction wa, Ie,,, severe. 
Thermal bum, develuped in 49 patients. In threc patienh, all 
tre'lll.'d with the 433-l\IHz technique, these were located suhcuta-
neously. There wa~ a remarkably lower number of second and 
third degree thennal bums in patients treated with the 433-I\IHz 
technique (27<;'c.), compareJ with the patients treated with the 
2450-MHz teehnitlUe (67%) (Table 4). Second-degree bums 
gl.'nerally healed within 2 month" without treatment. TIlirJ-degree 
hurll'i required 4-6 months of collSl.'rvative treatment to heal. As 
these bllms prderably develop at site" of lirniteJ sel1'itivity, they 
generally caused minimal symptoms. 
Clinically rdevant late toxicity was observed in a minority of 
patients. Part of the late effects of RT had been present before the 
start of the comhined treatml.'nt, be~'ausc of thc prcvious radiation. 
Moderate pigmentation W;L~ observed in three patients. moderate 
tclangiecta..,is in three, and ~ub":lItaneous fibro~is in 19. 
UkeratioJl~ were found in 14 patients, nine of whom had this 
ulcl.'ration at the tumour site hefore treatment. Ulceration without 
persistent tumour was pre,ent at la~{ follow-up in fil'e patients, In 
three of the~e P'<llicnlS, Ihis was at the site of a HT-induced hurn. Tn 
two patients, the ulceration re~ulted from radiation damagl.': one in 
the axilla where at the ~tart of the eomhined treatment severe 
!l.'!angiel'la~is wa..~ pre,ent hecau<,e of prel'io\l~ irradiation with 
50 Gy, and a second in a patient {re:lted for an ulcerating tumour in 
the intad brea~1 who h:ld .'eYere fibftlsi~ bel'au~e of previous RT 
(00 Gy). Bone Jlecm~i~. fracture or brachia! plexopathy were not 
ob,erved. 
Prognostic factors 
Influencing complete response and duration of local control 
Thl.' probability of achieving a CR dl.'l'rCa~ed if patients had bl.'~'n 
previou<;ly treated with chemotherapy (P < (WI) or hormonal 
therapy (P < 0.(2), had larger tumour voltlml.'s (I' < 0.01) and had 
larger maximum tumour diamcters (P < (l.OOI). Further, the CR 
rate inl'fl.'a~ed with higher Tmaxm,lx
ru
, in nOn1wl tissuf> 
(P < O,(~). Neither thl.' T90t-;_, values, for both nomlal (P = O.62) 
and tumour tis~ue (P = 0,:\0), nor the Tmaxmax
L
-,,-, in tumour 
tissue (P = 0.29) ,howed an a~~oeiation with CR. 
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Univariate Co~ regre,\ion WlL~ used to Ikknllinc iactors that 
\wn.' of intluence to nmtinu(lu~ duraliun of local contr~lL Fadors 
intluencing local contw! negativdy were previous chemotherapy 
(P = (J,O]). ;\ higher number nf le~ions (P "" OJ)2), a hlrger tumour 
vnluille (P ;=: ()'oI) and a larger maximum tumour diameter 
(/' < (WOI). A higher tumour T9(t" (1'= (W2) and a higher nonl1al 
tis,ue Tma\!1llL'\,-c_, (P =O.()2) improved local control duration, It is 
to be noted thill in the univariate Cox regres,ion there was no 
,ignificant difference in localnmtrol hetween p;lIients treated with 
2450 MHz and 433 MHz equipment (/' = (J.()S). 
All p;\nml~lers significant in the univm;.lIe regre~sion were 
te,k'd in the multivariate analysi\, which further inchakd HT 
technique. The multivariate Cox regression arHlly~i~ ~howed that 
tumour ma~imum diameter, divided into twu d;L~~es (S3 cm and 
>3 cm). app.:ared to he an independent, significant (P < (l.OOI) 
item with regard tn ilJL'al control. and thill 433 MHz e1luipment 
performed better than 2450 i\U/.lcquipment (P = 0.0-16). None of 
the otha factor~ wa~ ~ignificantly a~~ociateu with local control. 
Figures laud 2 show the pef\:entage~ of local control for 
2450 i\1H.l compared with 433 r>.fHz equipment, and maximum 
!Umuur diameter ~ma[]er than Of equal to 30 mm compared with 
larger than 30 mm. 
Influencing Iwperthermia damage 
TIle only par,lmeterinf1uencing risk of burn;:. WlL~ the technique u,ed 
for delivery of HT. Univariate logbtic regre,~ion ~hO\wd that 433 
MH7. treatments cau~ed much les~ acute damage (P < 0,0(1) than 
2450 MHz treatmcnL~. Neither til\.' T'}0r-."" nor the Tm;L\max""_l 
thernwl do,\, parameter .... for both nnnnal illltliumour ti~~ue influ-
encl'd hyperthennia-induced damage (P-values varying bet weco 
OJ') and 0.52). None of the evaluated parameters wac ;L<'\ociated 
with bite damage. 
DISCUSSION 
Treatment with a radiation do~e of only 32 Gy in combination with 
hYPdtl1L'rmia resulted in a complete re,pon~e in 71% of the 
patients with rt1acros~'opic tumours. With RT alone at dose'i of 
3(),--4() Gy, CR rate, varying from 2()~~· to 48'7(· have been reported 
for bre:L'>I cancer (van def Zee and \\'rnon, (990). TIle ~amc RT 
~chcdule of eight fraction, of 4 Gy without HT has been applied 
in the RTGa 81-0-1- ,tud)', resulting in overall 26~'ro complete 
re,ponse (Pef\.'.ll.'t ai, 1989). Ikccntly, the contribution of HT to 
the re,(llt of the combined treatment has been cnnfirmed by a 
randomized ,tudy (international Collabnrative Hyperthemlia 
Grnup, 1996). Within the ESHO 5-SR. wrnparing re-RT alone 
(,<1111e ,chcdule a, applied in the pr6ent study) with f\.'-RT plu, 
11'1'. the CR rull' after combined treatment Wil~ 78%, which wa~ 
~ignifk<lntly higher than the JW.'r, CR after re-RT alone, This 
nllldomi7ed ,wdy al'io denwn~trated that the difference in local 
contml i, duwhle. 
Wl' do not e:\p\'l'1 that a locally L'llIltrolled che.'twall rl'currence 
w ill intluenc~ nvefilll ~ur\'i\'al. Ne\'er1hel",~s, the ab~ence Ill' ,yrnp-
t0111atic local tumour can re,ult in an improvement in IIUlllity of 
life (Liu et nl, IY96). When a CR h,L~ been <lehkved, the median 
dur,lIion of lo(al control was 32 month,. In 27r;{. of all patienh, in-
field tumour n:growth wa~ oh~\'r\'Cd after a median follow-up time 
of II 111onth~. TIle median o\'efill! ,urvival lime in this gfl)up of 
patil'nt~ \\'a, 2() months, which m\'ans that the local palliation wa~ 
l1111intainell for half of the remaining life ~pan. 'I\venty-se\'en pl'r 
cent of the patienh have died withuut IrKal tumour regrowth, after 
a median follow-up timc of 15 month" whaeas 20% of the 
patients wac-free of local disea,e at la'>1 follow-up after a median 
follow-up time of 31 months. 
TIlerefore, the effect of th'" treatment i'i worthwhile for the 
majority of patients, where;L~ the treatment causes limited incon-
venience. 'Inc o\'erall duration of u treatment serie~ is 3.5--4 
week;;, during which periud patients come to the h05pital twice 
weekly for around 2 h. TIle HT treatment is generally well toler-
ateu. During treatment, patients were in~tnlclcd to report pain 
immediately: in fact this 'whjedive themlOmetry' is a very impor-
tant parameter in treatment control and should nol be considered a 
side·effeet of HT. TIle inter.~titiHI cath\'ters for thermometry gener-
ally do not cau~e rekvanl problem~ (yan der Zee et ai, 19X7). 
111e ~ide-cffc(·ts of the treatment arc tIcceptahle; the HT-indul'ed 
bums generally cau~", no pain because of their occurrence at sites 
nf decreased ~emitivity. Side·",ffl'd~ other than thennal bums 
\\WC no different than thm,e e:<ipected from re-RT alone. i.e. 
el)1hel11a and, in about Hl% of the patients, moist de'quanwtion. 
Clinically relevant treatment-related late to:\icity was ob,crved in 
only five patient~, with ulceration due to either HT nr RT toxkity. 
The indication to offer combined treatment to patients after 
incnll1piele re,ection of their recurrence was similar to that fnr 
patients with macroscopic \11111O\lr~: the safe re-RT do,e i~ inade-
quate for tumour control. For achievement of high local control 
rates with eiL'ctiv~ radiation, a dose of about 50 Gy in 2-Gy fra~'­
tiuns is required (Htldwinek et ai, 19)0;11/: Wither~ 1'1 ai, IYI)5). OUf 
re~u1ts in this ~ubgroup demolhtrate that additional HT at an 
,1Ikqll:lte level i~ beneficial for the,e patient~, Although the 
numbers are ,mali, thc percentage of patient~ treated with the 433-
MHz tel'hnique in who111 IlK,1I control wa~ maintained i~ ~ignifi­
eantly higher (,()111paR'u with patients treated with the 2450-MHz 
technique. 'fhb difference cannot be explained hy a hetter paticnt 
sekl'lion. A compari,nn of the time interval b",t\wen the primal)' 
RT and re-RT between the 2450-i\1H.l antl 433-r>.IHz technique 
group., ~huwed nn difference. Another indication of a beneficial 
effect of HT in miero,copic di.~ea...\e h the pfevioll, observation of 
re-recurrenl'es in five patients in which HT was app!ied to the 
maefl1~copk tumour ol1ly, within the re-RT-alone part of the 
treated area (van dcrZce et a!, (992). 
The r\',ul!;:. achieved with the 433-MHz technique ilR' rcmark-
ably better than tho,\, aL'hieved with the 2450-MHz technique, 
Multivariate Cox regres~ion of pmgno"tir paramder.~ ,hmwd onl), 
t\\'o parameters tn be n,'ociatcd with local control uumtion. i.e. 
tumour ~i~{' and HT tcchnique, TIle lldvantage of using 4.ll r>.11I.l 
or, in tWo ca\e~. lower frellllcnl'ie~ instcad of2450 r>.IH.l is tlwl with 
the lower freq11l'ndl's the penetration depth, and thereby the heated 
volu111e, is larger, which can b\' c:..pel'tcd to re,ult in an mkquate 
temperature incre,j\\, in a larger parI of Ilk' tumour volume. 111e 
impw\'em\'nl in temperature di"triblltion cannot be deduced from 
the thernlal dose par.lmetl'r>. calculated, which may bL' e:>.plained by 
the higher number of intratumour k'l11pcrature mell"uremenh with 
the 43J-MHz technique comparcd with the 2450-MII.l technique 
(van der Zee et ai, 19Y3). TIle i111pfOwment of roults with the 
better heating tcchnique in tumours with a mw..:i111ulll diHl11eler of 
>3 em under.,core., that it is important to u'"\' a ICl'hnique from 
whkh one can expect udequute ti"'11e heating. In fact. the 31 '}. CR 
rat\' achieved in the Inrga (;:>:3 em ma:<ii111U111 diameter) tumours 
with the 2450-i\lHz technique is not different frclm the CR rates 
found after re-RT alone with the ~ame treatment ~('hedl1lc, i.e. 26r;~ 
(Perez et ul, 1989) and 3XQ, (lntemational Collaborative Hyper-
thernlia Group, 1996). The impl)rtance of hyperthemlia tfl'iltmcnt 
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technique ha~ been pre\'iou~ly ~hown by Myerson et aI, (1990). TIle 
re~lIlts of the ~tudy presented here have shown that there is room for 
further improvement. In patients treated with the 4J3-MHz tech-
nique, the CR rule of fi5% in patients with larger tumours is still 
significantly lower [han that for patients with smaller tUIllOU~. We 
~pcculatc thai when optimum HT k\:hniqucs will be uvailable for 
all tumours, the ovaall CR rate may reach a value of about 90%. 
The dccre,L~e in HT-relatetl toxicity with the usc of the 433-l\IHz 
technique is another welcome improvement. Although blisters lind 
third-degree bums generally do not re,ult in relevant clinical proh-
le1l1~, becilu,e of the fact that these develop at sites of tko:rea,ed 
~('[l~iti\'ity, it is preferable to avoid buch side-effects. The most 
likely e.xplanatiun of the lower numher ofhum~ with the 433-MHz 
technique is the hetter contml of buperficial tcmperatures by the 
perru,ed water bolus. 
This study allows a few mure amwers to clinically relevant 
quest rom, which have to be precautious in vrew of the retro,pec-
tivc character of the ;:Hlaly . ,rs. In the fir~t place. it has b('en 
sugge";(ed that local thl'rllpy for recurrent hrea~t cancer should be 
an:ompanied by sy;;temic therap)' (Kapp, 1996). It has becn shown 
that systemic treatment after local treatment significantly 
improvt'd dbca..~c-free survival, hut had no impact on overall 
survival (Borner et at, I 99-l). In our ~tudy. continuation of 
chemothl'TiIPY during the tocal treatment series was not alluwed, 
bUI in IX patients with m.Knhcopil' tumours hurmonal therapy 
wa, continued. The CR rate in patients cnntinuing hOnllllnal 
therapy Wa.., (not significantly) higlK'r than in the remaining 
patienh: R9% compan_'d with 67~1 .. However, the ri,k (11' selection 
bias in this compari,on is 01wiou,: 75% of the patients continuing 
hormonal therap)' had ,tarted this more than 2 month, previou'ily, 
indicating that the therapy had beneficial effects. ThL'~c patknts, 
therefore, may repre'ient a Mlbgwup with a better prognosis. 
SeL'ondly, tumour l'xtcn~ion in depth is cOJ1.,idered a very impor-
tanl ,ek .. ·tion criterion for ~uperficinl hyperthcmli:l. We now 
'.H.Tept patients with tunwur.; lip to 4 cm maximum depth for treat-
ment with 433 ;\IHz. In this "tudy, there were 13 p;lticnb with 
deeper tumours. T11e CR r.lIe in the,e patients of 62% is not signif-
ic<lntly lower thiHl the 72c;{. in Ihe remaining patienh, and appears 
higllL'r than observed after RT alone. Thi, may bc explained by the 
eX"'eption~ that we have allowed to the maximum 4-clll depth 
criterion. 1 he,c wert' tumours with overlying ~lIbl'lItaneous fat, in 
which less energy is ah~nrbed than in ti~sue'i with a high wat~r 
content, and 'phL'rical tumour.; protruding ahove the ,kin burface, 
in whkh accumulation of energy from the various applicators can 
be expected at depth and in which the depth may deerea'ie during 
the treatment period when the tumour regr6sl's. A third clinically 
imp0l1ant que~tion is whether the eight ffacti(ln~ of 4 Gy plu~ HT 
,cheduk can be applied after previou'i RT, up to a tutal dose of 
60 Gy or more. In our material, the CR mte of 50';{. in a suhgroup 
of eight ~uch patIL'nh 'L'emcd lower than the 7M}. in the remaining 
patients, and a persistent uker developed in one patient. FUl1her, 
this subgroup appe.lred tn have a relatiwly "llOrt remaining life-
time compared with the other patients. Nl~\'erthcless, the 50c;{. 
chan"'e to achieve a CR may be worthwhile, depending Oil the 
sympt(}m~ of local di,ea,e and survival pmgnosis. 
CONCLUSIONS 
This study has ~hown that with the combination of rc-RI~ eight 
fr'lctions of 4 Gy in <\ weeks, and liT ~UL-ccssful palliation of local 
tumour recurrence of a worthwhile duration can be achieved in thc 
Chapter 2 
majority of patie-nts. In uddition, this treatment is wcll tolerated 
with acceptable toxicity. In The Netherland~, this com hi ned treat~ 
ment is btandard therapy offered to patients with !ocoregional 
recurrent hreast cancer in a previou'ily irradiated ~ite, providing 
that an adequate heating equipment is available. This ~tudy hilS 
also shown that the hyperlhemlia treatment tecl1l1i(llle is important 
for clinical ou\(ome. The development of better HT trcatment 
techniques, enahling a more effedive treatment of larger tumours, 
deserves further investigations. 
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PRACTICAL LIMITATIONS OF INTERSTITIAL THERMOMETRY DURING 
DEEP HYPERTHERMIA 
lACOnl\ VAN DER ZER, M,D .• PH,D,. JACQUELINE N. PEER-VALSTAR, M.D.,~: 
PAUL 1. M. RIETVELD, M.Sc., LUCYNA DE GRAAr-STRUKOWSKA, M.D. AND 
GERARD C. VAN RIIOON, PII,D. 
Department of Radiation Ono:o!ogy, Subdivision of Hyperthwnia, Univer~ity Hn~pital Rotterdam/Daniel den Hoed Cancer Center, 
Rotterdam, The NClheriands 
Purpow: IntrafullIor thennomclry during hn)crlhcnnia treatment Is considered importnnt for seve-ral rca.~on.~. 
The morbidity that we {'xIl£'rienced from interslilinlly placed catheters in dccp-scait'd tumurs gave reason to 
weigh the udnmtages and dislldnllliliges IIgalllit each other. 
Methods und i\laterials: The ayailahle thermometry In 215 patients treated with h)'flerthermia for deep·st'ated 
fliilio·rs· WR'i mHllped wHh the aim to enlluale practically feasible Intrlltul1lor mea.surt'ments. The innuence of 
intrafulllor measurements on the treatment procedure was assessed. 
Results: Total 120 catheters were placed Interstitially in 78 patients. Over the years, the percentage of patients 
\Iith interstitial thermometry decreased corulderabl}', Forty·nine catheters could remain in place during the 
whole hyperthermia treatment series. The remaining cathders had to be relllowd for more or less senre 
complications, including olle fatal event. In fact, the interstitial catheters calLwd the most .sen-re treatment· 
related morbidity. During 188 of the total 859 treatments, at least olle interstitial catheter was uvullable for 
thermometry. Per treatment with cathl'ler(s) ;11 sitll, the awrage Ilumbe-r of ilitralUllior measurement sites was 
6.9, The yaille of interstitial thermometry fOl' power steering dllring treatment, to both optimize intratumor 
temperature distribution and prewnltoxicity, appeared limited. The mean \'OluIl1e of the tumors \\HlI interstitial 
thermometry was 314 1'111'\ SD .\25. In relation to the large tUlllor Yolumes, tlU' thermal dose parameters 
calculated from the unllluhle datu is COllsillered to be of limited value. 
Conclusion: In \ie" of the possiblc sCYere cOlllplicatiuru ;lnd the limited dinical ,'alue of the information achlewd 
~-;-ilijcrsffiially placed Ihcl'Inollletry catheters, interstitial thermumetry \HiS not found to routinely belle lit tlit, 
indhidual patient. © 1998 Elsel'ier Science Inc. 
Deep h)'llerthermln, Intratumor tht'rmumeiQ', To~icity, 
INTRODUCTION 
Intratulllor thermometry during hyperthennia treatment is 
considered important for .'ieveml reasons. The RTOG quul-
ity assurance guidelines recommend the use of at least one 
interstitial catheter, and preferably three in directions per-
pendicular to each other (I), The aim of interstitial ther-
mometry is to verify the delivery of hyperthermia dose 
distribution, to allow calculating retrospectively the applied 
thermal dose, and to prevent toxicity. In our experience with 
clinically applied regional deep hyperthermia, interstitial 
thermometry in deep-seated tissues is the cause of the most 
severe treatment-related morbidity, as has been reported on 
previous occasions [(2, 3); Van der Ploeg et til., personal 
communication, 1993; Peerel al., personal communication, 
1995]. Over the years, the number of patients treated with 
*Current address: R:Jdiotherapy Institute Limhurg, Heerlen, The 
Netherlands. 
Reprint reque'its to: J. van der Zee, MD., PhD., Department of 
Radiation Onco!ugy, Subdivision of Hyperthermia, Unive~ity 
interstitially placed catheters decreased, In this artide, the 
experience in the nr.~t 215 patients treated for deep-scated 
tumors with the BSD-2000 system is presented, The pros 
and contras of interstitial thermometry arc discussed, and 
the absolute and relative contraindications listed. 
METHODS AND MATERIALS 
Patient,I' 
In the period June 1990 to June 1996, a total of 215 
putients were treated with the BSD-2{)OO system (4) for 
deep-seated tumors. Tumor types include rectal cancer (II "'" 
113), uterine cervical cancer (II = 56), urinary bladder 
cancer (II = 26), and various other tumor type.s (II = 20), 
mainly sarcoma. Patients were treated with hyperthermia in 
addition to radiotherapy or chemotherapy (Table I). Radio-
Ho~pital Rollcrdam/D.miei den Hoed Cancer Center, Gruene 
Hilledijk 301, 3075 EA Rotterdam, The Netherland~. 
Accepted for puhlication 25 Septemher 1997. 
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Table I. Patients with interstitial thermometry related to tumor location and .~tudy 
Number of 
Removed after Interstitia! treatments if all 
Interstitial Number of number of thermometry with interstitial 
thennometry treatments~ treatments all treatments thennometry 
Number 
of patients Nu Yes Range (Mean) Mean (Range) No Yes Range (Mean) 
Rectum 
+RT,t Phase 1II 63 47 16 2-5 (4.2) 1-4 (3) 13 3 1-5 (3.3) 
+RT, outside studl 8 0 8 1-6 (3.3) 2-2 (2) 2 6 1-6 (3.2) 
+reirradiation (40) 
or intmarterial 
ehemo (2) 42 18 24 1-4 (3.1) 0-3 (2) 12 12 1-4 (2.4) 
Cervix 
+RT, Phase III 29 24 5 1-5 (4) 1-4 (2) 3 2 1-4 (2.5) 
+ RT, outside study 9 4 5 2-5 (3.8) 2-3 (2.5) 2 3 2-4 (3.3) 
+chcmotherapy 18 17 I 3 I I 0 
Bladder 
+RT, Phase III IS 17 I 5 (] I 5 (5) 
+RT, outside study , 4 4 3-5 (3.8) 2-2 (2) 3 I 3 (3) 
Variuus 20 6 14 1-5 (3.6) 1-3 (2) 7 7 1-4 (2.9) 
'" Only the number of treatments in paticnts with inten.titial thermometry is given. 
t RT = radiotherapy. 
t Outside study: either treated within the pilot study preceeding the Pha~e ITI study (four patients in each tumor location group), or 
hyperthcrmia indicated by expectation of insufficient results frolll mdiothempy alone. 
therapy and hyperthermia wa~ given to patients randomized 
to combined treatment within the Phase III study on inop-
erable rectal cancer (primary or recurrent), cervical cancer 
(FIGO Stages lIB-distal, IIIB and IV), and bladder cancer 
(Stages T3-4NOivlO). Further, this combined treatment was 
given to patients with recurrent rectal cancer in previously 
irradiated areas, and to patients with other types of advanced 
tumors for whom radiothempy alone was considered inad-
equate. Combined chemotherapy and hyperthermia was 
given to patients with recurrent cervical cancer in previ-
ously irradiated arcas, partidpating in a Phase I-II study on 
the effect of weekly cisplatinulll and hyperthermia. Patients 
received aile to six (mean four) deep hyperthermia treat-
ments, to a total of 859. 
Technique of catheter introductio/l (flld fixatio/l 
Catheter placement was planned at least 1 day before the 
first treatment. For each patient, a CT scan was either 
available at referral, or made specifically for deep hyper-
thermia treatment planning. When interstitial thermometry 
wa" not contraindicated by other factors, it was decided 
during CT scanning whether catheter introduction wa~ pos-
~ible. The criteria for decision to place interstitial catheters, 
a~ developed on the basis of experience over the years, are 
listed in Table 2. During CT scanning, the fIrst step was to 
mark the skin at the site(s) from where catheter introduction 
nppeared possible. The puncture site, and the angle under 
which the catheter should be im.erted was selected. Follow-
ing sterilization of the insertion area with 0.5% chlorhexi-
dine in 70% alcohol and covering the area with sterile 
sheets, the insertion site was anesthesized with 2% procaine 
hydrochloride. Thereafter the needle, with an outer diameter 
of 2.1 111m nnd a total length of 18-23 cm, was introduced. 
[<"Iost catheters were placed transgluteal. After the needle 
had reached a depth of 8-10 Clll, a control CT scan wa~ 
made to verify insertion angle and depth (Fig. 1). If the 
insertion angle was currect, the needle was introduced fur-
ther to the opposite tumor margin. When the patient indi-
cated pain, not disappearing after interruption of pushing 
the needle, a slightly different angle was ehmen. The final 
direction of the needle was documented by CT scan. After 
completion of insertion the polyethylene closed-tip catheter 
(Willimn Cook Europe ApS, Denmark, outer diameter 1.6 
Illlll) was introduced through the needle. The catheter was 
Tahle 2. Criteria for ded~ion to place a catheter 
Cuntraindicatiun~ before availability of CT scan 
Usc of anticoagulants 
Pree:dsting radiating pain 
Preoperative treatment of ret·tal cancer 
Puncture ~ite not acre~~ible Juring CT st'llllning 
Spontaneous absolute refusal by the patient 
Contraindications on CT scan 
Risk of Jlenetration of bladder or bowel lumen 
Tumur lucatcd behind bune 
Tumor too small to get at least two intratumor mea~uring 
site~ 
Intratumor area of necrosis 
Discriminatiun betwcen tumor ami nunnal tissue not well 
possible 
Catheter fixation not pos~ible 
Catheter introduction only possible under a steep angle to the 
skin 
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Fig. 1. Procedure of CT-guided catheter introduction. 
protected from kinking by a nylon rod. TIle catheter was 
Ilxed by Histoacryl (B. Braun, tvtelsungen AG, Germany) 
and Tcgadcfm transparent dressing (~\'Iedical Products Di-
visionl3ivI, USA). First, an adhesive was amply placed over 
the puncture site. The remaining part of the catheter was 
curled up and, within a gallze, attached to the skin around 
the puncture site by another adhesive. This procedure al-
lowed reaching the exterior part of the catheter while leav-
ing the insertion site t:Overed. Patients were instmcted to see 
a doctor in case of increasing or otherwise severe pain, or 
fevcr, and were given an informative letter for responsible 
physicians outside the subdivision of Hyperthermia. 
Thermometl)' 
For thermometry, Bowman probes were available. These 
were calibrated once daily. Before each treatment, the 
probes were pulled straight in a current of hot air and 
sprayed with silicone to optimize the conditions for map-
ping within the catheters. Before each treatment, the patient 
W,IS questioned about recent history of either local pain or 
fever. In case of fever, other possible causes such a" nladder 
infection or pulmonary infection were excluded. The inser-
tion site was inspected, the invasive length of the catheter 
veritled, and the direction of the catheter derived from the 
form of the nylon rod. In case of symptoms of local inFec-
tion, or pain, that \\'as nadly tolerated by the patient (e.g., 
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causing sleeping problems), it was decided to remove the 
catheter after the treatment session. Patients were positioned 
supine. Before and after filling the water bolus, the fea."i-
bility of thermal mapping wa" tested. In case of distur-
bances, any possible cause of obstmction was corrected for, 
when possible. During treatment, thermal mapping was 
perfonned every 5 min; the step size was 1 em. 
Standard treatmellt procedllre 
Pati~nts were lightly sedated with 1 mg lorazepam. Fol-
lowing preparations, heating was started with power output 
at 400 Watt. Patients were carefully instructed to mention 
any unplea~ant sensation that might be the result of a hot 
spot, sllch as a burning sensation, a feeling of pressure, any 
pain, or bowel or bladder spasms. The treatment settings for 
frequency, amplitude distribution, and phase shifting at the 
start of the first treatment were chosen on the basis of the 2D 
pretreatment planning provided with the BSD-2000 system. 
Thereafter, treatment settings were adjusted depending on 
either information from E-field measurements or tempera-
ture distribution. Information on temperature distribution 
callle from both intraluminally and interstitially placed ther-
mometry probes, and from the patient. Any pain mentioned 
by the patient that disappeared within 1 min following 
power decrease was considered to indicate a too high tem-
perature, and the treatment setting,~ were adjusted to de-
crease power input at the specific location. Adjustments of 
treatment settings could be either changes in power output 
per channel, frequency or phase settings, or placement of 
additional water bolusses, Power output was increased to as 
high as the patient could tolerate without pain. Treatment 
duration was standard 60 min after any of the interstitially 
measured tumor temperatures had reached 42°C, or maxi-
mum 90 min. In cases where the intratumor catheters had to 
be removed before the last treatment, the time needed to 
reach 42°C averaged over at least two previous treatments 
with interstitial thermometry was chosen for subsequent 
treatments. 
The course of each treatment wa~ discussed within the 
clinical staff and the treatment settings and speciJic adjust-
metHs for the subsequent treatment selected on the basis of 
the previous experience. 
RESULTS 
Nllmber of interstitial catheters 
One to three catheters were placed interstitially, to a total 
of [20 catheters, in 78 of the 215 patients (36%) treated for 
deep-seated tumors (mean: 1.54/patient). Over the years, the 
percentage of patients with interstitial thermometry changed 
considerably. or the first 40 patients, treated in the period 
June 1990 to January 1992,36 (90%) had interstitial calh-
eters. Calculated over the first 50 patients (until June 1992), 
the percentage was 80%. In the second (June 1992 to 
October 1993) and third (October 1993 to January 1995) 
groups of 50 patients, the percentage decreased further to 44 
Interstitial thermometlJ! in deep IU1Jerthermia 
Table 3. Availahle intraluminal thennometry 
Patients with interstitial 
thenl1ol11e!ry (II = 78) 
Patients without inter.-;litial 
themlOme!ry (1/ = J 37) 
Number of 
intraluminal 
catheters: 
3 
2 
I 
() 
3 
2 
I 
0 
I, 
female 
24 
12 
2 
78 
8 
2 
I, 
male 
18 
22 
34 
14 
I 
and 20%, respectively. In the last group of 65 patients, 
treated in the period Jmnl<lry 1995 to June 1996, the per-
centage of patients with interstitial catheters was only 9%. 
The tumor volume in the group of patients with interstitial 
thermometry ranged from I to 1562 cnr" with a mean of 
314 cm.1 (SO 325), the average tumor maximulll diameter 
heing 98 mm. Of the 113 patients with rectal cancer, inter-
stitial thermometry was available in 48 (42<70). This percent-
age was lower for cervical (II of 56; 20%) and bladder 
cancer (5 uf 26; 19%), and higher for patients with other 
tumor types (14 of 20; 70%). In four additional patients, a 
catheter could be placed within the tumor through a tistula 
before each treatment, and in one patient, an intrauterine 
catheter was intruduced before the first, treatment. Forty-
nine catheters remained ill situ until the end of the last 
hyperthermia treatment. The 78 patients with interstitial 
catheters received a total of 287 treatments. During 188 of 
these treatments (66%), at least one interstitial catheter was 
available for thermometry. Besides catheters introduced 
into depth, 69 catheters were placed subcutaneously in 49 
patients. After experiencing that the temperature measure-
ments achieved from these catheters gave never reason to 
adjust treatmcnt sctup, the use of subcuntaeous catheters 
was omitted. 
Nllmher (!t intralumino! catlll'lers 
In the n patients with interstitially placed catheters, one 
to three (mean two) additional catheters could be placed 
intraluminally (Table 3). Catheters could be placed within 
the urinary bladder in 73 patients, intravaginal in 38, and 
intrarectal in 46 patients. In the 137 patients without inter-
stitial catheters, one to three (mean 2.4) catheters could be 
placet! intrahnninally in all but one. A catheter was placed 
in the bladder in 132 patients, in the vagina in 86 patients, 
and in the rectum in 110 patients. 
NlIlI1her of illferstitial fIImor therll/omctry siles 
By multiplying the number of catheters with the number 
of treatments that these were ill ,\'itll, the total number of 
interstitial catheters in situ during 188 treatments was 282. 
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Table 4. Morbidity from interstitial catheters 
Suhcutaneous infection 
Into1emble pain 
Deep infection 
Abcess formation 
D<'ath due to sepsis 
Arterial bleeding 
Venous bleeding 
Spontaneous loss outside the body 
Spontaneuus displacement tu inside the body 
Continuous loss of tissue Huid 
Tumor growth along catheter track 
Catheters 
25 
23 
16 
2 
I 
3 
I 
4 
2' 
" In one patient, the catheter had disappeared completely. Its 
intnlpdvic location was later cunfimled by diagnostic x-ray. 
t In two patient~ this wa.~ confimled histopathologieill1y; in une 
patient tumor growth wa~ strongly suggested by the clinical ap-
pe<lmnce. 
Sixty-five times (in 23<70 of the cases) it was not possible to 
Illap the thennometry probe within the catheter. From 18 
catheters (6%), no information on tumor temperature could 
be derived. This was either due to spontaneous displace-
ment, to kinking, or to failure to place the catheter within 
the tUlllor during introduction, for example, when the needle 
get stuck against a bone, or when the needle pushed the 
uterus aside instead of entering it. In 57 cases (20%), only 
one intratumor measurement could be derived from the 
catheter. This was mostly the result of failure to map the 
probe. Overall, the total number of intratumor measurement 
sites was 1291. Per catheter ill situ during treatment, the 
average number of intmtumor measurement sites wa5 4,6. 
Per tumor with interstitial thermometry during treatment, 
the avemge number of intmtumor measurements was 6.9. 
MorbillifY from illferslilia! cathelers 
Forty-three (36% of the total number) catheters, remain-
ing in place during 1-33 (mean 14.7) days caused no 
problems. Seventy-seven catheters caused some kind of 
morbidity, occlllTing after 0-26 days, mean 10 days. Cath-
eter removal in the Ilrst week after insertion (11 = 34) was 
done for morbidity in 74% of the cases. In week 2 (II = 47), 
week 3 (II = 18), week 4 or later (/I = 16) this was 73, 44, 
and 25%, respectively. A sllll1nHlry of the complications is 
given in Table 4. In 25 cases, the reason for catheter 
removal was a sllbculanaeolls infection. Subcutaneous in-
fections resolved after catheter removal without further 
treatment. In 23 cases the catheters caused pain of such 
severity that the patient experienced problems to sitting or 
sleeping. In 13 patients (16 catheters) a deep infection 
developed, despite antibiotic treatment resulting in abcess 
formatiun in two, and death due to sepsis in one. In this 
laller patient, the same bacteria isolatet! from the blood were 
found within the tumor. In three patients, one catheter 
apparently had penetrated through an urterial vessel, which 
hecame clear at the time that the catheter was remuved. Two 
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of these patients had experienced repeatedly considerable 
blood ims, which was reason to remove the catheter before 
the lust treatment. In the third patient, arterial bleeding 
occurred after the last treatment. In all three patients, bleed~ 
ing could be stopped by exerting pressure. In olle patient a 
venous bleeding, apparent immediately after catheter inser-
tion, could 1I0[ he stopped by exerting pressure, which was 
reason to remove it I h later, before the tirs! treatment. In 
three patients, all with progressive disease either during or 
shortly after thc treatment seric.~, tumor growth wa .. ob-
served along the track of the catheter. This Was histopatho-
logically confirmed in two patients with rectal cancer {Ihe 
history of one of these patients has been reported previ-
ously; (5)]. In one patient with recurrent ureteral cancer, the 
clinical appearance of a subcutaneously growing nodule 
strongly suggested tumor growth. Three of four catheters 
inserted through the perineum were lost. Two catheters 
disappeared to within the body; one completely (its intrapel-
vic position later confirmed by diagnostic x-ray), and one 
almost completely and was removed for that rea.~on. In four 
patients (five catheters) a continuous loss of iI considerable 
amount of tissue tluid, resulting in loss of adhesive cover-
ing, was observed. The thereby increased risk of infection, 
together with the impossibility to control the patient daily, 
led to the decision to remove the catheter. 
Rca.WJ/1S for 1101 pladllg illterstilial catheters 
The decision on placement, or removal before the last 
treatment session, of interstitial catheters wa~ very much 
influenced hy the experience acquired during the tirst years 
of applying deep hyperthermia. Patients with tumors show-
ing neaotic areas on CT scan appeared to have a larger risk 
on development of deep infection, unresponsive to antibi-
otic treatment. For patients with cervical cancer, it appeared 
diftkult to discriminate betwccn normal tissue and tumor 
tissue and further, insertion of the needle within the cervical 
tissue appeared not always feasible: the needle easier 
brushed the tissue instead of penetrating it. Furthermore, 
interstitial catheters in cervical cancer often cause a dull 
type of pain. In patients with preexisting radiating pain, 
caused by tumor exerting pres~ure on nervous tissue, the 
intratuillor catheter appeared to aggravate the pain. In cases 
where the catheter entered the body under a steep angle to 
the skin, thermal mapping often failed. This experience, 
together with the finding that the value of interstitial ther-
mometry wa~ limited with regard to improvement in tem-
perature distribution (see beluw), has led to increasing ac-
ceptance of applying treatments without interstitial 
thermometry. In the most recent years, the a\'ailability of 
two or three intraluminal sites for thermometry has eased 
the decision on not placing interstitial catheters. A list of 
reasons for not placing interstitial thermometry is given in 
Table 2. Ten patients used anticoagulants that could not be 
interrupted. Six patients were treated preoperatively for 
rectal cancer. In rectal cancer, implantation and growth of 
tumor cells in damaged tissues is nol hypothetical, and it 
Chapter 3 
was agreed with the surgeons that inter~titial tliermometl)' 
in these cases would be omitted. The most frequent reason 
(/I = 35) for not placing interstitial catheters was anatomy: 
the presence of either bone, or bowel, or bladder lumina 
hetween possible puncture site and tumor. In 29 of 56 
patients with cervical cancer and in 19 of 27 patients with 
bladder cancer no interstitial catheter was placed. In 20 
patients, preexisting radiating pain Was the reason for not 
introducing a catheter. The other contra indications played a 
role in the remaining 18 patients. 
Sleering possibilities 
Generally, the dinical impression is that effecti\'e steer-
ing within the target volume is not very well pussible. 
Treatment setup is adjusted in response to an observed 
temperature distribution in disagreement with the desired 
one, or to a too high temperature experienced by the patient. 
Within the group of patients with interstitital thermollletl)', 
it was almost never necessal)' to adjust power on the basis 
of too high measured temperatures. Further, it uppeared that 
the temperature distribution within the target vo!ume 
.~howed negligible effects of power distribution adaptation. 
Examples of temperature distribution during treatment arc 
given in Fig. 2A-D. From each tumor group, the patient 
with the highest number of interstitial measurelllents was 
selected. In each case, changes ill treatment setup do not 
decrease the gap hetween minimum and maximum intratu-
lllor temperature. The effect of steering is that higher power 
levels can be maintained or achieved than without treatment 
adjustment, resulting in overall higher temperatures. This 
figure also shows Ihat the intraluminal temperature is in 
most cases within the range of interstitial temperatures, and 
that the course of the intraluminal temperature in lllo~1 cases 
reflects the course of the interstitial temperatures. By the 
way, these four patients were all treated in combination with 
radiotherapy to a total dose of ?:50 Gy. In the patients with 
bladder, rectal and cervical can,:er a local tumor control was 
achieved for a duration of 18+ months, 5+, and 6+ years, 
re~pecli\'cly. The patient with a sarcoma died 3 months 
following treatment due to pulmonary metastases, with a 
partial response in the intrapelvic tumor. A possible advlIlI-
tage of interstitial therrnometl)' is that the total treatment 
duration can he shorter than total 90 min, when un intratu-
mar temperature of 42°C is reached within 30 min from 
start healing. This was the ca~e in only 39 of 287 (14%) 
treatments in patients with interstitial therrnometl)' during at 
least two treatments. The treatment procedure as described 
above has shown to he effective in avoiding hyperthermia 
induced toxicity. In 215 patients, only une seeond·degree 
skin bUrn, healed after 1 week, and one third-degree skin 
burn, healed following conservative treatment after 2 
months, has developed. Subcutaneolls burns were observed 
in less than 10% of the patients, generally located in the 
upper leg, causing tenderness for 1-2 days and thereafter 
spontaneously resolving. In one patient a larger suhcutnae-
ous fat burn developed in the ~llprapubic region and caused 
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Table 5. Possible advantages and disadvantages uf interstitial thermometry 
Advantages Disadvantages 
For the individual patient: 
During clinical treatment: optimization of intratul\lor temperature distribution Unplea,ant pwcedure 
Prevention of toxicity 
For scientific reasons: 
Retrospective assessment of treatment quality 
Learning how to use the equipment 
Useful in intertechnique comparison 
Verification of noninvasive thenIlometry and 3D planning 
tenderness for 6 weeks. III two patients a painful spot at the 
hip bone, probably caused by heat induced bone damage, 
necessitated to delay subsequent treatmcnt with one week. 
In none of thcse patients, interstitial thermometry would 
have yielded information on temperature distribution in the 
burned area. 
DISCUSSION AND CONCLUSIONS 
In our experience, the reluctance by the clinicians in our 
staff to place interstitial thermometry catheters increased 
over the years. This reluctance can be explained by the 
observation that interstitial catheters caused the most rele-
vant treatment-related morbidity, including death, combined 
with the experienced lack of beneficial effects. When the 
department started applying hyperthermia for deep seated 
tumors, the intention was to have interstitial thermometry in 
every patient. In the first 40 patients, exception was made 
only for 3 patients with bladder cancer and I patient \vith 
cervical cancer using anticoagulants. In the latter patient, an 
intrauterine catheter was placed before the Ilrst treatment. 
111ereafter, the percentage of patients with interstitial ther-
mometry continually decreased, Intralumor temperature 
measurements are considered important for several reasons 
(Table 5). Two types of arguments in favor of interstitial 
thermometry can be distinguished: first, that it is in the 
benefit of the individual patient under treatment, and sec-
ondly, that it is of scientific value-which is in the benefit 
of future patients. 
For the individual patient, the most important consider-
ation is that the treatment is applied optimally. This means 
that the intratumor temperatures are increased to as high and 
as homogeneous as possible to achieve maximum tumor cell 
kill, and that at the same time toxicity is avoided. With the 
presently available equipment the reality is that we are able 
tu move around a relative large volume with maximum 
energy disposition. If the aim is more specific, such as to 
change the temperature distribution within the tumor, the 
steering tools appear ineffective, as illustrated in Fig. 2. The 
influence of steering on intratumor temperature distribution 
for all patients will be the subject of a quantitative investi-
gation, to be published separately. Our clinical experience 
has been conJirmed by others using the BSD-2000 system 
Negative influence on quality of life 
Risk of bleeding 
Risk of infection 
Risk of penetrating howel or bladder lumen 
Risk of tumor seeding 
Time consuming 
Increased expense 
(6-8). The energy distribution within the Sigma 60 appli-
cator has been found to be influenced by anatomical and 
clinical factors and the resulting temperuture distribution by 
tissue perfusion (7). In clinical practice, the steering possi-
bilities arc used, together with placement of additional water 
bolusses, to eliminate power limiting local hot spots, which 
then allows to increase the total power output and thereby 
the overall regional temperature level. Interstitial thennom-
etry was neither an important requirement for prevention of 
toxicity, Well instructed patients do indicate hot spots rather 
adequately, as demonstrated by the relatively low percent-
age of thermal bums, Similar experience was reported by 
Gellerman et al. (9). The disadvantages of interstitial ther-
mometry were experienced to be many (Tables 4 and 5). 
CT-guided insertion of catheters is un unpleasant procedure 
and time consuming. It increases the lotal costs of a series 
of hyperthermia treatments with about HH. 900,-. (10). In 
Illany patients intolerable pain was reason to remove the 
catheter. Bleeding, severe infection, and tumor seeding have 
been observed, and one patient even died due to sepsis in 
relation to an intratul110rally placed catheter. The incidence 
of morbidity in our patient material is twice as high as that 
reported by Feldman et lIl. (II). They report problems in 26 
of 80 catheters placed in intrapelvic and intraabdominal 
tumors, with a severe complication in only 2, We have no 
explanation for this difference. We hnve not seen a higher 
incidence of complications with longer indwelling times, 
such as was observed by Wust c/ al. (12). The incidence of 
catheter-related morbidity may be lower when catheters are 
inserted before each treatment. However, even when this 
would be practically feasible, the advantages must outweigh 
the disadvantages. Altogether, in our experience the cost of 
interstitial thermometl)' far outweighs the benefit when the 
individual patient is concerned. Our rather negative experi-
ence with interstitial thenllometry for deep seated tumors is 
completely different from that with interstitial thermometry 
in superficially located tumors, In the first place, the inci-
dence of morbidity from super/icially implanted catheters is 
very low; our recent experience is not different from that 
previously published (13). Second, power distribution steer-
ing during superficial hyperthermia is possible with the 
multiapplicator Il1ultiamplitier microwave system used by 
us (14). 
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Fig. 2. IntratullIor temperature distribution during deep hyperthermia in four patients, in each patient measured within 
two interstitial catheters, and in a lumen in close rdation to the tumor. --0-: intraturnor T,,,",; _t._: intraluminal 
Trru,; _0-: intratUnlor Tmi ,,; *: startl.~teering. (A) Patient with stage 1'4 bladder cancer, with a total of]O intrutumor 
measurements. (8) Patient with large ren!n<:nt rectal cancer, with a total of 1(, intrahlmur meu-~ureillents. For this patient 
the temperature distribution during the set'ond treatment is given, because (hennal mapping during the fiThI treatment 
was possihle in only one catheter. Power distribution was changed only once, based upon the experience during the tirst 
treatment. (C) Patient with Stage lllll uterine cervical Cancer, with a Iotal of 12 intmtumor measurements. (D) P,ltient 
with recurrent ~arcoma, with a total of 29 intratllmor measurements. 
TIle second type uf arguments in favor of intratumor 
tempemture information concems scientific issues. Thc in-
formation can be used to asse~s, retrospectively, the treat-
ment quality in terms of thermal dme. It is clear that higher 
temperatures will result in more cell kill (15), Thermal 
dose-response relationships have been found in many clin-
ical studies (16). Howcver, clinically found relationships for 
thermal dose parameters are complicated, These are retro-
spectively defined, and not pre~cribed, thermal doses, and a~ 
such lIlay be just a rcpresentative of a tumor chamcteristic, 
which by itself is of progno~tic value. Such is suggested by 
the negative relation between parameters for thermal dose 
and the number of thermometry points, together with the 
positive relation between the number of thennometry points 
and tumor size (17-19), Further the recent findings of an-
giogenesis being an imlependant prognostic factor for sev-
eral types of cancer support this hypothesis (20). Dose-
respunse relationships havc also been found for 
intraluminally mea~llred temperatures (21, 22) and even for 
total power output (23. 24). Wust et al. (12) found a positive 
correlation between endoluminally and intratumorally mea-
sured power densities. Whether these relationships do exist 
in our piltients will be subject of further analysis. There are 
!>ituation~ where the value of interstitial themlOmetry will 
easier outweigh the possible risks. In the Ilr.';! place, in 
learning how to use newly installed equipment. Any infor-
mation on how changes in treatment .'icttings influence tem-
perature distribution are helpful in getting experienced, In 
the second place, when the intratllmor distribution is .~ubject 
of investigation, such as when two heating tecimiljues are 
compared, or when either nOnim'4:LSive thermometry or 3D 
treatment planning is verified. However, these goals are not 
in the benefit of the individual patient. To addre~s these 
questions, separate studies should be developed with strict 
demands on standardized thermometry, and patients will 
have to give informed consent for participation in such 
studies. TIle limited value of interstitial thermometry will 
remain to exi~t when new equipment, allowing slllnll-.~ealc 
SAR steering will become available for clinical use. The 
numbcr of h1\"L~ive thcrmometry sites within the treated 
volume is rclatively small and the criteria a~ formulated by 
the RTOG guidelines (I) can hardly ever be met. The 
infonnalion that can be achieved with interstitial measure-
ments on intratumor temperature distribution in deep-seatcd 
tumors is limited, In our patients with interstitial thermom-
etry, the number of measuring points per treatment was only 
6.9, which is mther low for tumors with an average volume 
of 314 cm3. Decreasing the thermal mapping step size to, 
Interstitial thermomeflJI il1 deep h)1Jerthermia 
for example, 0.5 em would have doubled the number of 
ll1ea.surement.~, but in our opinion not resulted in a relevant 
improvement of thermometry quality. We mllst realize that 
even if technology is no longer a limitation for small-scale 
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SAR steering, we will need considerable progress in other 
ilelds, such as noninvasive thermometr)" and real-time in-
formation on anatomy, tissue characteristics and blood flow 
within the patient under treatment. 
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A 433 MHz Lucite Cone w3yeguide applicator for superficial 
hYlJerthennia 
O. C. VAN RHOONt, P. J. M. RIETVELD and 1. VAN DER ZEE 
University Hospital Rotterdam, Daniel den Hoed Cancer Center, Department of 
Radiation Oncology, Section Hyperthermia, PO Box 5021, NL 3008 AE, 
Rotterdam, The Netherlands 
(R('f{'iI'cd 19 Novemher 1996; rel'ised /6 Jill)' 1997; accepted 28 AlIglift 1997) 
The elfective field size (EFS, SAR ?:'. 50% of the maximum SAR at I em depth) of 
a conventional 4331IHz water filled waveguide applicator (32cm2, aperture area 
loocnl) has been increased by: (1) replacement of the two diverging brass side 
walls which are panllld (0 the direction of thc electric field by Lucite walls; lind 
(2) Placement of a heterogeneous permittivity in the centre of the aperture. SAR 
distributions were measured at several depths in layered fat-muscle phantoms. 
With Lucite side walls the SAR distribution becomes wider in the H-plane of the 
aperture. resulting in a circular SAR distribution. In this situation the EFS is 
67em1 . Additional insertion ofa PVC cone with a top angle of 15~ at the centre of 
the aperture increases the EFS to 91 ± 6('011 for a waterbolus of IS x 18 x I cm3. 
The experiments also demonstrated that the resulting EFS is affected by the 
waterbolus size and shape. Calorimetric mellSlIremenls showed that the efficiency 
of the improved applicator is comparable to the efficiency of the conventional 
water tilted waveguide applicator, 50 and 56"/0 respectively. The modifications 
reported provide a simple and inexpensive means to increase the EFS and can be 
easily implemented in water filled wavegnide applicators. 
Key ll'ords: Superficial hyperthermia, microwaves, SAR distribution, water filled 
waveguide applicator, I\HV applicator arrays 
I. Introduction 
Superficial hyperthermia of chest wall recurrences of breast cancer is a frequently 
used modality in the clinical application of hyperthermia (HT). With the publication 
of the results of five randomized trials comparing radiotherapy (RT) versus RT + HT 
in the treatment of superficial located breast cancer by the International 
Collaborative Hyperthermia Group (ICHG 1961) it is also one of the sites for 
\vhich the combined treatment of RT + HT has been proven to be effective and, in 
several institutes, has become standard treatment. Unfortunately, as in other ran-
domized (Perez et al. 1989, Overgaard et al. 1995) and non-randomized trials 
(Meyerson et af. 1990, van der Zee et al. 1992, van tier Zee and Vernon 1996), it 
was also indicated in the studies reported by the IeHU (1996) that tumour depth is 
negatively associated with clinical outcome. For the same study material Sherar et al. 
(1997) found a significant dose response relationship between minimum thermal dose 
parameters and clinical outcome. Hence, it is generally expected that patients with 
large tumour volumes may benefit substantially from an improved quality of the 
superficial hyperthermia treatment of chest wall recurrences. 
tTo whom correspondence should be addressed. 
0165 6736198 S12.00 j) 1998 Tailor & Francis Ltd. 
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Improvement of the quality of the SAR distribution should aim for a large 
efrective field size (BFS as defined by Hand et a/. [1989]), good spatial control of 
the SAR distribution and sufficient penetration depth. In practice this can only be 
achieved with the use of multi-element HT applicator arrays. However, despite the 
ample clinical experience with superficial heating, the exact demands on spatial 
control, penetration depth and SAR converage arc still unknown. 
Currently, several applicator arrays with individual power control of each ele-
ment (Lee 1995) have been developed and are in clinical use. All these systems are 
constructed by using numerous (up to 25) conventional applicator elements, 
Characteristic for these conventional applicators is the relative low ratio of EFS 
to the aperture area (commonly 30--50%). By close packing of the clements a con-
tiguous EFS can be obtained, If special techniques are used (placing thcse elements 
at sufficient distance to the skin or over/apping of elcments) it is possible to limit 
SAR variations within the efrective field to 10%. 
Conceptually such small elemcnts may provide the best spatial resolution of SAR 
control and conformation to the body contour, however thcy also have some dis-
advantages. Firstly, small elements carry the risk of a loss in penetration depth 
(Hand \990). A larger aperture to skin distance may reduce this risk but due to 
the divergence of the electric field this has the consequence of a reduced spatial 
control. Secondly and probably more important the use of complex applicator arrays 
with many small elements ,vill put strict demands on information about the tem-
perature distribution under each array elemenl and automatic control algorithms in 
order to exploit the feasihility of SAR steering during clinical HT treatments. If 
power control is performed manually, as is still the case in most HT departmelits, 
the number of elements is dearly limited by the comprehension of the HT technician 
and practical limitations of thermometry, The relevance of these demands for the 
final quality of the HT-treatment should not be underestimated, as HT is still an 
empirical treatment with the final quality depending strongly on the experience and 
abilities of the HT technician. 
Based upon our clinical experience our approach to iml1rove the quality of the 
SAR distribution diners in the sense that we prefer to limit the number of elements of 
the array. This of course will affect the resolution of spatial control. To obtain a 
contiguous EFS under the array aperture using a limited number of elements it is 
essential to develop a waveguide applicator with an improved EFS preferable com-
parable to the aperture size. In this paper we describe our method to increase the 
small effective treatment area of our conventional 4331'vlHz water filled waveguide 
applicator. The performance of the improved applicator in an array configuration 
will be reported elsewhcre. 
2. Materials and methods 
2.1, Wal'egllide mod(ficatiollS 
Two types of waveguide applicators are used in the experiments, which are 
refered to as : 
2.1.1. COII\'('lItiolla/ lI'al'cguide applicator. A water filled, rectangular waveguide 
applicator made of brass and operating in the TEIO mode. The dimensions of the 
first part of the waveguide, that is at tbe dipole antenna, are 3.0 by 5,Ocm. Dipole 
dimensions: diameter 0.3cl11, insertion depth 2.5cm, and distance to the reflective 
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Figure I. Photograph of the various applicators and the diiTerent field adapters: (right) the 
conventional wUYeguide applicator; (centre) Lucile Cone waveguide applicator, note the 
PVC cone ut the centre of the aperture; (left) LUcile waveguide applicator. 
back-plane of the waveguide 2.4 em. The second part of the applicator starts at 
approximately 0.5), from the dipole. From this point the waveguide cross-section 
diverges to the final aperture size of lO.O x 1O.0cm2 (inner dimensions). As is well 
known the electrical (E) field of a TElO waveguide varies sinusoidally over the aper-
ture, with a zero E-ficld at the metal sides, which results in the reported small EFS. 
2.1.2. Lucile wavegllide app/im(or. Basically, this is the same water filled, rectan-
gular waveguide applicator operating in the TEIO mode. The first part is identical 
with the convcntional applicator. The second part is modified with the objective 
to increase the EFS. Thc modifications applied are: 
(I) Replacement of the two diverging brass side walls which arc parallel to the 
direction of the E-held, by Lucite (thickness 0.28 em). In this way a nonzero 
E-field condition at the boundaries is created; 
(2) Use of an heterogeneous permittivity in the horn of the applicator. Two types 
of field adapters were tested: (A) a PVC Calle with a basediameter of 4.0 em, 
height 5,5 cm, and top angle of 10, 15 or 20", and (8) a foam insert with a base 
of 4,0 x 10.0 x 1.0C1113 and on top of that a wedge of 4,0 x 10.0 x 4,5cm3, 
with a top angle of 15" and a width of 5 cm at the top. The base of the cone 
and the foam insert are positioned centrally in the plane of the aperture. The 
foam insert has its long axis parallel to the E-field. 
The applicators: conventional, Lucite and Lucite with field adapters are shown in 
figure 1, 
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2,2. SAR measurements for applicator modifications 
Relative SAR distributions of each applicator configuration are measured at 1 em 
depth using a flat (50 x 50 x IDcm3) muscle equivalent phantom (Guy 1971), In all 
experiments a water bolus (plastic bag filled with deionized water at room tempera-
ture) is placed between the applicator and the phantom. To measure the SAR dis-
tribution according to the ESHO quality assurance guidelines (Hand et at, 1989) the 
phantom is constructed in layers of I and 2cm thickness for the first Scm. To ease 
separation, each layer of phantom material is covered by a 0,005 em thick PVC 
mylar which has no influence on the resulting SAR distribution. The maximum 
duration of heating was limited to 1,5 minutes, In this time a temperature increase 
of 3-6°C was obtained at the location of maximum energy absorption, After removal 
of the applicator, waterbolus and the first (lor 2 cm) layer of phantom material the 
temperature distribution of the exposed surface was measured by an AGA infrared 
camera interfaced to a personal computer (Deursen and van Rhoon 1987) within 15 s 
after power off. Effectively, the measured temperature distribution represents the 
SAR distribution, During the experiments the applicator was connected to a 
433 MHz generator. Power was measured using Bird power meters and the average 
net power used ranged from 100 to 300 W. Following the temperature measurement, 
isocontour grey-scale plots of the SAR distribution were made for each applicator 
using in-house written software. The area within the 50% iso·SAR contour, the EFS, 
is determined by this software. 
2.3. Spcc{fic experiments for the Lucile COlle applicator 
The Lucite applicator containing the PVC cone (top angle 15°), hereafter called 
the Lucite Cone applicator (LCA), showed the largest EFS most promising for 
clinical applications. Therefore, a number of additional experiments, as described 
below, have been performed specifically for this applicator. SAR distributions have 
been measured at various depths in a homogeneous muscle equivalent phantom with 
and without a I em thick layer of fat-equivalent tissue (Guy 1971) ill front of the 
aperture. Additionally, the influence of various thicknesses (range 0-3 em) and sizes 
(18 x 18 and 25 x 3Ccm2 ) of tile waterbolus on the resulting EFS was investigated, 
To mimic clinical circumstances the magnitude of SAR distortion by placing the 
applicator with an angle of 20° on the flat phantom surface has also been investi-
gated, 
The eftlciency of the LCA has been measured calorimetrically, Hereto, the LCA 
is placed above a Styrofoam box (20 x 20 x 20cm3) with 5 cm thick walls, which was 
filled with saline water (9 gram NaC\ per litre water). In this experiment no water-
bolus is used and the aperture of the applicator is placed in close contact with the 
saline water surface, The temperature increase of the saline water is measured after 
1 h microwave heating at 200 W net input power to the LCA. To correct for heat 
exchange of the water with the environment and the applicator the temperature 
change of the calorimeter was recorded for 30 min before and after the microwave 
heating. The efficiency of the <lpplicator is defined as the ratio between the power 
absorbed in the saline water (corrected for all heat losses) and the net RF-power 
delivered to the applicator at the connecting N-plug. 
Finally, the stray radiation level was measured for both the LeA and conven· 
tional applicator radiating in the muscle equivalent phantom using a water bolus of 
18 x 18 x I cm3, Stray radiation patterns were measured using an isotropic monitor 
(Narda 8662). The normal frequency band of this monitor is from 0.3 to 300 MHz 
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with full-scale meter ranges of 2.0,20.0 and 200.0mW/cm2, For this occasion the 
meter has been calibrated specifically at 433 MHz (vun Swindell Laboratorium, 
Netherlands Measure Institute). 
3. Results 
The heating time of 1.5 min is longer than that recommended in the ESHO QA 
guidelines and may give some concern regarding thermul conduction errors, 
Therefore, figure 2 provide a comparison of the SAR-distribution of a Lucile 
Cone Applicator at 1 em depth in a muscle-equivalent phantom obtained by both 
the infrared thermograph method or by an E-field scanning method,] Special care 
\vas taken to have identical set-ups in both experiments. As is shov>'Jl, the SAR 
distributions are in good agreement: half beam \vidths as measured with the infrared 
an.d E-field scanning method arc 84 versus 85 Illlll along the E-field direction and 100 
versus 99 llllll for the direction perpendicular on the E-fieId, respectively. These 
differences are well within the accuracy (±IO%) of each method and, in our opinion, 
validates the further use of the infrared thermographic method with a healing time of 
1.5 min. 
3.1. COl/rel/tiol/a/ applicator 
The SAR distribution as obtained for the conventional applicator is presented in 
figure 3a. As expected, the SAR distribution has an elliptical shape, with the major 
axis parallel to the direction of the electrical field. The profiles shown in figure 3b 
provide more detailed information about the change of the relative SAR along the 
major axes, parallel with, and perpendicular to the E-fieId, of the applicator. Each 
point of the curves represent a spatial mean of the SAR of 4 pixels (total width I cm) 
at the axis. The EFS measured for the conventional applicator is 32cm2• 
Placement of the PVC cone or foam insert in the aperture of the conventional 
applicator did not resuit in a marked increase of the EFS. These results are summar-
ized in table I. 
3.2. Lucite applicator 
Replacing the brass side walls of the waveguide by Lucite walls made the SA R 
distribution at I Clll depth in the muscle equivalent phantom circular instead of 
elliptical and the width of the 50% iso-SAR contour is almost the same for both 
axes 79 and 87 mm2, parallel with-and perpendicular to the direction of the E-field 
respectively. For this applicator design the EFS is 67 cm2, approximately 2 x as large 
as. the EFS of the conventional applicator. 
3.3. Lucile applicatol' with/ield adapt('J's 
Adding the field adapters in the aperture of the Lucite applicator results in a 
further increase of the EFS. With the foam insert the EFS increases to 106cm2. The 
resulting SAR distribution (figure 4a) has the shape of an '8' with a constriction at 
the location of the wedge. As can be seen in figure 4h the foam insert resuits in a large 
improvement of the SAR distribution along the axis perpendicular to the R-field 
!In the E-tleld scanning mcthod the upplicutor and a receiving dipole antenna (made of 
5emi-ridged coaxial cable, dipole Uflll 5 111m) were connected to a nctwork analyser 
(HP875IA). A liquid musde-equivaJcnt phantom was IIsed (35.6% cthyl-alcohol, 63.2% dis-
tilled water and 1.2% NuCI; lOr = 57 and q = L2 S/m). 
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Figure 2. Relative SAR distribution at I em depth in a homogeneous muscle equivalent 
phantom measured with either the infrared thermographic method or with the E-field 
scanning method using a small dipole: (a) <lIang the axis perpendicular to; and (b) along 
the axis parallel with the E-field direction. HBW: half beam width. 
37 
38 
'r.oc-___________________________ '~10MM 
E-
2101-111 BRASS 
(a) 
" 
" 
':1 " 30 
" 
90 
'" SCALE \ SAR.· ... 
1------11---'1-\--,------1" 
" 
-wo -50 0 60 lOG 
POSlTlON FROM CENTER OF APERTURE (mm) 
----- PARALLEL TO E ---><-- PERPENOICULAR TO E 
(b) 
, 
'" 
Figure 3. (a) SAR distribution at 1 em depth of a fiat, homogeneous muscle equivalent 
phantom for the conventional applicator and a water bolus thickness of I em; (b) 
Relative SAR along the central axes, parallel and perpendicular to the E-field, of the 
conventional applicator. Each point or the curves represents a spatial mean or the SAR of 
four pixels (Iota] width I em), 
direction. Similar, for the PVC cOile the EFS increases to 99 cm2 (for six different 
LeAs 91 ± 6cm2 average ±l s.d.), For this applicator configuration the SAR dis-
tribution has an elliptical shape (figure Sa). Again, as can be seen in figure Sb the 
improvement of the SAR distribution is mainly along the axis perpendicular to the 
direction of the E-field. The experiments using the PVC cones with top angle of 10 or 
20° showed worse results. That is with a top angle of 20° the EFS increases only to 
73 cm2, while with a top angle of 10° it was not possible to reduce the reflected 
powcr2 to an acceptable Icvel « 20%) and no SAR distribution could bc mcasured 
(scc also tablc I). 
lFor all other applicator conllgurations the reflected power could be reduced to < 10% by 
adjusting the tuning rod located in the first part of the applicator. 
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Table I. Effective field size of the conventional waveguide applicator and the Lucite 
waveguide applicator at I cm depth in a homogeneous muscle equivalent phantom: 
effect offield adapters. Waterbolus 18 x 18 x Icm). 
Field adapter 
None 
Foam insert 
PVC cone 
10' 
15' 
20' 
Effcctive field size (cm2) 
Conventional waveguide 
applicator 
32 
37 
39 
38 
37 
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Lucite waveguide 
applicator 
67 
106 
99 
73 
Figure 4. Lucile applicator with a foam wedge. (a) SAR distribution at I em depth of a !lat. 
homogeneous muscle equivalent phantom and a water bolus thickness of I em; (b) 
Relative SAR along the central axes, parallel and perpendicular to the E-field. Each 
point orthe eurves represents a spatial mean ofthe SAR of four pixels (total width I em). 
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Figure 5. LudIc applicator with a 15" PVC cone. (a) SAR distribution at I em depth of u 
fiat, homogeneous muscle equivalent phantom and a water bolus thickness of I em; (b) 
Relative SAR along the central axes, parallel and perpendicular to the E-field. F.<lch point 
of the curves represents a spatial mean of the SAR of four pixels (total width I em), 
3.4. IlIflu<.'lIce (!(II'(ft(,l'bo/lIs size 11m/ llIitkll(!ss,/al fay£'/' (llId tilled posilioll OIlll1e 
SAR distributioll of tlie Ludle COl/e applicator 
Tahle 2 shows the resulting BFS of the LeA as fUllction of the waterbolus 
thickness for two diflerent waterbolus sizes. An EFS of 62 cm2 is measured when 
the LCA is placed directly 011 the phantom. For a watcrbolus size of 18 x 18cm2 the 
EFS increases to 98 cm2 for a waterbolus thickness of 0.5 em und to 103 cm2 for a 
waterholus thickness of 2.0 cm. For the larger watcrbolus of 25 x 30 cm2 the BFS 
measures 62 and 65cm2 for a waterbolus thickness of 1.0 and 2.0el11 respectively. 
Tahle 3 provides an overview of normalized EFS's at diOcrent depths as meas-
ured for the LCA using a homogeneous and a fat-muscle layer phantom configura-
tion. Normalization has been performed to the EFS value measured at 1 cm depth in 
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Tablc 2. Average effective field size of the LCA at 1 cm depth in a homogeneous muscle 
equivalent phantom for various thicknesses and sizes of the waterbolus between the 
applicator and phantom. 
Average effective field size (cm2) 
Wuterbolus thickness (cm) 
o 
0.5 
1.0 
2.0 
3.0 
18 x 18 
62 
98 
92 
103 
Watcrbolus size (cm2) 
25 x 30 
62 
62 
65 
64 
Table 3. Normalized' effective fieldsize of the LCA at different depth and for two phantom 
configurations. Waterboilis 18 x 18 x I cm3 , 
Location 
Surface fat layer 
Surface muscle tissue 
At I cm depth in the muscle phantom 
Muscle phantom 
133 
100 
Fat-muscle phantom2 
o 
148 
118 
'Normalization is performed to thc EFS at I cm depth in the homogeneous muscle equiva-
lent ph<lntom. 
2Fat-muscle phantom includes a 1 cm thick lut equivalent layer on the muscle phantom. 
the homogeneous muscle equivalent phantom. It was found that a 1 cm thick layer of 
fatty tissue in front of the aperture resulted in a 20% increase of the EFS at 1 cm 
depth in muscle tissue. 
Tilting the aperture of the applicator 200 parallel with the direction of the E-field 
results in 1:1 small effect on the SAR distribution. The SAR·profile along the axis 
parallel to the E·field is shifted by approximately 10-15 mm towards the direction of 
the lower end of the applicator aperture (figure 6), For the SAR·profile perpell· 
dicular to the E·field the width of the 50% iso·SAR is reduced by 18 mill (-70 to 
6911Ull in figure 5b versliS -61 to 60 nun in figure 6). The effective field, however, still 
nteasures 98cm2. For a 200 tilt perpendicular to the direction of the E·field the EFS 
is reduced to 81 cm 2 and a shift of the efiective field towards the elevated side of the 
applicator occlIrs (figure 7). For the SAR·profile along the axis perpendicular to the 
E-field this shift is from -70 and +69 mm to -81 and +60111111. In this case the width 
of the SAR·profile parallel to the E-field above the 50% value is reduced by 9 nun 
(-35 to 43 nUll in figure 5b versus -29 to 40 mill in figure 7). When this type of tilt 
would occur in an array of applicators the latter effect may cause a stronger coupling 
to the adjacent applicator. 
3.5. EJJiciellcy 
From the calorimetric measurements performed it was found that the efficiency 
of the LeA is comparable to the efliciency of the conventional water filled waveguide 
applicator, 50 ± 8% (1/ = 8) and 56 ± 76% (n = 6) respectively «werage ±I s.d.). 
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Figure 6, LeA with u 20° tilt of the aperture parallel with the direction of the E·field, 
Relative SAR along the central axes, parallel and perpendicular to the E-field. Each 
point of the curycs represents a spatial mean oCthe SAR of four pixels (totnl width 1 em). 
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Figure 7. LeA with a 20° tilt of the aperture perpendicular to the direction of the E-field. 
Relative SAR along the central axes, parallel and perpendicular to the E-fieid. Each point 
of the curves represents a spatial mean of the SAR of four pixels (Iotul width 1 em). 
3.6. Stray radiatioll !erefs 
Table 4 gives the stray radiation levels for both the conventional wavegllide 
applicator and the LCA along the major axes at various distances to the applicator. 
As is shown in table 4 the stray radiation level of the LCA is higher than that of the 
conventional waveguide. For both applicators the maximmll intensity of the stray 
radiation is measured along the axis parallel to the direction of the E-f1eld. 
4. Discussion 
A limitation of all presently used electromagnetic, radiative applicators is their 
small EFS compared to the aperture size (Lee 1995). Especially in the hyperthermia 
treatment of chest wall recurrences, which generally extend over large areas, the 
small EFS is a serious disadvantage. A significant increase of the EFS for mlllti-
applicator arrays compared to the EFS of a single applicator with the same dimen-
sions has been demonstrated theoretically and experimentally by Hand (1989). Of 
course for practical clinical use a trade-off has to be made between a small aperture 
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Table 4. Stray radiation levels (mW jcm2) measured for the conventional waveguide 
applicator and the LCA along the major axes. Values are normalized to an input 
power of 100 W. 
Distance from 
applicator (cm) 
COfl\'entional waveguide applicator 
50 
25 
10 
'H' 
0.01 
0.07 
'E': axis parallel to the direction of the E-field. 
'E' 
0.03 
0.39 
'H': axis perpendicular to the direction of the E-field. 
LeA 
'H' 'E' 
0.03 
0.10 
0.02 
0.16 
0.6 
size for spatial control of the energy distribution and a large aperture size for suffi-
cient penetration depth (Cheever e/ al. 1987, Hand 1987). Interesting approaches for 
applicator arrays are the flexible microstrip applicator (Lee et al. 1992), the current 
sheet applicator (Gopal el al. 1992) and the Microtherm 1000 system (Diederich and 
Stauffer 1993). Alternatively to the array approach several groups have investigatcd 
the possibilities to improve the EFS of the applicator itself. The resulting EFS of 
these modified applicators, dual spiral applicator, EFS 55% of the aperture (Ryan el 
al. 1995) and dual-antenna waveguide applicator, EFS 47% of the aperture 
(Leybovich el al. 1991) cannot compete \vith thc size and quality of the EFS obtained 
by the above mentioned array systems. 
Other methods focused on optimization of the SAR distribution through scan-
ning of the trcatment area with a single applicator (Samulski el al. 1990, Tennant el 
al. 1990), or by the use of a selective absorption bolus (Sherar el af. 1993, 1994). For 
the lattcr mcthod the maximum reported EFS covered up to 60% of the aperture 
area (Sherar et al. 1993). The disadvantage of this method is, however, that the 
power efficicncy of the whole system (applicator plus absorbing bolus) is dramati-
cally reduced and thus applicability of this method depends on the available power 
of the microwave generator. 
Compared to the above described methods our approach to improve the SAR 
distribution of the applicator is different in the way that is based on older and more 
established techniques to modify the characteristics of conventional waveguides. The 
use of the nonzero E-field boundary in the Lucite applicator can be regarded as a 
way to increase the width of the H-plane within the aperture (Epis 1961). For a 
conventional, hOl11ogenemlsly loaded, square aperture waveguide the E- and H-
plane radiation patten beamwidths usually arc unequal with a radiation polar dia-
gram that is elliptical in cross-section. Theoretically increasing the width of the H· 
plane is expected to result in a circular symmetrical polar diagram. This effect was 
indeed found for the Lucite applicator without field adapters and resulted in a 
doubling of the EFS to 67cm2 compared to 32cm2 for a conventional waveguide 
(table I). 
A well-known and simple method to improve the uniformity of the E-field dis-
tribution across the aperture of a rectangular waveguide applicator is to partially 
load it with high dielectric slabs (Kantor 1981, Tsandoulas and Fitzgerald 1972). The 
introduction of the heterogeneous permittivity in the waterfilled Lucite applicator 
shows some resemblance to this technique. As a result of the low permittivity insert, 
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foam insert or PVC-cone, at the centre of tbe aperture a dielcctrkally loaded horn 
applicator is milllicked with water as the dielectric slabs of high permittivity. Here 
again our experimental results, as reported in figures 4 and 5, agree with expecta-
tions. Although, the EFS of the Lucite applicator with a PVC cone (top angle 15~) is 
slightly smaller than that of the Lucite applicator with the foam insert, we consider 
the morc uniform SAR-distributiol1 of the Lucite appIicator with PVC-cone betler 
suitable for use in array applications. 
Characteristic for the LeA is that the major axis of the elliptical SA R distribu-
tion is oriented perpendicular to the direction of the E-field (parallel for a com'en-
tional waveguide) and extends outside the aperture, which might be advantageous in 
array applications. The results obtained with the experiments using an inhomogen-
COliS phantom are in agreement with those for the homogeneous phantom ,\I1d 
showed an additional increase of the EFS by approximately 20% with a 1 cm 
thick fat layer in front of the muscle tissue. 
The experiments performed with various shapes of the waterbolus indicate that 
size and shape of the waterbolus are affecting the resulting EFS. Dependence of the 
EFS of a microwave applicator on the waterbolus size is a known phenomenon and 
has been reported by others (Lee e/ al. 1992, Sherar e/ al. 1993, Ryan et al. 1995). 
Hmvever, the large difference in EFS as found here for the waterboli of 18 x 18cm1 
and 25 x 30cm2 is unexpected and cannot be explained from the current experi-
ments. A possible explanation might be the occurrence of resonance effects related 
to the precise dimensions of the waterbolus. This will be the subject of further 
experimental work and 3-D modelling. 
For clinical applications it was encouraging that the EFS was only affected, a 
decrease by 15%, for a tilt position of the LeA perpendicular to the E-field direc-
tion. Additionally, the facts that the efficiency of the LCA is comparable to that of a 
conventional waveguide and that the stray radiation is negligible at a distance of 
50cm from the LCA, are of importance during the clinical use of this applicator. 
Conccrning weight and size microstrip applicators offcr clear advantages over the 
bulky and rigid \vavcguide applicators. Howevcr, for treatment of tumours at the 
chest wall this problem is less important. Generally, there is enough room to place 
multiple applicators above the treatment field. By fixing the applicators to a well-
designed mounting system as we have in use (hydraulic arms, movable and attached 
to the ceiling) most applicator set-ups can be made with minimal discomfort to the 
patient. 
5, Conclusions 
Under laboratory conditions and within a fiat, layered, inhomogeneous muscle 
equivalent phantom the cfficiacy of: (1) replacing two brass side walls in the horn of a 
waveguide applicator by two Lucile side walls; and (2) placing 'field adapters', like a 
foam insert or a PVC cone, in the aperture of the Lucite applicator as a means to 
significantly incrcase the relative effective field size has been demonstrated. This 
method provides a simple and inexpensive means to realize an increased effective 
field size for waveguide applicators. For the Lucite Cone applicator preferred by liS 
for clinicallreatment the effective field size \vas increased from 32cm2 to 91 ± 6cml 
in an homogeneous muscle phantom. Wc expect that under clinical condition factors 
such as the dimensions of the waterbolus and the complex anatomy of the patient 
will influence the efrective field size. The latter is subject of further experimental 
work. 
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The Gaussian beam model (GBM) has been shown to be a successful tool in the 
development of the current sheet applicator. As a result, the effectiveness of the 
GB~I is investigated in single and dual array applications of the lucite cone 
applicator (LeA), The LeA is a modi/ied water-filled waveguide applicator 
with an improved eflective field size (EFS > 64cml, aperture IOcm x Wcm). 
The GB-source parameters were calculated from the emanating E-field ofa single 
LeA. The SAR distribution from tI singlc LeA was measured by E-field scanning 
and thermographic (TG) imaging, and compared with the Gil-prcdicted SAR 
distribution. Deviations in the principal planes were found to be Icss than 5%. 
TG-measured and Gil-predicted SAR distributions from three different dual" 
LeA configurations were compared and evaluated. When water was used as 
intermedium between LeAs and phantom, a maximum SAl{ difference of 27% 
was calculated. In the absence of water as intermedium, this diflerence increased 
to 44%. These large deviations were only found in areas where the measured SAR 
distribution was disturbed due to antenna interactions. The average SAR differ-
ences with and without water as in(enlledium were 7% respectively 11 %, indicat-
ing that the GB.l\I can provide good qualitative information about the SAR 
distribution of dual LeA-arrays. 
Key U"ord~: Superficial hyperthermia, microwave antenna, G,Hlssian beam mod-
elling, SAl{ distribution. 
1. Introduction 
In the last decade various theoretical models have been developed (Bach 
Andersen 1987, Paulsen 1990a, h, 1995) and are being used as an investigating 
tool for the development of microwave antennae. The models available differ in 
their degree of complexity, accuracy, computation time and computer requirements. 
Also the choice of the model to be applied depends on the necessity of modelling full 
three dimensional ohjects or whether a simpler approach is possible. In the general 
clinical application of superficial hyperthermia, most decisions on antenna choice 
* To whom corre-spondcnce should be addressed. 
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Figure I. Schematic diagram of (he lucile cone applicator. The left drawing shows the cross 
section in the principal E-field plane, the right drawing shows the II-field principal plane 
cross section. The aperture mcasurcs !Oem x IOem. 
and its configurations <Ire based on knowledge of the specific absorption rate (SAR) 
distributions obtained in homogeneous muscle-equivalent phantoms. In slich a situa-
tion the use of the Gaussian beam (GB) model as developed by Bach Andersen 
(l9~7), LUl110ri (1988) and Lumori et al. (l990a) might be a method of obtaining 
more knowledge of the behaviour of the SAR distribution from various antenna 
array configurations. 
The om'll has been used extensively by other groups (Lumori et al. 1990b, Gopal 
et al. 1992, Prior ('/ al. 1955) in the dcvclopment of the current sheet applicator 
(CSA). Thcy found the GB~'I to be a reliable tool in studying SAR distributions 
from CSA-array configurations in a multi-layered phantom. Thc advantage of the 
GRM is its simplicity with regard to the required source parameters and its low 
demand for computer power. 
As thc lucile cone applicator (LCA, figure I) is a completely different Iype of 
antenna (E-field) compared to the CSA (H-field), it was felt necessary to make a 
separate verification of thc eficctiveness of thc GDM for the LCA. Thc results of 
these investigations are reported here. 
It was found that thc dificrences between predicted and measured SAR distribu-
tions from LeA arrays are gencrally increased due to antenna interactions especially 
whcn water as intermedium was excluded. 
2. l\laterials and methods 
Thc investigation consisted of two parts. Firstly, the source paramctcrs for the 
GBIvf were attained from measurements of amplitudc and phase by a geometrical 
(approximate) method (Lumori 1988) and GD-predicted SAR distributions have 
been compared to TG-Illeasured SAR distributions from a single antenna. 
Secondly, these primary tests were followed by dual-antenna sct-ups for which, 
again, predicted and measured SAR distributions in homogeneous muscJc-equiva-
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lent tissue were compared to allow a more thorough testing of the GBM since the 
LeAs are commonly used in array applications. In this study dual antenna set-ups 
without and with a water Iaycr/waterbolus as intenllcdium between antenna and 
phantom were included. Measurements without watcrbolus call be modelled exactly 
whilc a/il/ite water layer (Le. a waterbolus) cannot be properly modelled in the GBM 
and its ell'ee! on thc pn:::dkted SAR distributions W,IS investigated. 
2.1. Lucile COlle (/pplim/or 
The lucite cone applicator (LeA), depicted in figure I, is a modified water-filled 
horn applicator operating in TEIO mode at 4331''t'fHz and lws been described earlier 
by Vall RhoOll et al. (1992,1998). In SUI1Ull<lry, the LeA is obtained by replacing the 
two diverging metal side walls parallel to the E-field of a conventional horn appli-
cator with lucite and adding a PVC cone in the centre of the aperture. By taking 
these measures the effective field size (EFS) is increased by a factor of 2--4 (Rietveld 
t'l al. 1990, Rietveld and Van Rhoon 1991, Van Rhoon et al. 1998). The fiHJi<lting 
aperture of the LeA is lOcm x JOcm (ouler dimensions: 10.5cm x 1O.5cm). 
2.2. Electric field probe 
The E-field distribuliull along the main axes of the antenna was measured lIsing 
I\vo types of unbalanced dipole antennae. The dipole arIll lengths were 5mIll and 
10 ml11 (total lengths of the dipole were 10 and 20 mm, respectively). The dipole 
antennae were constructed from an open-folded coaxial cable (outer diameters 
1.0 111m and 2.0 mill, respectively). 
The probes were connected to a HP8751A network analyser to measure the 
transmission coefilcients from antenna to probe. The positioning of the E-field 
probe relative to the antenna was controlled by an xyz-steppermotor de\'ice 
(WellhMer Kernphysik, SchwarLenbrw.:k, Germany), with stepsize 5 mIll and 
0.5 mIll precision. Measurements with the large E-field probe were performed manu-
ally. When using the smaller E-field probe, both the network analyscr and the 
WeHhMer steppermotor device were IEEE-interfaced to a pe which coordinated 
the position of the probe and measurement of ul11plitude and phase. 
For these measurements a tank containing a liquid muscle-equivalent phantom, 
consisting of water, alcohol and salt (Hand el al. 1989a) was used. The tank meas-
ured 401.:111 x 32cl11 x 14cI11 (I X w x d) and the antenna was positioned centrally 
under the tank, radiating upwards. 
In geneml, E-fie1d scans were done at 10, 20 and 30 cm depths relative to the 
radiating aperture with the probe orientation parallel to the main E-field direction 
(x) of the LeA. To minimize disturbance of the E-field, the coaxial leads of the 
unbalanced E-field dipole antennae were led in the z-direction when E-field profiles 
of the LeA were measured in the xy-plane. When measuring in the z-direction the 
leads wcre orientated in the y-direction (perpendicular to the dominant E~-field 
direction). 
Measurements were obtained with 5 mm spacing. No waterbolus was used 
between antenna and phantom. To correct for the imbalance of the E-field probe, 
the average of two oppositely orientated E-field scans was used to obtain the iil/al E-
field profile of the antenna. 
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2.3. Thermographic SAR l1/eWj/{T('1/lell/s 
SAR distributions at I elll depth in muscle were obtained using a layered semi-
solid muscle-equivalent phantom (48c111 x 48 em x 10cm) made of Super Stufi' (Guy 
1971). A thermographic camera (AGA Thcflnovision System 680/l02B, Lidingo, 
Sweden) interfaced to a PC was used to measure the temperature distribution at 
the exposed surface. 
In order to measure a proper SAR distribution in a dual-antenna set-up with the 
thermographic (TG) technique, the durtltion of the power pulse was set to I.Smin. 
Although the ESHO Quality Assurance (QA) guidelines (Hfllld £'1 al. 1989a) were 
violated with respect to the power pulse duration, heat conduction in the phantom 
was still ill the order of milli111etres «5111111) which was within the spatial resolution 
of the TG-camera. In other aspects the ESHO QA guidelines were followed. 
After correction for background radiation and non-linearity of the camera, a 
relative SAR distribution was calculated. Net power input per antenna during the 
experiments was about 130 W. In the case of a dual-antenna set-up, the antenna were 
driven incoherently with equally sct input powcr. 
The E-field orientations for the dual array configurations were: both E-fields 
horizontally orientated (HH); both E-field orientations vertically orientated (VV); 
the left E-field horizontally and right E-ficld vertically orientated (IIV). 
When a waterbolus was used in a single LeA TG-measurement, the dimensions 
were 18cm x 18clll x I cm. In all dual-antcnna TO-measurements, the waterbolus 
measured 28cI11 x 20cm x I cm. The waterholus dimensions are chosen according to 
the clinical sct-up of LeAs. 
2.4. Gamsiall hcm/l mndel 
The Gaussian beam (Gll) model has been deseribcd extensively elsewhere (Bach 
Andersen 1987, Lumori 1988, Lumori et al. 1990a, b). The model describes the E-
field distribution in lossy media by local Gaussian curves outside the near field region 
of the aperture. The source parameters for the model are the half-width (S) and the 
phase curvature of the wave front (R) both in the E- and H-principal planes. The 
source parameters for the GHM were calculated from the E-field mcasurements 
along the main axes of the antenna according to an algorithm described by 
Lumori (1988). 
A dual-layered fiat phantom configuration was used in the GB-predictions for 
incoherently driven LeA-configurations. The top layer represented water (E, = 76, 
a = 0.001 S/m) and the second layer represented muscle-equivalent tissue. The prop-
erties of muscle tissue wcre sct to E,' = 57 and a = 1.2 S/I11. 
In order to allow for a comparison between TG-measured and GD-predictcd 
SAR distributions, it was necessary that the relative net-power outputs of the two 
antennae were comparable for hath the measured and predicted SAR distributions. 
Therefore, the ratio of the net-power output of the two antennae, as estimated from 
the local maxima in the measured SAR distributions, were uscd as power parameters 
for the Gll-modelling to predict the respective SAR distributions. By optimizing 
these power settings in order to dccreasc the diflcrellce between TG- and GB-SAR 
distributions, a compensation can he made (partially) for the interactions bctween 
two antennae in the Gn predictions. 
ESHO QA guidelines demand the use of a waterbolus (Hand ('/ al. 19l-:9a para-
graph 6.2) if appropriate in a clinical set-lip. For that reason, first antenna set-ups 
without water as an intermediulll have been performed to chcek thc rdiability of the 
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GBM in (dual) array applications of the LeA, and secondly, the ESHO appropriate 
'clinical' relevant set-lip has been used to evaluate the technical usefulness of the 
Gm"f in array applications of the LeA. 
Overall SAR distributions from array applications where mixed E-field orienta-
tions were used (Le. the HV-conllguration) could be predicted only by calculating 
separately the SAR distribution of the horizontal (l-l) and the vertical (V) E-field 
alignment. Locally-written software was used to combine these H and V antenna 
SAR distributions into the required array-application, 
2.5. SAR-rallge related d(l/er(,lIces 
In order to make a quantitative evaluation of the effectiveness of the 
Oll-predicted SAR distributions in comparison to TO-mensllred SAR distributions, 
the area of the array aperture plus 5 cm arollnd the dual-antenna set-up was eval-
uated on SAR differences (20cm x 30cm). The TO-measured SAR distribution was 
aligned with the Oll-predicted SAR distribution and a regular grid (21 x 31 nodes) 
was created for both SAR distributions. The absolute SAR difrerences between -both 
distributions ISARTO-SARonl were calculated for all grid nodes resulting in SAR-
range related differences (SRDs). These SAR dinerences were sorted per range of 
1O%-SARG£l level intervals (10, 20, ... , 100) and the average SAR difrerence per 
1O%-SARoB range was calculated as well as the standard error of the mean. Also the 
maximum difference per SAR-range was obtained. 
3, Results 
3.1. Sillgle LeA scI-lip 
3.1.1. E/ectricjield mClIJW'el1lell/S alld Gallssiall heam sourcc paramc/cl' scta/ioll. Tn 
the single scan of E-field profiles, the location of the maximum power level was 
measured up to 20 mm off-centre. Averaging two oppositely orientated E-fleld 
scans corrected this imbalance and created symmetrical profiles which were suit-
able for calculnting OR-source pluameters. Table 1 gives a summary of the half-
width (S) of the power-profiles and radii (R) of the phase profiles as a function of 
depth obtained with both the small and large E-field probe. The averaged par-
mneters measured at IOmm depth, SE = 3.ge/ll, RE = 00, SH = 5.0em and 
RH = 35 em, were selected for further Gll-calculations. 
For additional E-field scans performed along the main axes, it was fOllnd that the 
contributions of lEi and IE712 to the overall SAR distribution at JO mill depth in 
muscle-equivalent tissue were less thun 0.5% and 2% respectively. The maximum 
lEi values were found under the brass rim of the aperture. The PVC cone did not 
increase the local near-field levels at JOmm depth. 
Table I. Half-power half-width (S) and phase radiu~ (R) of the LeA as function of depth. 
Dipole Depth (mm) 51' (cm) RE (cm) SI[ (cm) 
1 10 3.6/3.9 00/00 4.9/5.0 
1 20 3.4/3.7 00/00 4.7/5.1 
1 30 3.5 00 4.6 
2 10 4.2 00 5.0 
Average 10 3.9* 00* 5.0~ 
* Average value, calculated from al1mea~urements at IOmm depth. 
Dipole I: unbalanced, length IOmm; dipole 2: unbalanced, length 20ml11. 
RII (cm) 
35/35 
35/67 
35 
22 
31 ' 
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Figure 2. Relatiye SAR distribution lit IOmm depth in muscle in the principal (a) E-field 
pl<lne and (b) H-field plane orthe LeA as measured with the thermogmphic- lind the E-
Held scanning technique (20 min wide unbalanced dipole nntcnna) or as predicted by the 
Gaussian beam model. The E-field amplitudes as measured with the dipole arc converted 
to a parameter proportional to SAR (E x E), Half-power half-widths (a) TO: 4.3 em; 
dipole: 4.2('m; OD: 4.2cm; (b) TO: 5.1 em; dipole: 5.0cm; GB: S.2em. 
3.L2. Comparison vI GB-pret/icled {II/(/ TG-measlI/'cd SAR disfrihllfiol/s. The 
power-profiles in the principal planes were derived for a single LeA from a TG-
measured SAR distribution. Use of a walerbolus was excluded 10 enable a direct 
comparison with the E-field measurements and the OB-predicted SAR distribu-
tions. Figure 2 shows the power-profiles in the principal planes derived from the 
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Figure 3. SAR at 10mm depth in lllusdc~eqlli\'a!ent phantom from the HV~conliguratioll. 
No water-bolus/layer was used as inlermcdium. The antennae are indicated by the 
squares. SAR range: 0--100. (a) thermographic-measured SAR distribution; (b) 
Gaussian beam-predicted SAR distribution; and (c) absolute SAR-difterenccs (SRDs) 
between the GD-predicted and TG-measured SAR distributions. The SAR~difierenccs 
were calculated per GD~related 10% SAR-inlcTvals. The bars represent the mean v(l]ue 
per inlen'al, the error bars represenl the corresponding standard error of the mean. The 
line indicates the maximulll difference per Gll-interval. 
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Table 2. Estimated power settings derived from TO-measured SAR distributions and 
corresponding optimized GS-power settings. The power settings are normalized to 
I. Also TO-measured and OR-predicted effective field sizes (BPS) obtained at I em 
depth in muscle-equivalent phantom from threc different E-field orientated dual array 
applications of the LeA are presented for antenna sel-ups without aod with a water 
layer/holus. 
Antenna HH VV HV 
configuration 
TG GB TG GB TG GR 
no waterbolusjwater layer as intermedium 
Ph P1 1,0.9 0.9, 0.83 1,0.9 0.9,0.77 1,0.9 0.9,0.74 
EFS [cml] 134 129 98 119 115 123 
1 em thick waterbolus/watcf layer as intermediuIll 
PI> P2 1,0.93 0.93, 0.84 I, I 0.84, 0.84 0.9, 0.95 0.89, 0.95 
EFS [cn/J 136 131 123 110 139 144 
SAR measurement, the E~ficld scan with the large dipolc E-ficld probe and the 
SAR distribution as predicted by thc OHM. The full widths at half power as 
calculated ftom all thrcc tcchniques are given in the legcnd of figure 2. 
3.2. DUIII LCA set-lip 
3.2.1. Comparison vf GB-predicted ami TG-I1I(,lIsllred SAR distrihutions withvut 
water (IS illtermediulII. Figure 3a shows the TG-measured SAR distributions from 
HV orientated LCA array and figure 3b shows its corresponding OR-predicted 
SAR distribution. (Tn all figures containing relative SAR distributions, the 50% 
SAR contour has an increased line thickness.) 
Table 2 gives a summary of the measured (TO) and sct (OD) power levels 
together with calculated and predicted EfSs of the HH, VV and HV E-field orien-
tated dual-LCA configurations. 
Figure 3c shows the calculated SRDs for the HV configuration. The average 
SRD as well as its standard deviation and the maximum or SRD per 10% SAR 
interval are indicated. The average SRD within the predicted EFS area, (SRDEf:s), 
equals 25%. The results from the HH and VV configuration showed less pronounced 
differences bctween TO-measured and OD-predicted SAR distributions, the SRDEFS 
cqualled 8% (HH) and I I % (VV). 
In order to understand the enhanced SAR differences in the HV set-up between 
TG- and Gll-SAR distribution, an additional cxperiment was performed to quantify 
the antcllna interaction. Tn this sct-up only the 'V' antenna \W1S powered and the 'H' 
antenna was cOllllected to a 50 ohms dummy load, Figure 4a shows the TG-SAR 
distribution. A shift of the maXil11U111 SAR level of 3cI11 in the outward direction of 
the array Wl1S measured. 
3.2.2. Comparison of G B-predicted and TG-mea.w/'ed SAR distrihutiOlls lI'ill! \l'att'/' 
as illtermetiilllll. The antenna interactioll in the HV-set-up was measured firstly, 
with the powered 'V' antcnna and 'H' antenna connected to the dummy load. 
Figure 4b shows the TG-SAR distribution with water as intennediulll. The 
mltellna interaction shO\ved up less prominently. The shift of the maximum levels 
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Figure 4. Thermographic-mclIsured SAR distributions (range: 0-100) of the HV-orientated 
dual LeA-array configuration at IOmll1 depth in muscle-equivalent phantom. The 'V' 
antenna was powered in order to show the effeel of antenna interaction on the SAR 
distribution and the 'H' antenna was connc(:(cd to a 50 ohm load. The antennae are 
indicated by the squares. (a) no water used as intermedium; and (b) watcrbolus of I em 
thick used as intermediulll .. 
almost disappeared « 1 em) but still a distortion of the symmelry in the TG-meas-
ured SAR distribution is shown. 
Figures Sa and 6a show the TO-measured SAR distributions from two parallel 
orientated LeA arrays HH and VV respectively, whereas figure 7a shows the TG-
measured SAR distribution of two LeAs with perpendiculflr orientated E-fields 
(HV). The corresponding all-predicted SAR distributions flrc shown in figures 5b 
to 7b; HH, VV and HV. Table 2 gives a summary of the power ratios together with 
measured and predicted EFSs of the various dual antcnna configurations. 
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Figure 5. TU-measu[('d (a) and OD-predicted (b) SAR distribution (range: 0-\00) of the 
HH-orientated dual LeA-array configuration at 10 111m depth in muscle-equivalent phan-
tom. Water-bolusjlayer I em thick. The antennae are indicated by the squares. 
Figure g shows the calculated SRDs for the dunl afray applications of the LeA 
with water as intermedium. The SRDEFS per E-Jleld configuration equal 6% (HH), 
S% (VV), and 12% (HV), 
4. Discussion 
Experimental assessment of the behaviour of the SAR distribution of an array of 
antennae can be regarded as a cumbersome procedure as it is difficult or impossible 
to distinguish between the effect of each relevant parameter on the resulting SAR 
distribution. In such cases, the aid of proper theoretical models can be of great value 
in dramatically reducing the period of time needed to develop a clinical applicator. 
The reliability of a m<lthematical model is limited by the quality of the required 
source parameters. rvfeasurement of the source parameters for the GHM is done by 
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Figure 6. TG-measured (a) and Gll-predicted (b) SAl{ distribution (range: 0-100) of the 
VV-orientated dual LeA-array configuration at 10 111m depth in I11tlsdc-cquiv,IiCllt plwn-
tom. Water-bolus/layer 1 em thick. The antennae are indicated by the squares. 
means of a miniature dipole antenna. Some research groups have developed mini-
ature probes to measure the E-field amplitude and phase emanating from an antenna 
(Schneider el al. 1991, ~Jcicr ('/ lIl. 1992, Gopal et al. 1995, Wust l'1 al. 1995). These 
have dedicated designs which compensate for imbalance. Alternatively, as was 
demonstrated by Lumori e/ al. (l990a), it was possible to use unhalanced open-
folded coaxial cable as dipole antennae in order to probe the E-field of the LCA. 
The imbalance of the E-field probes can be corrected by averaging two opposing E-
field scans. Using this technique we found, in the case of the LCA, thai the con-
tribution to the SA R distribution of the near-field components, Ey and En at 10 mill 
depth, was negligible (less than 2%) and that the E,\-field measurements at IOmm 
depth formed a good representation of the E-field profiles. 
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Figure 7. TO-measured (a) and DB-predicted (h) SAR distribution (range: 0-100) of the 
HV-orientlltcd dU[l] LCt\~array configuration at IOmm depth in muscle-equivalent phan~ 
tOIll. Water-bolus/layer I em thick. Thc antennae arc indicated by the squares. 
From the comparison of the SAR profiles ill the principal planes at 10 mill depth 
in muscle for thc three different techniques (E-field measurement, TO-measurement 
and GD-prediction, figure 2) it was concluded that the GB1'vf can be used to predict 
SAR distribution frolll a single LeA. This was without the use of water as inter-
medium and the error was less than 5%. 
Other groups have already shO\\'Jl that the GSlvl can predict SAR distributions 
from array applications with good accuracy when antennae are placed directly on a 
muscle-equivalent phantom (Lumori et al. 1990b, Gopal et Ill. 1992). However, in 
LeA clinically relevant configurations a water bolus is used as intermedium. In this 
case the finite dimensions of the 18cI11 x 18c111 waterholus influence the EFS of a 
single LeA by 30% (Van Rhoon 1'1 al. 1998). It is possible to adjust the Gm.,,[ for 
these finite waterbolus effects on a single antenna by using the waterbolus when 
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Figure X. Absolute SAR-uifferences (range: 0-100) between the GB-predicted and TG-llleas-
ured SAR distributions from dual LeA arnlys. 1 em thick water layer/holus used as 
interOlcuium. The SAR-ditfereoccs were l\vcmged per On-related 10% SAR-intervals. 
Errorbar.~ indicate the st;lndaru efroT of the mean and the line represents the maximum 
SAR-diflerencc per GR-intervaL (a) HH-dual array configumtion of LeAs; (b) VV-dual 
array configuration of LeAs; and (c) HV-dual array configuration of LeAs. 
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measuring the E-field profiles. HO\vever, in predicting SAR distributions from array 
configurations the latter would require E-field measurements for each relevant 
antenna orientation in the array configuration as the total waterbolus is a variable 
and asymmetric load to each antenna. This is considered to be too time-consuming 
and contra-indicative for the lIs,lbiIity of the GEM. On the other hand, if a relatively 
large waterbolus is used (25 cm x 30 em x 1 em) for single LCA experiments, 
TG-measured and GB-predieted SA R distributions correlate well (64 and 68 cm2 
respectively, Van Rhoon el al. 1998). For these reasons we lIsed the GB-source 
parameters derived from a single LeA, measured without the use of a water bolus, 
for GB-based predictions of SAR distributions from LeA arrays. 
Dual array configurations williolll water as intennedimn can be described exactly 
with the GBM. Although the GB-power settings were optimized to minimize SAR-
distribution differences (table 2), large qpantitative differences were found: a SRD 
maximum of 44% in the HV-configuration; maximum ayerage over all 10% SAR 
ranges per dual array configuration: 19% (HY) and global average 12%, aye raged 
over all three E-field configurations and all SAR ranges were calculated. Especially 
in the HV-configuration (figure 3), the 3cm shift of the local 'V'-SAR maximum 
caused high values of the SRD. Additionally, in this set-up there was also a poor 
qualitative similarity (i.e. geneml shape of the SAR-contours) between TG- and GB-
ohtained SAR distribution. These deviations are considered unacceptable for model 
predictions. The large deviations were caused by antenna interactions which cannot 
be incorporated in the OBM. This effect was demonstrated clearly in the experiment 
of a single powered 'V' antenna in the HV-configuration, for which high SRDs were 
calculated in the plus 50%> SAR range. The SAR distribution frolll the 'V' antenna is 
pushed aside by the adjacent 'H' antenna (figure 4a). 
The quantitative SAR diITerences were generally smaller (figure 8) for the water 
layer/waterbolus set-up (SRD maximum: 27% (HV); maximum average oyer all 
10% SAR ranges: 8% and global average 7%, averaged over all three E-field con-
figurations and all SAR ranges). Again deviations between measured and predicted 
SAR distributions are caused hy unmodelled antenna interactions (figures 5, 6 and 
7). It is as yet unclear how the antenna interactions behave exactly and further 
investigation is necessary. However, the TO-measured SAR distribution from the 
single powered 'V' LCA in the HV-configuration (figure 4b) showed that these 
antenlla interactions are less prominent when a water bolus is used. The elfect of a 
finite water bolus on the SAR distribution is of less magnitude than the antenna 
interactions (and might even compensate partly for these interactions). The qualita-
tive comparison hetween the GB-predicted and TO-measured SAR distributions, 
with respect to the general shape of the SAR-contours and to the 50% SAR-cQntOtlr 
(=EFS) in particular, is of a greater resemblance which is reflected in a lower average 
SRDEFS : 14.5% (no water) verslls 8.4% (including a water layer/waterbolus). 
In conclusion, for a single LeA, the GllM predicts the SAR distribution cor-
rectly if the source parameters for the GBM are obtained according to the experi-
mental set-up. If single LeA source parameters ,ire used to predict SAR 
distributions from dual arrays of LeAs with a waterbolus, the GBM is accurate 
enough for qualitative predictions. This is not the case without a waterbolus as 
intermediulll. 
As the configuration parameters (e.g. power input <lntellna or alignment) are 
better controlled in the OBM than in experimental sct-ups and because only a single 
antenna is necessary to ohtain source parameters for the clinically more interesting 
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array configurations, the OHM is found to be a useful tool for (a) guiding experi-
mental verifications of LeA configurations and (b) performing qualitative studies of 
SAR distribution from clinically relevant LeA array configurations. 
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Abstract. SAR distributions from four different E-field-orientated 2 x 2 arrays of incoherently 
driven Ludle cone applicators (LeAs) were investigated, The LeAs operated at 433 MH1; with 
an aperture of 10.5 em x 10.5 ern each. Two techniques were llsed to obtain SAR distributions 
in flat layered phantoms: Gaussian beam (OB) predictions and thermographical (TO) imaging. 
The OB predictions showed that the effective field size of the different rumy configurations 
varied by up to 3%. 
The TO-measured SAR distribution showed significant deviations [com the GB-predictcd 
SAR distributions (madmum 34.6%). The difference between GB-predicted and TO-measured 
SAR levels (averaged per 10% GB-predicted SAR intervals) equalled less than 11.3% [or the 
parallel E-field orientated UlTay and respectively 15.1% for the clo(kv.isc-orientaled array. 
When antennae in the clockv.ise-orienlated array were more widely spread (may aperture 
23 em x 23 em) in order to diminish their mutual interactions, these differences decreased 
to 12.4%. However, the overall difference v.ithin the 50% SAR or higher range decreased [rom 
14% to 9%. The results lead us to conclude that LCAs can be used clinically and their antenna 
interactions are not considered to be a problem under clinical conditions. 
1. Introduction 
In earlier publications (Rietveld et al 19901 1991 1 19981 Van Rhoon et al 1992, 1998) we 
have reported on the progress of the development of the Lucile cone applicator (LCA), 
In the same publications we have demonstrated the value of the Gaussian beam model 
(GBM) (Lumori et (1/ 1990a) as an efficient and practical tool for investigating the specific 
absorption ratc (SAR) distributions from single- and dual-clement array configurations of the 
LCA. Although a disadvantage of the currently available GBM is that antenna interactions 
and other practical side cffects can only partly be integrated by means of optimizing GB 
input parameters (Lumori et at 1990b), current available 3D models capable of dealing with 
tissue structures and antenna interactions arc yet not feasible for applications presented herc. 
§ Reprint requests to: P J Iv{ Rietveld, Daniel den Hoed Cancer Center. Department of Radiation Oncology, 
Subdivision of Hyperthermia, PO Box 520t, NL-3008 AE Rotterdam, The Netherlands. E-mail address: 
rielvc!d@hyph.au.nl 
SAR distributions from 2 X 2 LCA arrays 
However, time-consuming thermographic (TO) measurements of SAR distributions in flat 
layered muscle equivalent phantoms demonstrate such interaction effects clearly. 
In this paper we report on the techl/ical perfonnance of the four possible 
E-field-orientated 2 x 2 LCA array configurations and a comparison is made between 
the OB-predicted and TO-measured SAR distributions in a flat layered muscle equivalent 
phantom. The quality of the arrays will be evaluated based on the ESHO quality assurance 
guidelines for superficially used single antennae (Hand et af 1989). 
Differences between OB-predicted and TO-measured SAR distributions of the four 2 x 2 
LeA-array configurations will be discussed. These differences cannot be expressed only by 
the effective field size (EFS: area enclosed by 50% SAR contour at 1 cm depth in muscle 
tissue, Hand et af 1989) since location or shape of the effective field relative to the aperture 
is not incorporated in this parameter. Therefore, an additional SAR-derived variable, the 
SAR-related difference parameter (SRD), will be defined to quantify the TO-measured SAR 
deviations from the OB-predicted SAR distributions. It will be found that the relative E-field 
orientations in the 2 x 2 LeA array do not contribute to a significant difference in EFS and 
that the mcan difference between OB-predicted SAR distributions and TO-measured SAR 
distributions is caused by antenna interactions and finite watcr bolus effects. 
2. Materials and methods 
In order to evaluate the technical performance of array applications of the LCA, firstly the 
SAR distributions at 1 cm depth in a homogeneous muscle-equivalent phantom from all 
four possible E-field configurations in a 2 x 2 array set-up are predicted with the OBM. 
Secondly, the SAR distributions from the parallel and clockwise orientated array set-ups 
of the 2 x 2 array are measured and compared to their corresponding OB-predicted SAR 
distributions. 
2.1. Lucite cOile applicator 
The Lucite cone applicator (LCA) is a modified water-filled horn antenna operating in TEIO 
mode at 433 MHz and has been described in detail by Van Rhoon et af (l992, 1998). The 
outcr dimensions measure 10.5 cm x 10.5 em and thus a 2 x 2 LeA array creates a total 
aperture of 21 em x 21 em. 
2.2. Antenna array configurations 
Figure 1 shows the four relative E-field configurations in a 2 x 2 array of LeAs which were 
tested. In all experiments a non-perfused water bolus at room temperature was used which 
measured 28 em x 25 em x 1 cm. 
1\\'0 series of experiments were performed. In the first series, the antennae were 
positioned adjacent to each other (compact array). The total aperture of the compact 2 x 2 
array was 21 em x 21 em. 
In the sccond series the antennae were separated from each othcr by creating a virtual 
antcnna aperture of 11 em x 12 em (II em in the E-lield direction and 12 em in the ll-ficld 
direction). In this series only the clockwise orientation was evaluated conccrning properties 
of the SAR distribution. The total aperture of this inter-antenna-spaeed 2 x 2 array was 
23 cm x 23 cm. 
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Figure 1, Relative E-field orientations in a 2 x 2 array of LeAs. The E-field directions 
are indicated by arrows, the antennae by squares. (a) Parallel orientated, (b) Q.-Qrientntcd, 
(c) U-orientated and (d) clockwise orientated. 
2.3. Thermographic SAR measurements 
SAR distributions at I em depth in muscle were obtained using a layered semi-solid muscle-
equivalent phantom (48 em x 48 em x 10 em) made of Supcr Stuff (Guy 1971), A 
thermographic camera (AGA Thermovision System 680/102B) interfaced to a PC was used 
to measure the temperature distribution of the exposed surface. 
Net power input per antenna during the experiments was about 130 W; the healing 
lime was set to 1.5 minutes in order to obtain a significant temperature rise. The antennae 
were driven incoherently and powers were adjusted in order to obtain an equal net power 
output at the aperture of each antenna. If within the aperture of each antenna a local SAR 
maximum of 70% (relative to the absolute SAR maximum under the antenna array) was 
measured then this measurement was considered acceptable. 
2.4. Gallssiall beam model 
The Gaussian beam (GB) model has been described extensively elsewhere (Bach Andersen 
1987, Lumori 1988, Lumori et af 1990a,b). The LCA source parameters for the model, the 
half'power half-width (S) and the phase curvature of the wave front (R), in both the E-
and H-principal planes were derived from E-field measurements: SE = 3.9 em, RE = 00, 
SH = 5.0 em and RH = 35 em (Rietveld e( af 1998) and are based on single antenna 
measurements without use of water as an intermedium. The E-field measurements were 
derived from the dominant E-field component (Ex). Ey and E~ contributed less than 2% 
to the entire E-field distribution (Rietveld et af 1998). 
A triple-layered flat phantom configuration was used in the GB predictions for 
incoherently driven LCA configurations. The top Jayer represented water (s, = 76, 
(f = 0.001 S m- I ), the second Jayer represented fat (s, = 5.6, (f = 0.05 S m-') and the third 
layer represented muscle-equivalent tissue (Sf = 57 and a = 1.2 S m-I). Locally written 
software was used to calculate SAR distributions from the mixed E-field configurations and 
to calculate EFSs. 
SAR distributions from 2 X 2 LCA arrays 
The antenna power seUings in the ODM were set equally when investigating the effect 
on the BPS of the four possible E-field configurations. For comparison of TO-measured with 
the OB-predicled SAR distributions, the OD-set power level of each antenna was estimated 
from the TO-measured local maximum under the antenna. By trial and error these power 
settings were adjusted in order to minimize the difference between the TO-measured and 
its corresponding GB-predicted SAR distribution. 
2.5. Quantification of differences between TG-measltred and GB-predicted SAR 
distriblltiolls from array applications of LCAs 
In order to compare SAR distributions from the OBM and TG measurements, the ESHO 
quality assurance (QA) guidelines provide the EPS, the surface enclosed by the 50% SAR 
contour(s). However, the EPS does not contain information about the location of the 50% 
SAR contour(s) related to the antenna apertures in the array. The SAR-related difference 
(SRD) represents an average SAR difference between OD-predicted and TO-measured SAR 
distributions based on ranges of 10% SAR values as predicted by the GB model. Since 
the GBM predicts Gaussian beams with its centre located in the middle of the aperture, the 
SRD also incorporates a location sensitivity. The SRD j is defined by: 
ISARTO - SARoB (i)1/1I1 
11/ = number of data in GB-predicted SAR range j; i = t: [0,10), 2: [10,20), ... , 
10: [90, 100]% iso-SAR. 
By averaging the SRDls in the 50---100% SAR range, an EFS-derived parameter 
is defined, the SRDEFS, which contains both information on position misfits and SAR 
differences for the enclosed OD-predicted 50% SAR contour(s}. The SAR distributions 
were superposed on a 55 x 55 grid, resulting in a 0.5 cm x 0.5 em resolution. 
2.6. Measuremellt of cross-coupling in 2 x 2 arrays 
Cross-coupling in the 2 x 2 arrays was measured on a muscle-equivalent phantom using 
the HP network analyser 8751A. Firstly, the reflection coefficient was minimized for all 
antennae, secondly the transmission between two antennae was measured both with and 
without the use of a water bolus. The other two antennae were terminated with 50 ohm 
loads. The accuracy of the measurements was ±3 dB. 
3. Results 
3.1, First series; compact 2 x 2 LCA arrays 
Figures 2(a) to 2(d) show the OD-predicted SAR distributions at 1 em dcpth in muscle of the 
four different E-ficld configurations of the compact 2 x 2 LCA array with equally set power 
levels. Figures 2(e) to 2(11) show the SAR distributions for the same configurations but 
now with an additional 1 Col thick fat layer. Table 1 gives a summary of the OD-predicted 
EFSs of all E-field configurations of a 2 x 2 LCA array both without and with the use of 
a 1 em thick layer of fat on top of muscle tissue. The minimum SAR in the centre of the 
2 x 2 array equalled 55% without and 65% with a 1 em thick fat layer. 
Figures 3(a) and 3(b) show the TO-measured and the corresponding OB-predieted SAR 
distribution of the parallel orientated 2 x 2 LCA array. The EFSs equalled 331 cm2 and 
261 cm2 respectively. During the experiment with the LCAs in the parallel orientation, 
reflected power levels of 5-12 W (still below 10% of the forward power level) were 
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Figure 2. Gaussian-beam-predicted SAR distributions (SAR r.lllge 0--1) [rom 2 x 2 LeA arrays 
at 1 em depth in muscle-equi\'ruent tissue. The antennne (indicated by squares) are equally 
powered and the total aperture measured 21 em x 21 em. The E-fieJds are orientated according 
to figure 1. A I em thick waler Jayer was modelled as intennedium. The effective field is 
indicated by the bold line. The used configurations are: (a) parallel orientated, (b) Q-orientated, 
(e) U-orientated and (d) chxkwise orientated. 
measured. In the H~field direction (the 'Lucile' direction of the LeA) the width of the 50% 
iso-SAR contour measured 18.8 em and 21.4 em for the GB-predicted SAR distribution 
and the TO-measured SAR distribution respectively. In the E-Jleld direction this width 
measured 17.1 cm and 17.3 cm. 
Figures 4(a} and 4(b) show the TG-measured and its corresponding GB-predicted SAR 
distributions of the clockwise-orientated 2 x 2 LeA array. The EFSs equalled 303 cm2 and 
248 cm2 respectively. The reflected power levels were in the range of 1-6 W. The local 
maxima under each antenna showed a significant shift in the H -field direction, towards the 
edge of the array. 
Figures 3(c) and 4(c) show the calculated SRDs from the parallel and clockwise 
TG-mcasured and their corresponding GB-predicled SAR distributions. The SRDEfs 
equalled 9.4% and 14.0% for the parallel respectively the clockwise configuration. 
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Figure 2. (Continucd). (e) to (II) like (a) to (eI) but now including a I em fat layer on top of 
the musc1e-equivalent tissue. 
Table 1. Summary of the GB-predicted effectiYe field sizes of fOUf different 2 x 2 LeA array 
configurations. The antennae were equally powered and closely packed. A water layer of I em 
thickness has been modelled. The total aperture eoYered 21 em x 21 em. 
To quantify the shift of the local maxima, as shown in figure 4(a), a single antenna in the 
clockwise-orientated array was powered while the remaining antennae were terminated with 
a 50 ohm load. The resulting SAR distribution is shown in figure 5(a). The corresponding 
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Figure 3. SAR distributions at 1 em depth In muscfe equivalent tissue obtained [rum a parallel 
E~field orientated 2 x 2 LeA lUT3y. A I em thick water bolus (TO) or water layer (OB) 
was included as in\crmedium. The antennae are indicated by squares; the effeetiyc field (EF) 
is indicated by the bold line. (a) Thermographic (TO) measurement (SAR range: 0-100); 
(b) Gaussian beiUll (GB) predicted, with power settings optimized to fit the corresponding TG 
measurement (SAR range: 0-1); (el absolute SAR differences (range: 0--100) between the OB-
predicted ami TO-measured SAR distributions c(l1culated relative to 10% OB-predicted SAR 
ranges. Bars indicate the average pcr SAR range, errorbars indicate the standard crror of the 
mean and the line represents the m:uimum difference per 10% OB-predicted SAR rangl.1. 
EFS was 41 cm2 and the shift of the local maximum in the II-field direction equalled 3 em, 
No shift was observed in the E-field direction. 
Table 2 summarizes the measured cross-coupling between antennae in the compact 
parallel- and clockwise-orientated arrays. 
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Figure 4. SAR distributions at 1 em depth in muscle equivalent tissue obtained fTom a elockwise-
E-field·orientated 2 x 2 LeA array. The E·fields arc orientated according to figure I(d). A 
I em thick water bolus (TO) or water layer (OB) was included as intennedium. Antennae ure 
indicated by squares: EF is indicated by the bold line. «(I) Thermographic (TO) measurement 
(SAR range: 0-100); (b) Gaussian beam (GB) predicted, with power sellings optimized to fit the 
corresponding TG measurement (SAR range: 0-1): (e) absolute SAR differeuces (range: 0-100) 
between the GR-predicted and TO-measured SAR di~lributions calculated relative to 10% GB· 
predicted SAR ranges. Bars indicate the average per SAR range, e!ToTbill's indicate the standard 
error of the me.an and the line represents the muimum difference per 10% GR-predicted SAR 
range. 
3.2. Second series: illfer-elelllelli spaced clockwise·orientated 2 x 2 LeA arra), 
Figure 5(b) shows the SAR distribution of a single-powered antenna in the inter-element 
spaced 2 x 2 LeA array setup, while the other antennae were terminated with 50 uhm 
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Figure S. TO-measured SAR distribution (range: 0-100) from a single-powered LeA in a 
2 x 2 clockwise-orientated LeA array. The E-ficlds are orientated according (0 figure l(d). 
The total aperture measured: (a) 21 em x 21 em (closely packed array) and (b) 23 em x 23 em 
(inter.-element spaced array). 
Table 2. Summary of the cross-coupling between LeAs in a 2 x 2 array. The antenna 
configurations are chosen as in figure 1. In the compact configuration the army aperture 
measured 21 em x 21 em; in the inter-element spaced configuration the array aperture measured 
23 em x 23 em. The water bolus measured 25 em x 28 em x 1 cm. 
No bolus With bolus 
Antenna configuration Couple [dB] [dB] 
parallel, (Ompact 'J' --t '2' -18 -18 
parallel. compact 'I' -7 '3' -26 -27 
pamllel, compact '\'4 '4' -22 -24 
cllX"kwise, compact '1'4 '2' -28 -33 
dock""ise, compact 'I' ---+ '3' -26 -32 
ptlIallel, spacious 'I' 4 '2' -36 -33 
parallel, spacious 'I' 4 '3' -39 -33 
parallel, spacious 'I' ---+ '4' -21 -21 
dod;v.ise, spacious 'I' ---+ '2' -32 -36 
clockwise, spacious 'I' ---+ '3' -34 -35 
loads. The shift in the H -direction of the SAR maximum still equalled 3 em, However, 
the TO-measured EFS equalled 61 cm2 which was an increase of 20 cm2 compared to 
the equivalent compact setup. Figure 6 shows the SAR distribution of the inter-element 
spaced 2 x 2 LeA-array: (a) GB predicted, equally powered, (b) TG measured, (c) GB 
predicted wilh TO-derived and optimized power settings. Figure 6(d) shows the SRDs as 
calculated from the TG-measured and GB-predicted SAR distributions. The measured EFS 
(384 cm2 ) and predicted EFS (equal antenna powers: 370 cm2 ; power settings according 
to TG measurement: 330 cm2) vary by 16%. When a 1 em fat layer was incorporated 
in the OB model, the EFS equalled 444 cm2. The SRDs ranged from 8.2% to 9.4% and 
the SRDEFS equalled 8.8%. The GB-predicted minimum SAR at the centre of an equally 
powered inter-element spaced 2 x 2 LeA array was 39% and 59% respectively without and 
with a I cm thick fat layer. 
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Figure 6, SAR distributions from the inter.-element spaced 2 x 2 clockwise-orientated LeA 
array. The B'-fields arc orientated according to figure I(d). Data are obtained from: (a) Gll 
prediction with equally set power levels, (b) TO measurement and its (e) corresponding Oll 
prediction. 
Table 2 also summarizes the measured cross-coupling of the inter-element spaced 
clockwise-orientated configuration. 
4. Discllssion 
4. J. QlulIltijicatoll of the quality of arrays of antennae 
The total SAR distribution of an array of antennae is generally not a superposition of the 
SAR distributions of individual clements, since adjacent E-field dislributions may overlap 
or antennae may interact. Although only incoherently driven LeA arrays are evaluated and 
constructive E-field interference between individual antennae can be excluded, the array 
must be evaluated as if it were a single antenna (Ibbott et al 1989), i.e. an evaluation is 
made of the total EFS, as defined by Hand et al (1989). 11\C expected penetration depth 
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Figure 6. (Colllinil/cd). (d) Absolute SAR differences (range: 0-100) between the CD-predicted 
and TO-measured SAR distributions calculated relative to 10% OD-predicted SAR ranges. Bars 
indicate the average per SAR range, errorbars indicate the standard error of the mean and the 
line represents the maximum difference per 10% GB·predictcd SAR range, 
of the incoherently driven array will be of the same order as of a single LeA (Hand et af 
1992), Evaluation of the penetration depth of 2 x 2 LeA arrays is excluded from this report 
since deviations from the single-LeA penetration depth of up to 20% are not measurable 
with techniques available to us, 
The EFS of an array of antennae quantifies the technical usefulness since it is a measure 
of the covered (reatment area under the total aperture, However, whether the EFS (relative 
to the total aperture's physical dimensions) is the measure for ensuring clinical 'quality of 
an antenna array, is still debatable (Oleson 1989, Myerson et af 1990, Gelvich et af 1996). 
In fact, unambigious clinical quality requirements of a SAR distribution for any application 
of hyperthermia has not been defined as yet (Hand et af 1989, lbbott et al 1989, Oleson 
1995). 
For arrays of antennae, the EFS is calculated from the total SAR distribution from the 
array, However, the location of the effective field (EF), relative to the total aperture, is 
not expressed in the EFS, This is not considered to be a problem when used for single 
antenna applications: the EF has its centre of gravity located near the centre of the aperture, 
For arrays of antennae, the EF has generally a more complex shape, In characterizing 
antenna arrays, the mutual interaction between antennae can cause changes in the SAR 
distribution which may not influence the BFS from that array significantly but which can 
change the shape of the EF significantly, In the GBM, effects of antenna interactions on SAR 
distributions can be discriminated into a superposition of (a) a change of GB power settings 
of each individual antenna and (b) a change of GB source parameters for each antenna, The 
latter will result in a different SAR print of each individual antenna depending on its place 
in the configuration of the array, This is only possible when the 2 x 2 antenna interactions 
are fully analysed, TIlis is beyond our comprehension. For that reason we use the GB 
source parameters obtained from a single antenna operated without adjacent antennae. 
The SAR-related difference (SRD) combines differences between TG-measured and 
GB~predicted SAR distributions and relates these differences to the location in the 
GS-predicted distribution which is a superposition of apcrture-cef1:'-ed single~antenna SAR 
SAR distriblltiolls ji'OIll 2 X 2 LeA arrays 
distributions. The SRD therefore quantifies the SAR anomalies in an array which are caused 
by antenna interactions in the array. 
4.2. Effects of Ejield configurations or a/at layer 011 the SAR distriblltions/rom 2 x 2 
arrays 
When optimizing the temperature distribution during a hyperthermia treatment, one of the 
procedures is to rotate an antenna over 90", thereby changing the E-field orientation and 
thus creating a different array configuration. From OB-predicted EFSs for the four different 
E-field-configured 2 x 2 LeA arrays as shown in figure 2 and as summarized in table 1, it 
can be concluded that the different configurations have little effect on the resulting EFS of 
a 2 x 2 array and have equal power deposition quality. 
All four E~field configurations of the compact 2 x 2 LeA array have a OB-predicted 
minimum SAR level at the centre of the array of above 55% when calculated at I cm depth 
in a homogeneous muscle-equivalent phantom. Incorporating a I em thick fat layer in the 
GBM increased the minimum SAR at the eentre of the array to 65% and the average EFS 
of the four possible E~lield conligurations from 348 to 383 cm2 • Incorporating a fat layer 
increases the reflected power level by up to 56% (Johnson and Ouy 1972) and thus reduces 
the effective heating of the underlying muscle tissue. Since the available power units could 
not produce an adequate temperature rise within 90 seconds when a fat layer was used, TO 
measurements involving a fat layer were excluded from the experiments. 
Although the QA guidelines (Hand et al 1989) have no regulations on the shape of 
the EF, we find it appropriate for array applications to demand a contiguous EF under the 
array when obtained in a homogeneous muscle phantom. SAR values within the 50% SAR 
contour should therefore not drop below this 50% SAR level. Adding a fat layer in the 
GBM improved the quality of the EF in this respect. 
4.3. Comparison of GB-predicted and TG-measured SAR distributions from 2 x 2 LeA 
arrays 
The TO-measured and OB-predicted SAR distribution of the parallel2x2 array configuration 
showed a good qualitative resemblance (figure 3(a) and figure 3(b) respectively). 'Illis was 
reflected in low average SRDs of around 10% (figure 3(c» and SRDEFS (9.4%). The main 
difference in TO-measured and OB-predieted BFS of the parallel 2 x 2 array configuration 
(331 versus 261 cm2), especially in the 'open' H-field direction, is caused by a finite water 
bolus effect (Van Rhoon et al 1998). 
Low reflected power levels arc observed in the clockwise orientation of the 2 x 2 array, 
which is to be expected because the adjacent E-fields are orientated orthogonally. Therefore, 
the average cross-coupling is significantly lower than in the parallel configuration (5 dB, no 
water bolus used; 9 dB, with water bolus; table 2). However, in the case of the clockwise-
orientated array, a 3 em shift outwards in the H-field direction of the local maxima under 
each antenna was measured (figure 4(a». This shift of local SAR maxima in the c1ockwise-
orientated configuration is inherent to the 'open' design of the LeA and was confirmed 
by the single-powered LeA in the clockwise-orientated 2 x 2 array (figure 5(a). This 
phenomenon is caused by interaction of the RF field through the 'open' Lucite side wall 
with a metal side wall of an adjacent antenna. This was rellected in a high SRDEf's (14.0%) 
whereas the SRDEf's equalled 9.4% for the parallel configuration. 
In the second series the LeAs were separated from each other by a gap of 2 em, and 
through taking this measure, the cross-coupling between the antennae was substantially 
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decreased (averaged over all configurations: 8.4 dB, without water bolus; 4.8 dB, with 
water bolus, table 2), The resulting TO-measured SAR distribution of a single-powered 
LeA in this intcr-element spaced 2 x 2 clockwise-orientated array confinned these findings 
(figure 5(b». The EFS of the single-powered antenna in the inter-clement spaced 2 x 2 
array was in the range of the EFS of a single LeA as measured with a large water bolus 
(Van Rhoon et af 1998). Still the same shift of the maximum SAR level was found 
as in the compact array but the odd shape of the single-antenna EF in the inter-element 
spaced 2 x 2 oITay was less prominent, reflecting less disturbance. This was confinned 
by a smaller SRDEFS (9.1% for the inter-element spaced array versus 14% for the compact 
array). Although the lower level SRDs for the inter-element spaced array configuration were 
higher than for the compact configuration (figure 6(c) respectively 4(c)), the overall average 
SRD from the inter-element spaced array configuration was lower (9.7%) than that from the 
compact array (10.4%). Cross-coupling can have a significant effeet on the position of the 
local SAR maximum under each antenna (figure 5(a» but it neither results in poor quality 
(Le. diseontiguity) of the SAR distribution from a 2 x 2 LCA array (figure 4(a» nor leads 
to unacceptable levels of reflected power. 
By creating the inter-element spaced array, the OB-predicted EFS increased by II cm2 
to 370 cm2 but also bccame discontiguous. Comparison between the TO-measured and 
OB-predicted SAR distributions again showed that the TO EFS was enlarged by antenna 
interaction and water bolus effects. The discontiguity of the OB-predicted EFS disappeared 
when a I cm thick fat layer was modelled, 
In summary: the OB-predicted EFSs from the 2 x 2 arrays of LCAs showed no 
significant sensitivity to selected E-lieid configurations. Differences in shape between 
OB-predicted and TO-measured SAR distributions have shown firstly that OB predictions 
alone are insufficient to describe full RF behaviour of the LCA in an array application 
and secondly that for antenna array applications quality assurance guidelines should be 
rormulated concerning necessity of contiguity of the BFS. The relalively large EFS of the 
2 x 2 arrays of LCAs provides a solid basis for clinical use of the LCA power settings and 
E-lIelJ configurations. 
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abstract 
The technical comparison of Current Sheet Applicator (CSA) and Lucite Cone Applicator 
(LeA) anays covering an area of approximately 20*20 C1112 is investigated based on Gaussian 
beam (GB) predicted SAR distdbutions. The comparison is made in muscle equivalent tissue 
at 1 em depth (maximum 8AR nonnalised to 100%) and over a volume of 3 em depth under 
the aperture of the antennae. The planar 8AR distribution is tested on field sizes (FS.,: area 
covering x% SAR), penetration depth (PD) and homogeneity coefficient (HC ~ FS,,IFS,,), 
From the SAR volume, a SAR-Volumc histogram (= volume enclosing y% SARI total 
volume) is calculated as well as the volumetric He. 
Firstly, the prototype CSA (aperture 58*67 mm', FSso ~ 21 cm') is technically modified to 
assure clinical safety and load independence. The modified CSA, the D-CSA, has an aperture 
of 66*75 mm' with an FSso ~ 28 cm' and a PD of 10 mm, the LCA (aperture 105*105 nlln') 
has an FSso ~ 76 em' and PD ~ 12 mm, The HC equals 0.21 (D-CSA) respectively 0,22 
(LCA), 
Secoudly, a 3*3 D-CSA array is compared with a 2*2 LCA may, The FSsos equal 72% 
(D-CSA) respectively 75% (LCA), The SAR-volume histograms, planar and vo!tlmclric HC 
show no significant difference, however the planar HCs for D-CSA and LeA increase from 
0.2 to 0,3 indicating that incoherently powered arrays from these antennae build SAR 
distributions constmctively. 
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1. Introduction 
In the treatment of recurrent breast cancer with superficial hyperthelmia, we have shown 
that a) improved technology results in better clinical outcome (Van der Zee ef al. 1999) and b) 
an enlarged effective field size results in higher interstitial temperatures (Rietveld et al. 1999). 
The basis for both these studies was a clear technical improvement of equipment: a) a change 
from 2450 MHz to 433 MHz combined with higher quality applicators and b) further 
technically improved applicators (Van Rhoon ef al. 1998). Other groups have also reported on 
technically improved antennae and/or their clinical relevance. The technical possibilities of 
micro strip antennae in array applications have been extensively repOlted on by, for instance, 
Samulski ef al. 1990, Lee ef al. 1992, Tharp and Roemer 1992, Zhou and Fessenden 1993, 
Diederich and Stauffer 1993, Ryan ef al. 1995, Stauffer ef al. 1998, Rosetto and Stauffer 1999 
and they show that small antennae are capable of heating a large area adequately. Also, the 
clinical performance of small antennae has been reported to be satisfactory. 
In more than 1900 treatments (over 260 patients) we generally used arrays of 2 to 5 
waveguide antennae operating at 433 MHz- i.e. conventional water-filled waveguide 
applicators (WGA) or the improved waveguide antennae, the Lucite Cone Applicators (LCA) 
(Van Rhoon ef al. 1998, Rietveld ef al. 1998a) - both with an aperture of about 10*10 em'. 
We treated the entire reinadiated area and, since we drove the anterUlae non-coherently, the 
power level of each antenna was the main control parameter. The treatment area was 
composed of a complex distribution of varying tissue types and a very inhomogeneously 
distributed blood flow. These inhomogeneities require adjustment of power levels to create an 
optimal SAR deposition. Although theoretically one can make finer volumetric SAR 
adjustments with small antClUlae, the complexity of treatment optimisation increases quickly 
with the number of antennae. Also, theoretical studies have demonstrated that a negative 
consequence of small aperture antennae is lesser penetration depth (Hand and Hind 1986, 
Heinzl ef al. 1990) which may counteract the benefit of higher spatial control. 
As yet, it is not clearly understood what impact the combination of penetration depth and 
spatial resolution has on the quality of the 3D-SAR distribution for anterma used in array 
applications. The technical SAR-evaluatioll parameters as described in the current available 
Quality Assurance guidelines (Hand et al. 1989, American Association of Physicists in 
Medicine (AAPM) report No. 26 'Perf0l111anCe Evaluation of Hyperthennia Equipment '), the 
Effective Field Size (EFS~FS5o) and penetration depth (PD), are based on the 50% SAR value 
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(relative to the max, SAR value at lcm depth in muscle~like tissue), However, thus far, the 
only clinically substantiated prospective SAR-indicator is the 25% SAR area from an array of 
antennae (Myerson e/ al. 1990, Lee e/ al. 1998). On the other hand, Gelvich e/ al. (1996) have 
defined an additional evaluation parameter from a more technical point of view: the 
Homogeneity Coefficient (HC) which is defined as the ratio of the 75% SAR field size (FS,,) 
over the 25% SAR field size (FS,,) at I cm depth in muscle-equivalent tissue. Because of 
these variations in quality definitions, we require an extensive technical comparison of 
antennae before we begin a clinical comparison between different antenna types. 
To answer the first question conccll1ing the relevance of spatial control and penetration 
depth, we technically compared the SAR quantities of the LCA (aperture: 105*105 mm') and 
the Current Sheet Applicator (CSA, aperture about 70*60 nun') at 75%, 50% and 25% in 
1 em depth in muscle-equivalent tissue We also compared the 3D-SAR distributions over the 
entire treatment volume, 
Bach Andersen e/ al. (1984) and Johnson e/ al. (1987, 1990) have developed the basic 
principle of the CSA. Lumori e/ al. (l990a,b) and Gopal e/ al. (1992) have developed the 
antemla into a clinical version, the first of two prototypes, the G-CSA. Several groups used G-
CSAs and have reported tecllllical and clinical results (Leigh e/ al. 1994, Prior e/ al. 1995). 
A second clinical prototype CSA, the P-CSA, became available to other groups via a 
COMAC-BME programme'. In 1993, we obtained two examples of the P-CSA. It was 
repOlied to have some major drawbacks conceming load dependency, tuning frequency and 
cross-coupling (T. C. Cetas, personal communication). 
In this repmi we present technical results of the P-CSA and a redesigned and improved 
low-cost Dutch CSA, the D-CSA. The D-CSA will prove to have a better technical 
perfomlance than the P-CSA concerning tuning stability as function of tissue load and a lower 
cross-coupling. The D-CSA meets the European Society for Hyperthennic Oncology (ESHO) 
Quality Assurance (QA)-guideIines making it suitable for clinical applications. Also we will 
show that the GB-modelled SAR distribution ofa 3*3 array application ofD-CSAs meets!he 
quality of that ofa 2*2 LCA array. 
I official denominatio: COMAC-BME Concerted Action in Biomedical Engineering, Ee Medical and Health 
Research Programma 1987-1991, Target 11.1 Medical Technology Development, Area 11.1.2 Treatment and 
Rehabilitation, Title 'Optimization of Hyperthermia Teelmology and the Assessment of its Clinical Efficacy in 
the Treatment of Cancer' 
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Currently we are carrying out a clinical study to compare the perfollnance of the D~CSA 
with that of the LCA. This will bring our investigation on the D-CSA to an end. 
2. Material and Methods 
2.1. AnteJll/ae 
In this study two CSA type antelmae were used, the version two-prototype CSA (P-CSA) 
and the redesigned Dutch CSA (D-CSA). The technical behaviour of the CSA has been 
described in detail by Bach Andersen e/ al. (1984), Johnson e/ al. (1987, 1990) and Gopal e/ 
al. (1992). The LCA with which we compare the D-CSA has been described in detail by Van 
Rhoon e/ al. (1998). The teelmical qualities of the LCA in array applications have been 
reported by Rietveld e/ al. (l998b). 
2.1.1. P-CSA Two P-CSAs were obtained through the COMAC-BME programme. The outer 
dimensions of the antenna are 67*58 JlUU2 (I*w) and 23 mm (h). The inner parts are 
constmcted of polytetrafluorethylene (PTFE) plate (0.85 mm and 3.2 l1ll11) and copper plate 
(0.8 111m). The P-CSA is built in stainless steel housing. The PTFE-plate at the radiating 
surface is held in place by two metal rims from the steel housing located at the short side of 
the aperture. Note that the steel housing is in close contact with the radiating part of the 
applicator and its load. The RF~design of this antenna is symrnetrical but the feeding line, a 
coaxial cable, is asymmetric i.e. the outer conductor is cOlUlected to emih. Since the outer 
conductor of the coaxial cable and feeding point are also connected to the housing of the 
antenna, the housing becomes a part of the radiating stmcture of the antelma. 
2.1.2. D-CSA The locally redesigned CSA (D-CSA) is made of sticky copper foil (0.05 mm) 
and polyethene (PE) (for the RF-circuit I and 3 mm PE plates and the copper foil were used, 
see figure la). The outer dimensions of the antenna are 75*65 n11112 (I*w) and 19 mm (h). The 
radiating aperture equals 55*49 mm2• The housing is constmcted of copper foil glued onto a 
PE~box. A 1:4 112 wavelength balun was integrated in the housing of the antenna creating a 
balanced radiating structure. The balun is made of type RG 316 U coaxial cable, positioned in 
the PE box holding the radiating parts, and is kept in place by (black) polyurethane-cement 
(figure la). The construction is such that the radiating antelma parts, including housing, are 
placed in the watertight PE-container (figure la (left side) and b). The D-CSAs can easily be 
set up in an array with use of Velcro which is attached to the side walls of the watertight PE-
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container (not shown in figure 1) and which acts as a semi-rigid connection to adjacent CSAs. 
A heatsink is glued on top ofthe copper housing to transport intemal RF-Iosses (figure lb). 
Figure 1. Photographs of the Dutch Current Sheet Applicator (D-CSA) 
a) shows the inner parts of which the D-CSA is constructed. At the left side the watertight PE container; in 
the middle the upper part of the radiator is shown, containing the coaxial feed plus the 1,4 lambda balun 
which is held in position by black polyurethane-cement. TIle balun is connected to the nyo upper 
capacitor plates. In fronl of the upper part the 1 nun thick PE sheet, which is used as capacitor dielectric. 
At the right, the resonance circuit is shown which is COllstnlcted of copper foil glued on 3 mill and I mIll 
(middle piece) thick PE plate. TIle front piece shows the capacitor parts, which face the upper part of the 
radiator. 
b) complete D-CSA with heat sink placed in the watertight PE-container. 
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2,2, RF properties of antennae 
The measurements from a single eSA on resonance frequency, transmission and reflection 
(at 433 MHz) were obtained with a network analyzer (Hewlett Packard 875IA). 
Efficiency of the antennae was measured via the transmission coefficient using two 
oppositely positioned antennae each connected to the network analyzer, 
Load dependence of a single eSA was measured for four configurations: I) eSA directly 
positioned on a flat semi-solid muscle-equivalent phantom (48*48*(1+2+2+5) cmJ) made of 
Super Stuff (Guy 1971)),2) Icn!-thick solid rat layer (20*20 cmJ , (Guy 1971) added on top of 
the muscle layer, 3) a lcm-thick water bolus added, no fat and 4) both water bolus and fat 
layer added. 
Stray radiation fi'ol11 one antelma positioned on muscle~equivalent tissue and powered at 
50 W was measured with an isotropic Holaday-E-field probe (HI-3000) at 0.2 and 0.5 m 
distance in the aperture plane. No water bolus was used in these experiments, 
Cross-coupling between two adjacent eSAs was measured on the flat muscle~equivalent 
phantom, Both 2* 1 atTay configurations i.e, long sides adjacent or short sides adjacent, were 
measured, In these experiments a water bolus (20* 12* 1 cmJ) was used as intenlledium to the 
phantom. The accuracy of the measurements was ± IdB. 
2.3. Thermographic SAR measurements 
SAR distributions at 1 cm depth in muscle were obtained using the layered semi-solid 
muscle-equivalent phantom with and without an additional 1 cm-thick fat layer on top of the 
muscle~equivalent tissue. The eSA was driven by a power pulse of approximately 75 \"'1 for 1 
minute. A thennographic camera (AGA Thermovision System 680/1 02B) interfaced to a PC 
was used to measure the temperature distribution at the exposed surface. 
The effective field size (EFS), defined by the ESHO QA-guidelines (Hand e/ al. 1989) was 
calculated from thermographically (TG)~measured SAR distributions. 
2.4. Gaussian beam modelling ofSAR distributions from (arrays oj) antennae 
Gaussian beam (GB) modelling is extensively used to predict SAR distdbutions fi·om CSA 
arrays (Lumori e/ al. 1990a,b, Gopal e/ al. 1992, Prior e/ al. 1995). The GB-inpnt parameters, 
half-power width (S) and phase radius (R) in both E- and H-field directions in Ihe principal 
planes for the D~CSA, were obtained from measurements of the dominant Ewfield directions in 
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liquid muscle-equivalent tissue (Hand e/ al. 1989) using an unbalanced I em wide dipole and 
measured: SE= 2.1 em, RE= ~50 em, SH= 3.7 em and Ru= 23 em. The unbalance of the dipole 
sensor was corrected for by averaging two opposite-orientated dipole scans, 
The resolution of the GB-model was 0.6 em in both x- and y-direction. This led to a P-CSA 
aperture of 75*66 mm2 which was created by averaging the results from calculations with a 
78*66 mm' and 72*66 mm' aperture. From the GB-predicted SAR distdbution the EFS, FS" 
and FS 7S are calculated (FS.\: area covering x% or more SAR relative to the maximum at 1 em 
depth in muscle-equivalent tissue). Also the homogeneity coefficient as defined by Gelvich et 
al. (1996) HC ~ FS,/FS,s is calculated. 
2.4.1. Spatia/resolution and penetration depth from an array of antennae We compared a 3*3 
CSA array with a clock-wise E-field orientated 2*2 LCA array (Rietveld et al. 1998b). Both 
LCA and D-CSA alTays covered about 20*20cm' of treatment area i.e. 21.0*21.0 em' (LCA) 
and 22.5*19.8 em' (D-CSA). By calculating a single D-CSA SAR footpdnt and adding a 
single footprint into a 3*3 CSA alTay pattem, a SAR distribution was obtained from an 
equally llonMcoherent powered 3*3 an·ay ofCSAs. From that SAR distribution, again the FS2S ' 
EFS, FS 7S and HC were obtained at I em depth. 
To inCOlporate the penetration depth into the quality evaluation of the antelllla being tested, 
GB-predicted SAR distributions from the 2*2-LCA and 3*3-CSA array at different depths in 
muscle (delta z = 1 nUll) were included to calculate a SAR-volume histogram. The SARM 
volume histogram is defined by: 
Volume ofrelatiye SAR [%] / total Yolnme, 
where the 100% SAR level is defined as the maximum SAR at I em depth in muscle. The 
volumes are restricted by the ollter boundaries of the antenna alTay times 3 cm depth into 
muscle tissue. 
From the total SAR volume the ESHO defined PD was obtained as \vell as the volumetric 
field sizes (FSV) based on 25%, 50% and 75% SAR. The quotient FSV,/FSV" represents the 
volumetric HC (HCV). 
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3. Results 
3.1. Antenna properties 
For both the P-CSA and D-CSA an overview of the transmission at the resonance 
frequency and at 433 MHz as a function of (tissue) load is given in table 1. It clearly shows 
that the D-CSA was more stable in resonance frequency than the P-CSA as a function of the 
(tissue) load, &f=3:MHz versus 14 MHz. Also the reflected signal at resonance fi:equency was 
lower: (-9 .. -29 dB) for the D-CSA than for the P-CSA (-5 .. -21 dB) as a function of the 
tissue load. 
The efficiency of the P-CSAs could not be measured accurately due to tuning problems. 
The efficiency of the D-CSA measured 60% (+1- 10%) and was comparable to that of the 
LCA, 50% (+1- 5%) (Van Rhoon e/ al. 1998). 
Table 1. Overview of the resonance frequency fN • and reflected signal at 433 MHz sll(433) and at the 
resonance frequency su(fm) of the prototype CSA (P-CSA) and the redesigned CSA (D-CSA) as a 
function oflhe antenna load. 
Antenna: P-CSA D-CSA 
fres SlI(t;.e,) s,,(433) fr~s sn(fre;) s,,(433) 
LOAD: [MHz] [dB] [dB] [MHz] [dB] [dB] 
Muscle 442 -5 -5 436 -12 -ll 
1 em fat, muscle 456 -20 -2 436 -9 -8 
lcm water bolus, muscle 445 -12 -6 433 -18 -18 
lcm water bolus, lcrn fat, 451 -21 -4 433 -29 -29 
muscle 
The TG-measured EFSs from the P-CSA and D-CSA equalled 21 cm' (standard deviation 
(sd): I COl', n = 4) respectively 28 cm' (sd: 3 cm', n = 5). A water bolus (20*20*1cm)) was 
used as intennedium. A complete overview ofSAR-related parameters is given in table 2. For 
comparison, the G-CSA data (Gopal e/ al. 1992, Gelvich e/ al. (996) and LCA data (Van 
Rhoon e/ al. 1998, Rietveld e/ al. 1998a) are included in table 2. 
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Table 2, Overview of basic SAR~related 2arameters from a sinB:1e eSA or LeA. 
aperture FS 2S EFS (FS lO) FS75 HC PD 
[mml] [em'] [%] [cm2] [%] [em'] [%] [mm] 
P-CSA(TG) 58'67 52 134 21 54 9 23 0.17 
D-CSA(TG) 66'75 87 176 28 56 10 20 0.11 
D-CSA (GB) 66'75 58 117 28 56 12 24 0.21 10 
G-CSA(GB) 59*73 36 83 17 40 7 16 0.20" 10 
0.27') 
LCA (GB) 105'105 144 131 76 69 31 28 0.22 12 
TIle 25%,50% and 75% 8AR related field sizes (respectively FS 2S , EFS (-FSso) and FS 15) from 
both thennographically (TO) measured and Gaussian beam (G8) predicted SAR distributions at 
1 em depth in muscle-equivalent tissue are calculated. Data are presented in both absolute measure 
and relative to the aperture size. Also the SAR homogeneity coefficient (He = FS1s/FSn) is given. 
The OB-predicted SAR distributions were obtained with all infinite water bolus of I em thickness. 
Data from the G·eSA were obtained from Gopal et al. (1992), Gelvich et al. (1996) and additional 
Gaussian beam calculations (PD), 
Data from the LCA obtained from Van Rhoon ef al. (1998) and Rietveld ef al. (1998). 
I) according to our GB-predicted SAR distribution 
2)according to Gelvich e/ al. 1996 
The stray radiation levels from the antelUlae fed with 50 \V input and measured at 20 cm 
and 50 cm distance are given in table 3, For comparison, we also included data from the LeA 
in table 3. Although Ihe LCA would appear to be of a design thaI permits more RF leakage, 
stray radiation levels are considerably lower than in Ihe case of the D-CSA. The P-CSA 
generated the highest level of stray radiation, which was due to the unbalance in the antenna. 
Table 3, Maximum stray radiation levels [mW/cm2] of the P-CSA, D-
CSA and LeA at 0,2 m and 0.5 m measured with a Holaday HI-
3000 isotropic field strength meter. TIle power input equalled 50 W, 
Antenna: Stray radiation at 0.2 m Stray radiation at 0,5 m 
P-CSA 2.5 0.2 
D-CSA 1.0 0.1 
LCA 0.3 0.04 
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Table 4. Cross-coupling between two D-CSAs measured on a muscle-equivalent phantom 
with a water bolus of 25*18*1.5 em] as intennedium. The antennae were positioned 
centrally on the water bolus. 
long sides adjacent 
short sides adjacent 
cross-coupling (mean (sd» cross-coupling (mean (sd» 
between two D-CSAs with Velcro between two D-CSAs without 
at side walls; [dB], n=5 Velcro at side walls; [dB], n=3 
(single antenna aperture (single antenna aperture 
75*66 mm2) 71 *62 mml) 
-16(0) -16(0) 
-26 (2) -29 (1) 
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An overview of the cross-coupling between two adjacent D-CSAs is given in table 4. This 
table also includes data from D-CSAs without Velcro strips. 
3.2. D-CSA- and LCA array-related parametel'sji'om GB-predicted SAR distributions 
The GB-predicted SAR distribution at 1 cm depth in muscle-equivalent tissue from an 
equally non-coherent powered close-packed 3*3 array ofD-CSAs is shown in figure 2a. The 
" 
~'~ " " 
I '(*~)~ 
! 0 ! 0 
Ilt/,,~),,~ , ~~O I/~ " I~" ~" 
"!,. 0 .'.S" 0 
" ,,"'-1 '(0"1 
Figure 2. Gaussian beam predicted SAR distribution arrays of antennae. The SAR is calculated 
at 1 cm depth in muscle-equivalent tissue and the maximum nonnalised to 100%. The 
rectangles indicate the apertures. 
a) 3*3 D·CSA array (E-fields parallel) 
b) 2*2 LCA array (in a clock-wise E-field orientation) 
conesponding EFS measured 320 cm2 (72% of the 3*3 array aperture). Figure 2a shows 
clearly that the GB-prcdicted EFS was contiguous over the 3*3 anay as was also the case for 
the 2*2 LCA array (figure 2b, EFS~332 cm'). The homogeneity coefficient He equals 0.33 
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for the 3*3 CSA array and 0.34 for the 2*2 LCA array. The upper part of table 5 gives a 
complete overview of all 25, 50 and 75% SAR-based field sizes at 1 em depth in muscle-
equivalent tissue. 
Table 5: SAR related parameters from GB-predicted SAR distributions of arrays of antennae. 
surface at 1 em depth 
3*3 D·CSA array 
2*2 LeA array 
volume of 3 em depth 
3*3 D-CSA array 
2*2 LeA array 
FS" FS" ( -EFS) FS" HC 
[em'] [%] [em'] [%] [em'] [%] 
434 97 320 72 145 33 
495 112 332 75 170 39 
FSV1S FSVso FSV75 
[em'] [%] [em'] [%] [em'] [%] 
1094 82 554 41 261 20 
1250 94 622 47 290 22 
0.334 
0.344 
HCY 
0.239 
0.232 
The upper part gives values obtained from the SAR distribution at 1 em depth in muscle. 111e 
lower part gives numbers based on the entire SAR volume, which covers 3 em depth in muscle 
equivalent tissue. 
The values in lenns of percentage are related to the size of the aperture. The 3*3 array aperture of 
D-CSAs measures 19,8*22.5 cml, the 2*2 array aperture ofLCAs measures 21*21 cm1. 
By calculating the SAR distribution from an array of antennae from 0 to 3 cm depth per 
1 mm, a volumetric SAR distribution was obtained from which the SAR-volume histogram 
was derived. Figure 3 shows the GB-predicted SAR-volume histograms obtained from a 3*3 
D-CSA an'ay and a 2*2 alTay of LCAs. The GB-predicted 50% SAR volume of both antenna 
types was 41 % for the D-CSA array and 46% for the LCA array relative to the covered 
volume. The array-PD of the D-CSA and LCA array: 11 and 12 IlUIl respectively, we obtained 
lIsing the volumetric SAR-data. A complete overvie\v of the volumetric field sizes FSV~ 
(x~25, 50 and 75%), and vohunelrie homogeneity coefficient (HCY) is given in the second 
part oflable 5. 
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Figure 3. Relative SAR-volume histogram obtained from Gaussian beam predicted planar SAR 
distributions at 1 mm interval in depth. Normalisation is to the volume of 3 em depth, which 
covers the entire aperture of the array under test. The 100% SAR is defined as the maximum 
SAR value at 1 em depth, 
4. Discussion 
4.1. Single CSA 
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The predecessor of the P·CSA, the G·CSA, is used successfillly under clinical conditions. 
It is a robust antenna, and gives no trouble. The P-CSA was an initial commercial prototype 
that was distributed to a few centres before satisfactory refinements were carried out. Due to 
several extelllai causes, the final refinements were never made \vhich left two main defects in 
the constmction of the P-CSA. 
The first defect was the metal housing. This became an active pat1 of the radiating 
structure, as the outer conductor of the coaxial cable was both connected to the metal housing 
and also to one of the capacitor plates inside. The CSA is a RF symmetrically·designed 
radiator (Johnson ef al. 1987, Bach Andersen ef al. 1984) and since the metal housing of the 
P·CSA was in close contact with the load (less than I nuu), the unbalanced P·CSA showed a 
RF·behaviour strongly dependent on the load (table I). The second defect was the 
constmction of the U-shaped bottom PTFE'platc in the P·CSA, which allowed water 
94 Chapler 7 
contamination of the RF circuits and could lead to unsafe clinical situations. Due to these two 
serious drawbacks, we decided that a rigorous redesign of the construction was necessary. 
4.1,1. RF-properlies of a single antenna The unbalance in the feeding point of the P-CSA ,vas 
neutralised by the implementation of a balun in the D-CSA. Also increasing the distance from 
the metal housing to the aperture from less than 1 mm (P-CSA) to 4.5 mm (D-CSA, including 
the PE-box) improved the stability of the resonance frequency as a function of tissue load 
(table I). 
E.fficiency of the P-CSA was not measured. The opposed antelUla set-up was not feasible 
because of a) direct coupling from one metal honsing to the opposite metal housing which 
influenced the efficiency significantly and b) too large a discrepancy in resonance frequency 
between the two antennae. A caloric efficiency measurement on liquid muscle-equivalent 
tissue was not successful because the liquid penetrated the inner constmction of the P-CSA. 
This caused power eITors and the experiment had to be abandoned. 
The efficiency of the D-CSA was equal in quality to that of the LCA. 
Stray radiation from the P-CSA was largely due to standing waves at the outer conductor 
of the coaxial cable. By implementing a balun in the D-CSA the stray radiation levels dropped 
significantly to a level far below I mW/cm' at a distance larger than 0.5 m (table 3). Although 
the LeA has two open (Le. Lucite) side walls, the stray radiation level \vas less even when 
operated at the average power level of62 W (Rietveld el al. 1999). 
The cross-coupling we measured for the D-CSA was the same level as measured by GopaJ 
el a/. (1992) for the G-CSA (-16 dB: long sides adjacent; -22 dB short sides adjacent) when an 
inter-element spacing of 10 mm was used. Since the D-CSA is contained in a PE-box, the 
inter-element spacing is intrinsically dealt with in its design. Furthennore, the PE-box 
automatically functions as insulation for the patient. We tested the D-CSA under clinical 
conditions and came to the conclusion that the Velcro-connections might not be suitable for 
larger arrays. Therefore, we did cross-coupling measurements without the Velcro attached to 
the PE-box. Although the inter-element spacing is reduced by 4 nun, the level of cross-
coupling remained 100v (table 4). 
4.1.2. SAR-relaled properties a/a sillgle alllelllla The FS" and FS" of the TG-measured SAR 
distributions from the P-CSA and D-CSA (table 2) were obtained from the most 
representative TG-images. We found the TG-obtailled FS25 to be especially sensitive to heat 
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conduction during a 1 minute power pulse. This explains the discrepancy in the He obtained 
limn a TG-measured and a GB-predicted SAR distribution (table 2) and our preference to use 
GB~predicted SAR distributions to obtain quantitative parameters. 
The EFSro of the P-CSA (54%) was larger than that of the G-CSA (37%, Gopal ef al. 
1992). The EFSTG of the D-CSA compared with that of the P-CSA was larger on an absolute 
scale aud (almost) equal if related to the sizes of the apertures. The GB-calculated EFS 
(EFSGil) relative to the apel1ure for a single LCA was highest, followed by the D-CSA and G-
CSA (table 2). 
The PD obtained from GB-predieted SAR distributions showed that the D-CSA and G-
CSA were of equal magnitude (10 mm, table 2) while the PD of the LCA was 2 nun larger, a 
significant difference on this scale. 
Based on these EFS aud PD findings, the quality (according to the ESHO guidelines) ofthe 
P-CSA and D-CSA are about equal. We incorporated the HC-parameter to further quantify the 
quality of the antelmae. We used the entire SAR areas from an (alTay 01) antenna(e) to define 
FS", EFS (and FS,,). We calculated the HC(G-CSA) to be 0.20 by weighing the areas 
covering 75% and 25% SAR cut out from an enlarged photocopy of figure 3b in GopaJ et al. 
(1992). Using this method we obtained an EFS~17(.4) cm' (40%), as reported by Gopal ef al. 
(1992). The cOlTesponding values of the graphically obtained FS" and FS" (table 2) were 
used to calculate our HC-value. However, Gelvich ef al. (1996) reported the HC(G-CSA) to 
be equal to 0.27 (table 2). Since we found an EFS(G-CSA) equal to that reported by Gopal ef 
al. (1992), we concluded, using ollr data (table 2), that the GB-based HC ofD-CSA, LCA and 
G-CSA were of comparable quality. 
Use of the GB-predicted SAR distribution for obtaining a reliable FS" and HC of the 
D-CSA in its comparison with the LeA was justified by the good similarity between the TG-
measured and GB-predicted 50% and 75% SAR field sizes. 
In conclusion, we found the constmction of the D~cSA to be simple and cheap. It is a good 
quality antenna, suitable for use in the study of array applications and was a useful counterpart 
to the LCA in the comparisons made between the arrays of the two. 
4.2. SAR-related properties of antenna arrays 
The LCA atTay oulperfonned the D-CSA array by 3% in EFS (~FS50)' The FS", when 
calculated relative to the aperture, was 15% larger for the LeA than for the D~CSA. However, 
if the absolute 25% SAR area of both antenna arrays, are compared, as depicted in figure 2, 
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the difference is caused mainly by the LeAs 25% SAR areas outside the array-aperture. Since 
in our clinical practice the entire (RT-}treatment area is covered by antennae, this FS25-
difference between D-CSA and LCA does not play an important role. 
In both arrays of antennae, the He was increased significantly compared to the values of 
the single antermae (table 2 and table 5). This was due to a constmctive inter-antelma SAR 
overlap. From the GB-predicted SAR distributions, we found that the SAR-volume histogram 
ofthe D-CSA array and LCA array differed by less than 3%. 
Although it is not yet clear which parameter best describes the tec1mical perfonnance of an 
antenna atTay, we conclude, from the fact that their differences fall within acceptable limits, 
that the D-CSA and the LCA show comparable teclmical perfomlance in array applications. 
Up to now, the D-CSA worked without problems under clinical conditions (maximum 
array size 3*2), The reflected power remained within acceptable limits. However, in larger 
than 3*2 arrays, the Velcro inter-antelUlae connection was not sufficient to keep the antelUlae 
in position and additional rods have been placed on top of the heatsink to overcome this. 
These rods can be used to fix the CSA in a mounting device in order to maintain a stable 
position relative to the patient. 
Technical adaptations in hard- and soft-ware are currently being made to be able to use up to 
4*3 arrays ofD-CSAs in the clinic and to extend the clinical evaluation. 
4.3. Problems concerning the technical evaluation of antenna arrays 
We lack one single parameter that reflects the quality in both spatial control and 
penetration depth of an array of superficial antennae (operating under clinical circumstances). 
In the presented study we compare a small aperhlre type of antenna with a large one. It is clear 
that a small antenna has better spatial control over a treatment area than a large antenna since 
the degrees of freedom to adapt to the SAR deposition requirements for that given treatment 
area are prop0l1ionai to the number of anteIUlae. On the other hand, it has been shown 
theoretically that an aperture of 8*8 cm2 or smaller has less penetration depth thail a 
10*10 cm2 aperture antemla (Hand and Hind, 1986). For that reason, a theoretical comparison 
between the LCA and D-CSA on their ability to adapt to clinical heterogeneous SAR 
requirements in a treatment volume will not help to detemline the imp0l1ance of the 
combination of spatial control and penetration depth. Therefore, we have decided to use a 
Technical comparison of arrays of improved CSAs and LCAs 97 
basic approach to compare the SAR distributions from incoherently equally powered D'CSAs 
or LCAs in mr array covering about the same treatment area. 
The minimum quality requirements for an atTay can be tested by applying the ESHO 
guidelines (Hand ef al. 1989) to a single applicator. These are based on 50 % SAR (EFS aud 
PD) on an atTay of antelmae. The AAPM Report No. 26 'Perfonuance Evaluation of 
Hyperthenuia Equipment' describes how an array can be evaluated, but it does not provide 
infol111ation on minimum required quality aspects. Since the perfonuance of antennae in an 
atTay canllot generally be reflected by the superposition of a single antenna 8AR distribution 
because of cross-coupling or other side effects (Gopa1 ef al. 1992, Lumori ef al. 1990b, 
Rietveld ef al. 1998a) we believe that: 
• the EFS from one antelma is not satisfactory as basic parameter in evaluating an array, 
• the PD gives only velY local infonnation about an atTay i.e. the maximum depth of 50% 
SAR under I cm depth in muscle-equivalent tissue, 
• the array must be evaluated as an intact unit (as suggested in the AAPM report No. 26 
and the ESHO guidelines (Hand ef al. 1989)) and 
• insisting on 50 % SAR as an indicator of quality may be too strict a noml since Lee et 
al. (1998) and Myerson ef al. (1990) have reported that the 25% SAR coverage is a 
prospective indicator which is correlated to clinical outcome. 
Furthermore, Ge1vich ef al. (1996) have studied homogeneity of SAR distributions which 
were based on both 75% and 25% SAR levels. For these reasons, we have evaluated the SAR 
distributions from the arrays on 75%, 50% and 25% SAR levels with the restriction of equal 
powering of all antennae in the array. 
\Ve introduced the SAR-volume histogram, which t.akes the whole volume under the 
antenna array into account as a more global measure for the PD of an atTay of antennae. To 
enable comparison between the D-CSA alTay and LCA array SAR-volume histograms, the 
volumes are given as a percentage of the total volume. The 3 cm depth that we used was 
chosen rather arbitrarily but covers the maximum depth for which (incoherently driven) 
superficial antennae can be used. 
98 Chapter 7 
Acknowledgements 
The authors thank Dr. Theodoros Samaras (on visit in Rotterdam 011 TMR grant 
ERB4001GT975062) for his help in setting up post-processing of the GB-data. We thank Ms. 
Annette Rogers for addressing several language issues and improving the clarity of the text. 
This work was supported by the Dutch Cancer Society grant 93-603. 
References 
Bach Andersen, J., BaunI, A., Haonark, K., Heinzl, L., Raskmark P. and Overgaard, J., 1984, A hyperthemlia 
system utilizing a new type ofil1ductive applicator. IEEE Transactions 011 Biomedical Engincering, 31, 21-
27 
Diederich, C.]., and Struuffer, P.R., 1993, Pre-clinical evaluation of a microwave planar array applicator for 
superficial hyperthemlia. Ill/ematiollal Journal of Hyperthermia, 9, 227-246 
Gelvich, B.A., Mazokhin, V.N. and Troshin, I.I., 1996, An attempt at quantitative speculation of SAR 
distribution homogeneity. Illteniatiollal Jou1'IIai of Hyperthermia, 12,431-436 
Gopal, M.K., Hand, I.W., Lumori, M.L.D., Alkairi, S., Paulsen, K.D. and Cetas, T.G, 1992, Current sheet 
applicator arrays for superficial hyperthemlia of chestwalliesions. International JOlfr1lal of H)perthermia, 8, 
227-240 
Guy, A.W., 1971, Analyses of electromagnetic fields induced in biological tissues by thennographic studies on 
equvalent phantom models. IEEE Transactiolls on Microwave TheOlY alld Techlliques, 19,205-214 
Hand, I.W. and Hind, A.I., 1986, A review of microwave and RF applicators for localized hyperthennia. 
Physical Techniques ill Clillical Hyperthermia, edited by l.W. Hand and J.R. James, (New York and 
Chichister: Wiley), pp.98-148 
Hand, J.W., Lagendijk, J.J,W., Bach Andersen, l. and Bolomey, J.e., 1989, Quality assurance guidelines for 
ESHO protocols, IlIlemutiollal Journal of Hyperthermia, 5, 421 - 428 
Heinzl, L., Homsleth, S.N., Raskmark, P. and Andersen, 1.8. , 1990, Electromagnetic applicators, All 
illtroduction to the Practical Aspects of Clillical Hyperthem/ia, edited by S.B. Field and J.W. Hand, 
(London, New York, Philadelphia: Taylor & Francis), pp.275-304 
Johnson, H.,H., Preece, A.W., Hand, J.W., James, J,R., 1987, A new type of lightweight low-frequency 
electromagnetic hyperthemlia applicator. iEEE Ttallsactiolls 01/ Microwave TheOlY alld Techlliques, 35, 
1317-1321 
Johnson, R.H., Preece, A.W. and Green, J.L., 1990, TIleoretical and experimental comparison of three types of 
electromagnetic hyperthermia applicator. Physics ill Medicille al/(I Biology, 35, 761-779 
Lee, E.R., Wilsey, T,R., Tarczy-Homoch, P., Kapp, D.S., Fessenden, P., Lohrbach, A. and PriOllaS, S.D., 1992, 
Body conformable 915 MHz microstrip array applicators for large surface area hyperthermia, iEEE 
1hmmctiolls 01/ Biomedical Engilleering, 39, 470-483 
Lee, H.K., Antell, A.G., Perez, GA., Straube, \V.L., Ramachandran, G., Myerson, R.I., Emami, 8., Molmenti, 
E.P" Bucker, A. and Lockett, M.A., 1998, Superficial hyperthemlia and radiation for recurrent breast 
carcinoma of the chest wall: prognostic factors in 196 tumors. inlema/iollal Journal of Radiation Oncology, 
Biology, Physics, 40, 365-375 
Technical comparison of arrays of improved CSAs and LeAs 99 
Leigh, B.R., Stea, B., Cassady, l.R., Kittelson, 1. and Cetas, T.e., 1994, Clinical hyperthemlia with a new 
device: the current sheet applicator. Illternaliollal Journal of Radialion Oncology, Biology, PhYSiCS, 4, 945-
951 
Lumori, M.L.D., Hand, l.W., Gopal, M.K., and Cetas, T.C., 199001, Use of Gaussian beam model in predicting 
SAR distributions from current sheet applicators. Physics in Medicille alld Biology, 35, 387-397 
Lumori, M.L.D., Hand, l.W., Prior, M.V., Gopal, M.K., Cetas, T.C., 1990b, Gaussian beam optimization of 
bolus thickness and inter-element spacing of current sheet applicator arrays. Strahlell/herapie 1/1/(1 Ollkologie, 
8,524. 
Myerson, R.l., Perez, e.A., Emami, B. Straube, W., Kuske, R.R., Leybovich, L. and Von Gerichten D., 1990, 
Tumor control in long-tenn survivors following superficial hyperthermia. International Journal of Radiatioll 
Oncology, Biology, Physics, 18, 1123-1129 
Prior, M.V., Lumori, M.L.D., Hand, J.W., Lamaitre, G. Schneider, J., and Van Dijk, J.D.P., 1995, The use of a 
Current Sheet Applicator Array for Superficial Hyperthemlia: Incoherent Versus Cohercnt Operation. IEEE 
Transac/iolls Oil Biomedical Engineering, 42, 694-698 
Riep,'eld, P.J.M., Lumori, M.L.D., Hand, J.W., Prior, M.V., Van der Zee, J. and Van RhoOll, G.c., 1998a, 
Effectiveness of the Gaussian beam model in predicting SAR distributions from the lucite cone applicator. 
IlIlernaliollal Journal of Hyperlhermia, 14, 293-308 
Rietveld, P.J.M., Lumori, M.L.D., Van der Zee, l., and Van Rhoon G.e., 1998b, Quantitative evaluation of2x2 
arrays of Lucite cone applicators in flat layered phantoms using Gaussian-beam-predicted and 
thennographically measured SAR distributions. Physics ill Medicine alld Biology, 43, 2207-2220 
Rietveld, P.J.M., Van Putten, \V.L.J., Van der Zee, l. and Van Rhoon, G.e., 1999, Comparison of the clinical 
effectiveness of the 433 MHz lucite cone applicator \vith that of a conventional waveguide applicator in 
applications of superficial hyperthemlia. Illternational JOllmal of Radiatioll Ollcology, Biology alld Physics, 
43,681-687 
Rossetto F, Stauffer, P.R., 1999, Effect of complex bolus-tissue load configurations on SAR distributions from 
dual concentric conductor applicators. IEEE Tral/sac/ions 011 Biomedical Ellgineering, 46, 1310-1319 
Ryan T.P., Back'"us, V.L. and Coughlin, C.T., 1995, Large stationary microstrip arrays fpr superficial microwave 
hyperthennia at 433 MHz: SAR analysis and clinical data. II/Iema/follal Journa! of H)perthermia, 11, 187-
209 
Samulski, T.V., Fessenden, P., Lee, E.R., Kapp, D.S., Tanabe, E. and !vfcEuen, A., 1990, Spiral microstrip 
hyperthennia applicators: technical design and clinical perfommnce. IlIlematfollal JOllmal of Radiation 
Oncology, Biology alld Physics, 18,233-242 
Stauffer, P.R.,Rossetto, F., Leoncini, tv!., Biffi Gentilli, G., 1998, Radiation patterns of dual concentric 
conductor micros trip antennas for superficial hyperthermia. IEEE Transactiolls 01/ Biomedical Engineering, 
45,605-613 
Tharp, B.S. and Roemer, R.B., 1992, Optimal power deposition with finite-sized, planar hyperthemlia applicator 
arrays. IEEE Transactiolls 01/ Biomedical Engineering, 39, 569-579 
Van der Zee, J., Van der Holt, B., Rietveld, P.l.M., Helle, P.A., Wijnmaalen, A.J., Van Putten, W.L.J. and Van 
Rhoon, G.c., 1999, Reirradiation combined with hyperthennia in recurrent breast cancer results in a 
worthwhile local palliation. British Journal ofCallcer, 79,483-490 
Van Rhoon, G.e., Rietveld, P.J.M. and Van deI Zee, J., 1998, A 433 Mhz Lucite Cone waveguide applicator for 
superficial hyperthemlia. II/Iema/lollal Journal of Hyperthermia, 14, 13 - 28 
Zhou, L. and Fessenden, p" 1993, Automation of temperature control for large-array microwave surface 
applicators, Illternational JOIln/al of H)perthermia, 9,479-490 

Chapter 8 
Comparison of the clinical effectiveness of the 433 MHz 
Lucite Cone Applicator with that of a conventional 
waveguide applicator in applications of superficial 
hyperthermia 
P JM Rietveld, \VLJ van Putten, J van der Zee and GC van Rhoon 
Reprinted from : 
International Journal of Radiation Oncology Biology and Physics, Vol. 43, No.3, pp 681-687, 
1999, with pennission from Elsevier Science 
Chapter 8 
Pnoted in th~ USA. All right, re<u\'cd 
0l6n.}Hl/jj991S---,ee fo'nt m~!(er 
ELSEVIER PH S03fiO·J016(98)00-l4J·X 
PHYSICS CONTRIBUTION 
COMPARISON OF THE CLINICAL EFFECTIVENESS OF THE 433 MHz 
LUCITE CONE APPLICATOR WITH THAT OF A CONVENTIONAL 
WAVEGUIDE APPLICATOR IN APPLICATIONS OF SUPERFICIAL 
HYPERTHERMIA 
PAUL j, M. RIETVELD, M.Sc.,* WrM L. J. VAN PUrTEN, M.Sc"t JACOBA VAN OER ZEE, M.D., PH.D,,* 
AND GERARD C. VAN RHOON, PH.D.*' 
"Department of Radiation Oncology, Subdivision of Hyperthermia, and tOepartmcnt of Statistics, University Ho"pital 
Rotterdam-Daniel den Hoed Cancer CenterlDijk.zigt Hospital, Rotterdam, The Netherlands 
Purpose: This reflort presents the finnl slage of our program to impro\'e Ihe quality of om' superficial 
hyperthermia treatments. We haw already demonstrated that Ihe Lucile cone upplicator (LeA), our technically 
improH'd waler-tilled, "m'e-guide applicator (WGA), is superior to the conventional WGA. The main ohjective 
of the present study was 10 investigate whether the technical improvelllents of a WGA were reflected in an 
improved clinical performance, e.g., II heller teJ1lllenlfure distribution. 
Methods and Materials: Power and temperature unulyses \\'ere performed retrospectively on 128 treatments of 
superHcmlly loca~tcd tUlllors (less than'" C1l1 depth). Twenty·three palienls werc treated alternately "ith a WGA 
setup and II LeA setup. 
Hesulls: The averilge IlOwer leHI pel' antenna In un array was 48 W ~lIId 62 W for Ihe WGA lind LCA 
respectively. The Hverage illmsl\'ely measured tempcratures hH'l'e,,-~ed by O.27°C when the LCAs were used. The 
temperature difference between the center lind the periphery of an antenna, aycraged over till' complete array 
of antellnae, wa~ 0,43°C using WGAs and -O.OS~C mlng LCAs indicHling a more uniform heating. The T •. IO of 
the iumslHly measured temperatures remained unchanged (WGA: 39,.,j°C HI'SUS LeA: J9.5"C) .. 
Conclusion: The LCA i~ no\\' our standard applicator for superficiul hyperthermia treatments as it is technically 
~lIld clinically pro'l"en to be superior to the WGA. 01999 Els(',ier Srienee Inc. 
Supcrfirial hyperthermiu, l\licro\\"ilw antenna, Thermal do~illletry, Clinical sillily. 
INTRODUCTION 
Since 1985 we havc used a conventional 433 r."IHz water-
nIled, wavc-guide applicator (WOA) with nperture sizes of 
5 X 5 C1112, 5 X 10 C1II2, 7.5 X 10 cm2, and 10 X to cm2 for 
the clinical applicntion of superficial hyperthermia (m<ud-
mum depth 4 cm). The majority of our patients arc treated 
with superficial hyperthermia in addition to reirradiation fOf 
recurrent brea<;t cancer. The treatment sllrfaces of these 
patients vary from 64 cm2 to 800 C/u2 with a mean of 316 
C111
2
• When hyperthermia is applied in combination with 
reirradiation, the department's strategy is to heat the entire 
radiation treatment Held. This means that the majority of 
these paticnts are treated with an aITay of applicators, the 
number of applicators varying from 1 to 6. 'nlC combined 
treatment modality of reirradiation (8 X 4 Oy in 4 weeks) 
Reprint reqlle,t to: P. 1. 11. Rietyeld, University Ho,pitai Rot-
terdam-Daniel den Hoed CancerCenter/Dijkzigt Hmpital, Depart-
ment of Radiation Oncology, Subdivision of Hypertherrnin. P.O. 
Box 5201, NL-30GS AE Rotterdam. The Netherlamk 
Atkno\l'ledgll1cnls-We thank Pia Bruekmcyer-Roerink, Lia Ver-
loup-van't Huf, and Juup Stakenburg for their efforts in optimizing 
patient treatments and precbe administration of treatment-related 
variable,. TIlh wurk was supported by Dutch Cancer Society 
and hyperthennia (following each frnction for a duration of 60 
minutes) has resulted in good clinical results in tills patient 
group. TIw overall probability of complete re.~po!1se (CR) is 
74% which is higher than the results lollowing 30-40 Uy uf 
radiation alone (20-48% CR) (I). However, in larger tumors 
(maximum dimneter > 3 cm) a significantly 10werCR rate wa~ 
observed (65%) compared to ~!I1aIler tumors (maximum dial11~ 
eter < 3 em; 87%) (2, 3). Although it is known that larger 
macroscopic tumor volumes are negatively correlated with 
treatment outcome (4, 5), we hypothesize that due to the 
intrinsic small effecti\'e field si7.e 1 (EFS) of the WGA, the 
larger treatment fields have been treated with a lower hyper-
themlic quality (2, 6) and therefore we expect that the current 
clinical result'> can be improved by using a higher technical 
quality of specific absorption rate (SAR) distributions, i.e., 
Lucite cone applicator (LeA) ,urays. 
Grant 93-003, "Stichting Willem H. Kroger," "Stichting Bevur-
dering van Vo!kskracht," and "Maurits en Anna de Kock Stich-
ting." 
Accepted for publication 9 October 1995. 
I TIle EFS is defined as the arca enclosed hy the 50% ,pecilic 
absorption nlte (SAR) contour measured at a depth of 10 mm from 
the surface of a plane homogeneous phantom with the dielectric 
pmperties of muscle. 
Clinical comparison ofLCA amI WGA arrays 
I'i-c L Photograph of the conventional water-filled wave-guide 
,q'pliL'ator (left) and Lucite cone applicator (right). Both antennae 
Ila\<, a radiating aperture of 10 X ]() cm2 , 
In order to improve the technical quality of SAR distri-
hut inns, we developed the LCA which is technically supe-
1 i"I' to the \VOA and has an EFS ofapproximatcly 100 cm2 
1-:'-9) compared to 33 em2 for the WGA. In array configu-
I:llions, the EFS is contiguous using LCAs as opposed to 
1',,1iI' local hot ,~pots when using \VGAs (6). Based upon this 
111~her EFS value of the LCA, we expect that LCA arrays 
\\ 111 heat the treatment area more homogeneously than 
\\ CiA arrays and that the average temperature will increase. 
I {( ,wever, given the fact that a temperature distrihution is 
81'~'atly inlluenced by tissue irregularities and blood flow 
~ h~lracterbtics and given the good clinical results obtained 
II ilh the \vOA (10), we decided to quantitatively assess 
\\ Ildher the LCA arrays would indeed perform better than 
\\ (iA arrays under clinical conditions. 
Therefore a clinical .~Illdy was pertormed in which the 
,:lll\e patienl was treated altemately by \VGA and LeA 
.l11,lyS. In this way a comparison could be made on power 
lklivery and achieved temperatures between the two an-
k'lI11a types. Twenty-three patients with superficially loc,ltcd 
iLllllorS were entered in this study. 
[I will be shown that the LCA is a better antenna than the 
\\ (iA concerning invasively measured temperature 
I ).2JOC) and that average temperature differences be-
1\\ ,'<:'n the central mea and periphery under the antennae 
d,',w<lsed to zero when LeAs were used. 
METHODS AND l\IATERIALS 
\!.'I('/I/I(I(' 
Both antennue, the conventional WGA aild the LCA, 
\ 'I,,'l"ate in TEw mode al433 i\'lHz and ure wlIter-filled, Both 
I'tliliiting apertures measure 10 X 101:1112. Pigure I shows a 
1111l1lOgraph of both antennae. 
I'lle first part, that is the dipole, of the antennae are 
Ilklltical and mcasures 3.0 I:m by 5.0 cm (E X H). The 
~L'L'(][lll part of each antenna starts at approximately V2 
1~llllhda from the dipole. From this \evel, the wave-guide 
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cross-section diverges to the radiating apel1ure of 10 X 10 
cm2, The outer dimensions of the antennae are [I X II cm 2 
for the WGA and 10.5 X 10.5 cm2 for the LCA. In case of 
the WGA the sidewalls are brass, as in the first purt of the 
antenna. In case of the LCA, the two diverging sidewalls, 
which are parallel to the E-field, me replaced by Lucile. 
Further a polyvinyl chloride (PVC) cone (ba~e diameter 3 
cm, hcight 5 em) is introduced into the center of the aper-
ture. 
Both modifications to the conventional WGA resulted in 
an EFS of 100 cm2 (8 X 13 cml, F., X H diredion) for the 
LeA compared 10 an EFS of 33 cm2 (8 X 5 cml, E X H 
direction) for the WGA. In any configuration of an LCA 
arra)', the EFS is a contiguolls area whereas WGAs in an 
array wntiguration only produce local hot spots. 111e phys-
ical pcrfonnance of both antenna types has hecn reported in 
detail elsewhere (6, 7, 9). 
The efficiency of both antenna types is in the range of 
45-55%. 
Temperature recording 
A 24-channel fiber optic thermometry system (Tabaka 
Ff12lO) was used to measure temperatures superlicially or 
invasively. Thc temperature probes are immune to RF ra-
diation and the prohes arc sequentially scanned. The aver-
age measuring time per channel is 3.3 seconds and an 
update of all 24 channels is given each 80 seconds. The 
technical performance under clinical conditions are (tem-
perature range 30-45°C): resolution 0.1 DC, accuracy D.2°C, 
l\Iultipoint probes have up to 4 measuring points with an 
intcrelcmcnt spacing of lO, 15, or 20 mm. Probes were 
placed invasively within a closed-tip catheter. 
The average number of thennolllctry sill'S per treatment 
in this ~tudy was 21.0, of which 10.0 were invasive (5.1 
sites in macroscopic tumor tissue and 4.9 in other tissue). 
POll'(,/" delivemll(,(, alld recordillg 
Each antenna is powered by a single RF generator (150 
W max), therefore in an array application, the antennae are 
driven incoherently. After each optimization during treat-
ment, the forward ;lnd reflected power level per antenna, a.~ 
indicated by the generator, are manually recorded. In order 
to analyze power level data, the power levels as registered 
at each 5 minute-interval during steady stale (Le., more than 
10 minutes treatment time), were copied into a unique 
patienl- and treatment-related ASCII file. 
Clillical proCt'(llIres durillg IE)l'l!I'therJllia trealments 
Before the first hyperthermia (HT) treatment starts, the 
physician and physicist decide: (a) whcre invasive ther-
mometry is possible and preferable and (b) the optimal 
antenna configuration for both WGA and LCA applications. 
Closed-lip catheters are positioned invasively and remain in 
place during the entire HT series (II). Information on 
thermometry sites concerning the location in the treatment 
Held, tissue type, and depth, is documented (12). After each 
treatment Ihe clinical team evaluates the treatment using the 
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available temperature data and dose parameters and if nec-
essary, the clinkal setup is adapted. 
In the first half of the week WGAs were used and in the 
second half of the week LeAs were used during HT treal-
ments. The start of a treatment series was dictated by the 
department's time schedule and can be considered as ran-
dom. The first treatment is default started with 50 W for-
ward power per antenna in order to ie.un the patient's 
characteristics, e.g., what temperature rise is obtained by the 
applied power level and how the patient reacts 10 the heat 
load. If possible the power level is increased gradually 
during the treatment. Since the two antenna types arc used 
alternately and might behave differently, the second trcat-
ment in this study, which is performed with the other 
applicator type, is administered as if it were a first treatment. 
From the third treatment on, the power level settings at the 
beginning of each treatillent arc adjusted to the power levels 
used in the previous treatment of that antenna type. 
During treatment, the hyperthermia technicians per-
formed the norillal procedures in order to optimize the 
treatment and to react to treatment-related information from 
patient and hardware. On indication of patient discomfort, 
pain and/or achieved temperatures, the E-field orientation of 
individual antennae, power distrihution, antenna positioning 
anti tilt, water bolus thickness, and water bolus temperature 
were changed according to the technician's experience. This 
was done regardless of the applicator type used and was 
permitted in order to achieve the highest quality of treat-
ment. Changes in antenna setups (e.g., E-field orientation) 
during treatment wcrc recorded but lcft out of the analyses. 
7h'uIJIIl'111 ('h{/ra(·tt'ri.~tics 
All patients receivcd radiotherapy (RT) in combination 
with HT. The total RT dose (32 Gy) was administcred as 
S X 4.1l Gy per treatment twice a week, i'vfonday-Thursday 
or Tucsday-Friday. Each RT fraction was followed by a HT 
trcatment with an average interval of 40 minutes. Thc COIll-
bined treatmcnt series started any of these 4 days. The HT 
treatments la~ted 60 minutes. 
Depending on the dimensions of the treatment area, .thc 
optimum number of antennae to be lIsed during HT treat-
ments W,L~ decided upon. The number of antennae in ihis 
-"tudy ranged from I to 5. When using WGAs, a 7.5 X 10 
crn
2 
aperture antenna also was available and was used to 
optimize the WGA treatment when necessary. In the LeA 
treatments only 10 X 10 em2 aperture sized antennae were 
available. In some cases a 2 X 2 array of WGAs wa~ used 
whereas only a 2 X I .may or LeAs was applied to have an 
optimal SAR coverage of the treatment area. 
All paticnts were clearly informed about the nature of the 
clinical study ami they gave informed consent to participate 
in this study. 
QU(llItijit'lIliOl! of trcatmCI/I part/II/cters 
Power [('I'd Wlrillb/cs. Per treatment the net power per 
antenna was calculated during steady statc. Per time record-
ing (each 5 minutes), the standard deviation over the net 
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(A) (B) (e) 
Fig. 2. Schematic di<lgram of 11 I X 1,2 X 1, antI 2 X 2 arTilY of 
LeA indicating the ilrea~ "center" and "periphery". Each center 
area measures 6 X 6 cm2 and is indicated by the ~haded square. 
powers was calculated. From these parameters, the average 
net power level over all antennae was calculated (P,,,g) and 
the average .~talldard deviation in time (Psn) was calculated. 
Pmg: expresses the deposited cnergy in the trcatment volume 
and PSD is a measure for the homogeneity in power levels 
over the entire treatment volume. 
Temperature \'lIriables. Onl)' invasivel)' measured tem-
peratures were included in the analyses since superficially 
measured tcmpcratures are influenced by water bolus tem-
peratures (13). In ordcr to have the lllostuseful temperature 
infonnation during a treatment, the position of the temper-
ature probes could change from treatment to treatment as <I 
result of experience obtained during a former treatment and 
a~ a consequence, the number and/or position of invasively 
mea.~ured tissue temperatures per tre<ltment series could 
vary. In all cases <In optimi7ed distribution of multipoint 
prohes was used to havc maximulll invasive thermometry. 
Since the entire treatment mea is considcred at risk, no 
discrimination was made between temperature prohe loca-
tions in invasive macroscopic tumor sites and othcr inva-
sively measured Iocations. 
For quantitatively technical comparison of the homogc~ 
neity of the temperature distributions obtained by WGA and 
LeA, the aperture of each antenna was divided in Iwo 
rcgions. TIle ('('II IeI' rcgion measured 6 X 6 cm2 and is 
located centrally under thc apcrture (approximately the di-
mcnsion,s uf the EFS of the WGA); the remaining region of 
the aperture is named periphery. In this wayan overall 
treatment area built with /I antennae was divided into /I + I 
regions (Fig. 2). Two corresponding temperature parameters 
were defined: the average illva~ive center located tempera-
ture (TJ and the average invasive periphery located tem-
perature err) which were calculated during steady state of a 
HT treatment. The data were obtaincd by laheling the tissue-
indicator of each invasive temperature site in the tempera-
ture Iiles. TIle difference between these two parameters T~ 
and Tp expresses the homogeneity in the temperature dis-
tribution under the evaluated array. 
For further clinically relevant evaluation of a HT treat-
ment, the average temperature (,r",I") over all invasive tem-
perature prohes recorded during .qeady state and the T'}jl' i.e. 
Clinical comparison of LCA and WGA arrays 
Table I. Overview of number of patients, number of treatment 
~eries, and number of treatments as a function of treatment 
series 
No. of 
No. of patients in Total no. 
l['eatment series II series of series Tutal no. of 
H I' IHp treatments 
1 16 16 107 
2 6 12 88 
3 1 3 24 
Total 23 31 219 
the 10th centile of all invasi\'e tempemture recordings dur-
il1g steady state, were calculated. 
Statistical setllp IIlld ('xcll/sioll criteria. Twenty-three pa-
tients entered the study, of whom six patients received two 
,c:ries of treatments and one patient received three treatment 
\<"ries on separate areas (Table 1). In 10 series the number 
(It" HT treatments \vas less than 8 (range: 3-7 treatments; 
median 4.5). In total 31 series containing 219 treatments 
\\"ere entered in the study. 
A series of exclusion criteria had to be met to enter the 
.lIlulyses of the study Cfable provides an overview). From 
;111 219 treatments evaluated (Le., 219 records), 90 were 
11c:'rformed with the WGAs, 118 were performcd with the 
I.CAs, and II treatments were performed with a mix of 
WGAs and LCAs. The mixed-antenna treatments were ex-
,'lllded from the analyses (208 records left). TIle avemge 
Illput power and invasive temperature showed a significant 
lwrelation (p = 0.025, by analysis of variance [ANOYA]) 
II ith the treatmcnt number, All statistical analyses were 
I'"rformed with Stata 5.0 (Stahl Corporation, College Sta-
ti,m, TX). After excluding the first two treatments from the 
~lIlalysis, this trend disappeared (p = 0.3) and 151 records 
II ere left. Four treatments (in the range of 3rd-8th tn:at-
ment) were excluded from analyses due to a lack of invasive 
thermometry (147 records left). 
I ,thle 2. Oven'iew of effect of cwlusion crilerifl* on number of 
evalllLlble treatments and serie~ 1 
No. excl. No. excl. 
'\0. ExcJu,ion criterion trtments ~eries 
,\-lixed LCA-WGA antenna 
treatments II 0 
Treatment number I and 2 57 0 
1 Nu invasive thermometry 4 I 
" 
Lack of WGA and LeA treatments 
in a serie~ of 3rt'! to Hth 
treatment 19 
" T,'lal 91 9 
The number of excluded treatments and series as given in the 
Idhle arc taken from the {~ub}set of still included treatments and 
,c'l ies. For example exclu~ioll of treatment 1 and 2 in originally 31 
,tI"ie~ re,ult~ in only 57 exclmkd treatment~ because the fir..-t 
,':'[1lied exclusion criterion excluded already 5 treatments I or 2. 
Odgin<llly .11 ~t'ric~ containing 219 trt'atments were entered 
,[11(\ the ~tudy. 
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In order to be able to analyze differences betwcen the two 
antenna types using a patient as his or her own reference, 
each patient had to be treated at least four times including 
two WGA and two LeA trcatments since the first two 
treatments were excluded from the analyses. This criterion 
excluded H series with a total of 19 treatments from the 
analysi.~ resulting in 128 evaluable records. From the total 
set of 219 treatments in 31 series, 128 treatments (59 WGA 
and 69 LeA treatments) in 22 series passed the exclusion 
criteria. The 22 series were obtained from 16 patients. 
From this final set of 128 treatments, four treatments (2 
LeA and 2 WGA treatments) were stopped after less than 
60 minutes treatment time. Reasons for this premature stop 
were: general discomfort and pain of the patient (2) and 
technical problems (2). From the final data set, several 
parameters wcre calculated. Per treatment series and per 
antenna type (x), with x equal to LeA or WGA, the P"lg(x), 
PSD(x), Ta\"g(x), Tc(x), Tp(x), and T,}II(x) were calculated as 
the average of the curresponding parameter per treatment 
series as previously defincd under "Power level variables" 
and 'Temperature variables." Nine treatments did not have 
"center" thermometry sites and olle treatment did not have 
a "periphery" thcrmometry sill'. This resuited in an average 
temperature difference dT
e
.p (= T<. - Tp) calculated ovcr 
II H records. 
The average number of antennae used was 4,02 (SO: 
1,03) for the WGA and 3.79 (SD: 1.27) for the LeA. 
Statistical analysis consisted of the calculation of means 
and .~tandani deviations over patients of the parameters per 
antenna type and their paired differences. Analysis of vari-
ance was applied to test for differences between the two 
antenna types in the distribution of the parameters per 
treatment. In this analysis treatment parameters, for exam-
ple the T3"~ of the treatment, were used as dependent 
YUriahles, while patient and antenna type were included as 
categorical covariates. 
RESULTS 
TIle power and thermal dose parameters averaged over all 
treatment series per antenna type are shown in Table 3. The 
corresponding parameter differences per antenna type are 
abo shown in Table 3 a.~ well as their statistical p-values 
obtained from ANOY A, 
The average power olltput of the LeA was statistically 
significantly higher than the output of the WGA. No differ-
ence was observed in the variation in an array of the output 
pO\vcr. The average invasive temperature, using the LCA, 
wa~ 0.2RoC higher than under the WGA (p = 0,004), which 
was primarily due to higher peripheral temperaturcs T p' No 
difference in centrally located invasive temperatures (T.) 
was observed. 
DISCUSSION AND CONCLUSION 
The relationship between SAR and any thermal dust' 
parameter is still a complicated maHer and subject of dis-
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Table 3. Overview of calculated power and temperature related 
dose pammeters* 
P,,,g(W) 
Pso(W) 
T~\,~ (oq 
TJC) 
T r (~C) 
dT,], (~C) 
T.JII(CC) 
WOA LeA 
Difference 
LCA~WGA 
Mean SD Mean SO Mean SD p-Vulue 
OX 12 62 15 14 9 <0,0001 
14A 5.7 16.4 8.7 4 14 O.IS 
40.90 0.69 41.171 0.55 0.28 0.4 0.00-1-
41.26 O,6.j. 41.20 0.59 -0.03 0.6 0.8 
4n.77 0.81 41.20 0.70 0,43 n,s 0,0006 
+0.43 0.92 -0.05 0.96 ··0.49 0.7 n.OOS 
39.44 0.77 3l}.54 0.73 0.10 0.6 0.46 
'" The average vaiues were calculated over the treatment ~eries 
per antenna type. 
t The awmgc invusivcly measun.x[ kmpefillure fur LeA treat-
ments (T,,,,; 41.17 ~C) is 0.03 CC lower than both corresponding T •. 
and Tp. Tllis artefact is caused by lack of either Teo or T p site~ in 10 
treatments. 
cuss ian (14-17).111 fact, literature cOllceming clinical eval-
uation of the dose-effect relations of hyperthermia provides 
a broad field of treatment-related parameters whkh all cor-
relate more or less with CR or other dellned endpoints (4, 
14, 16-24). Hyperthennic quality expressed in terms of 
dose parameters is not defined yet (25). 
TIle question whether the technical superior LCA will 
result in better clinical outcomes of the HT treatment series 
can only be conclusively demonstrated in a randomized 
prospective study. Since the CR rate is already in the range 
of 70-90% (2, 3) for combined reirradiation plus HT, it is 
statistically not likely that such a study with the current 
patient accrual (40-50/yr) can be finished successfully in an 
appropriate time scale « 5 years). 
In this study we arc lIot primarily interested in a corre-
lation between clinical outcome and antenna type used, 
therefore we concentrate only on basic treatment parameters 
as a function of antenna type used to quantitatively evaluate 
the effect of an increased EFS of the LCA under clink,t\ 
conditions. Firstly the power-related parameters Pavg and 
PSD are discllssed and secondly Ihe temperature-related 
parameters are discussed. 
E),{III/(//ioll of poH'er-rclatt'd paralllc/<'I'S 
Averagc IJOII'£'1' (1''''_.'1). Although net power (P~\) as a 
hyperthermic parameter does not contain any biological or 
clinical input cxcept fur patient tolcrant'c, it is a simplc 
variable to relate to SAl{ distributiolls (or EFS). If the EFS 
is small, the antennae will effectively heat only a small 
volulllc undcr the aperture. An increa~ed EFS results in a 
smaller derivativc of thc SAR us a function of position x in 
the horizontal plane (dSAR/dx). Furthermore, the absolute 
maximum SAR level is dictated only by a small volume 
element under tbe antenna wbere either a maximum toler-
able temperature is measured or the patient feels a pain 
~ensation. Both antenna types have centrally located maxi-
mum SAR, therefore we think that the absolute miLximum 
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SAl{ level is more patientltreatmenl-area-dependent than 
antenna-dependent. So, in a particular treatment area the 
100% SAR in tbe relative SAR distributions from WOA and 
LCA will have about equal magnitude. 
A positive correlation between p,,\),: and a SAR distribu-
tion (or EFS) is probable, because the LeA has a smaller 
dSARldx, and thus an ovcrall higher energy deposition (as 
indicated by P",),:) can be delivered to the target \'olume 
under the antenna aperture. This effect is counteracted by 
the following factors: (1) local tissue properties: an in-
creased energy depm'itioll in HR'a.~ where the WOA doe.~ not 
heat adequately can also lead to additional hot spots when 
the LCA is used and may caUse additional limiting power 
depositions in those cases where LeAs are used, which are 
not present for WOAs; and (2) preheating of peripheral 
incoming blood can create an additional temperatllre rise in 
the center regioll of the uperture (26, 27). Although the EFS 
of the LCA is roughly threefold thc BPS of the WGA, the 
combination of above-Illentioned negative side effecls re-
sulted only in a !-;ignificutlt 14 W power increase for LCA 
arruys (JOt;~.), 62 W versus 48 W for the WGA applications. 
HOJ/logeneity ;11 polI'er s('ttill<~.\· (r.m ). The homogeneity 
in power levels in an array upplication, as expres\ed by the 
standard cic"iution of power levels in ,Hl array, PSI), did not 
('hunge significantly as a function of antenna type (14.4 \V 
versus 16.4 W for WOA and LeA treatments respectively). 
We expected Ihat by using the LeAs the cham'c of ('reating 
hot spots would be diminished becausc the range of per-
centage SAR in the treatment mea is snlUller. This <I~"llll1r­
lion was based on Gaussian beam predit:tillIlS of SAl{ dis-
tributions from arruys ofWGAs and LeAs (6). Although in 
an arrayal' LCAs a t'Onliguolls BFS is feasible (by 'lpplying 
an equal power ovcr thc antennae) (6), local power ~teering 
remained a necessity in order to optimize the hyperthermia 
treatment. Anticipation on (dynamic) local tissue cilaracter-
istks (e.g., blood liow and e\cetromagnetic properties) had 
a strong impact on power settings independent of the an-
tenna type used. 
Emilla/ioll t!f bn'(I!;,'i\'e{y IIIc(/SIIred telllpl'l"lI/IIH'-reltlted 
paralllc/ers 
Tissue chamcterist1cs make the influence between a SA\{ 
and its corresponding temperature distribution a dynaIllit~ 
process which is still unpredictable in its development (2Q, 
29). However, it is unlikcly that an increased tissue tcmpcr-
ature will result in a decreased hyperthermic effect (19), 
therefore we assume that improvement of the tel'hnit:al 
quality of a HT tr!;'atment (when using technically improved 
antennae) can abo he tested by analyzing temperature-
rcluted variables. 
Al't'I"lIgc /elllf/era/Ilre (T",.,J TIle average invasive tem-
perature increased from 40.9(·C for the WGA to 41.2 Q C 
whcn the LCA wus used. Although this improvement may 
seem small from a clinical point of view, in the restricted 
setup of this study where Ihe technical improvements were 
investigated clinieally, it is stati~tically significant. :vfore 
Clinical comparison of LCA and JVGA arrays 
detailed analyses (not presented in this paper) did not reveal 
any additional understanding of this minor increase in in-
vasive temperature in relation to the m:~ior increase in EFS. 
Temperalllfc d(flert'll('(' betweeJl cellla (TcJ alld periph-
oy (T, ,) (~fl"c lifo/lire, The small EFS of the WGA results 
in a hot ~p{lt located in the center region of the antenna, If 
the WOA is lised in an array application, there nre no 
significant overlapping SAR levels at the periphery of each 
,lpertllre including the aperture periphery located in the 
center of the 2 X 2 array (6). A difference in dTcp is 
expected for the WOA and LCA because the EI-'S of the 
LC A in an aITay application covered almost the entire 
outside contour of the 2 X 2 array and has a local SAR dip 
of 50-SOI,(' SAR at the center of the 2 X 2 nITay (6), For 
that n'llson, the periphery region located in the center of an 
array is not treated as a separate region, 
In the clinical application of the LCA, the difference be-
tween tell1perature~ (tiT,!,) mea~ured over the center region and 
periphery region of all nITa), of antenna (Fig. 2) is about zero 
for the LeA, wherea~ in ca~e oflhe WOA the center regions 
107 
under the antennae reach n 0,43"C higher tempemture th,1I1 the 
periphery (T,lble 3), The nvemge tempemture in the center 
region of the nperture, the region of highest SAR levels for 
both antenna types, remained unchanged as a function of 
antenna type used (-(J,03°C, f1 = n.R) antithercrore, with the 
increase of average peripheml temperatures in ca~c thc LCAs 
were used, the unchanged '1'\1(1 (39,44"C [\VGA] and 39.54°C 
[LCA]) can only be explained by a minimum peripheral tern~ 
pemture during treatment me<L~ured at n peripheral local voJ-
ullle clement that could no! be heated properly with either 
\vOA or LCA. Since the '1'<)(1 is more dependent on the locnlion 
of the thennometry site, we think it is a le~s relevant theroml 
parameter in investigating a technical improvement than the 
inva~ive temperature, 
The results obtained frolll the~e analyses have led us to the 
conclusion that lise of the LeA in treatments of brea~t cancer 
with superficial hyperthemlia does givc a slightly belter inva-
sivc tempemtme in thc trl."atment area without any negative 
side effects, For that rea~orl the LCA is now lised a" Ollr 
... tandard antenna in the treatment of ,~\lperJidal hyperthermia. 
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Abstract 
The benefits of using superficial hyperthenllia together with radiotherapy has long been 
proven for recurrent breast carcinomas. The Incite cone applicator (LeA) has been introduced 
by some hospital hYPcl1hennia units for superficial treatments. It is characterized by a large 
effective field size (EFS). The modeling teclmiques used iu the past for the study of this as 
well as other applicators used for superficial hyperthclmia have failed to address the 
significance in clinical practice of some treatment parameters, like the dimensions of the 
waterbolus. In this work the Finite-Difference Time-Domain (FDTD) method is used for 
modeling the applicators, The llumerical results are c0111pared with thermographic 
measurements. The agreement between predicted and measured SAR distributions is velY 
good. The use of the FDTD method is expected to promote the study of treatment specific 
factors and help improve future treatment quality. 
FDTD-Illodelling of the LCA 111 
I. INTRODUCTION 
The Intemational Collaborative Hyperthelmia Group has clearly demonstrated the benefits 
of combining radiotherapy with hyperthennia against radiotherapy alone in the treatment of 
superficial breast cancer [I]. Since the publication of the results superficial hypclthcnnia has 
become a standard treatment modality in several institutes, especially for the treatment of 
chest wall reCUlTcnces of breast cancer. Although it was found that clinical outcome is related 
to thermal dose [2]. it still remains unclear which of the physical parameters of the treatment 
can improve its quality and, therefore, its efficacy. 
The main requirements which arc put fonvard in the development of new systems for 
superficial hyperthennia are the achievement of a large effective field size (EFS I ), sufficient 
penetration depth2 and good spatial control. It is usually necessary to employ an array of 
applicators to fulfill the above requirements. 
The itwite cone applicator (LCA) is a superficial hype11hellllia applicator which offers a 
large EFS and can be used in an array configuration. Its efficiency has been confilmed both in 
technical [4] and in clinical [5] tenns. The theoretical modeling of the applicator with the 
Gaussian beam model (GBM) has given very good agreement with the experimental results 
for some configurations [6], [7]. However, there are some drawbacks of this modeling 
technique in the case of the LeA: The GBM cannot take into account the finite size of the 
waterbolus which is placed between the applicator and the patient in order to couple the 
electromagnetic energy into the body and to control the skin temperature. Yet, the waterbolus 
seems to have a direct effect on the SAR (specific absorption rate) distribution [4] and, hence, 
the ability to model it is impo11ant. Another disadvantage of the GBM is that it cannot predict 
correctly the coupling between the applicators, when they are used in an alTay configuration 
[6], [7]. The above problems of GBM can be overcome, if electric field measurements are 
perfonl1ed before modeling for every treatment configuration, but this is a cumbersome task. 
Finally, the GBM cannot deal with tissue inhomogeneities, which arc present in the clinical 
situation. 
In this work it will be shown that it is feasible to study theoretically both the LCA and the 
older applicators used for superficial hyperthennia with the finite-difference time-domain 
1 The effective field size is defined as the area which is enclosed ,vithin the 50% iso-SAR curve at tern depth 
inside the flat homogeneous phantom [3]. 
2 TIle penetration depth is defined as the depth in the phantom at which the SAR becomes I1e2 of its value at the 
surface of the phantom. 
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(FDTD) teclmique. This numerical method allows the use of a more realistic model, but is 
more expensive in computational resources compared to the GBM. The major advantage of 
the FDTD method is that it allows a 3-D analysis of the applicator configurations, without the 
need for time-consuming measurements. Quantities like the penetration depth and the EFS 
can directly be deduced fr0111 the calculated results. From the 3-D analysis we expect to gain a 
good insight in the significant parameters of the treatment leading to treatments of better 
quality. 
II. MA'fEIUALS AND METHODS 
A. Lucite calle applicator (LCA) 
The conventional applicator which has been used in the past for superficial hyperthcllllia 
consists of a water-filled rectangular waveguide which ends to a horn antclma. The waveguide 
is made of brass and operates at TEIO mode at 433MHz. The waveguide dimensions are 3cm x 
Scm and the apel1ure size of the radiating antenna is lOcm x lOcnl. The LeA is a 
modification of the conventional applicator: The two diverging metal walls of the horn 
antemla which are parallel to the electric field are replaced by lucite walls. Additionally, a 
PVC cone with a height of 5.5cm is inserted in the applicator at the center ofthe aperture. 
Fig, 1 Photograph of the various applicators: (left) the lucite applicator (LA) with the two 
diverging walls of the horn antenna parallel to the electric field made of 1ucite; 
(center) the hlCite COlle applicator (LCA) similar to the lucite applicator with a PVC 
cone inserted in the center of the antenna; (right) the conventional applicator (CA) 
made totally of metal. 
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Different cone angles have been tested and it was found that the angle of 15° gave the best 
results. The LeA is described extensively in [4]. The various applicators are shown in Fig. 1. 
B. Electromagnetic modeling 
The FDTD technique is used for modeling the LeA. The technique is well established in 
the field of biomedical applications of electromagnetic radiation [8], although most of the 
work perfonned with it in the area of hyperthermia COllcems deep regional treatments, 
The developed numerical model attempts to simulate the experimental set-up as closely as 
possible, The assumed electrical properties of the materials are shown in Table I. The 
applicators are placed on top of a flat muscle-equivalent phantom constmcted according to 
[9]. 
The size of the phantom used in the experimental measurements was 50 x 50 x 1 Oem3• 
However, the simulated phantom dimensions were chosen to be 38 x 30 x 14cm3, in order to 
reduce the computer memory requirements. The choice for these dimensions was based on the 
results presented in [6]. In this study it was shown that in a liquid muscle-equivalent phantom 
of almost the same size (40 x 32 x 14cm3) the dishibution measured with a scanning electric 
dipole under the aperture and at lcm depth agrees with the measurements perfomled for the 
semi-solid phantom with the thennographic camera. 
Table 1. Electrical properties of the materials used in the numerical calculations. 
Material Ii, (J" (S/m) 
De-ionized water 76 0.001 
Lucile 2.59 0.003 
PVC 2.2 0.004 
Muscle phantom 57 1.2 
A unifornl rectilinear mesh was used with a celI size of 0.2cm. The total size of the 
computational domain (including the applicator) was 190 x 150 x 225 cells. The domain was 
tenllinated with Mur's second-order absorbing boundary conditions [10]. The applicators 
radiate mainly into the direction of the tissue-equivalent phantom which is made of a lossy 
material. The dimensions of the simulated phantom are large enough with respect to the 
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wavelength of the radiation in it to ensure that the largest part of the power reflected on the 
tnmcation planes will be dissipated on its way to the radiating aperture. Hence, the above 
boundary conditions are expected to be adequate in this case (see [11], [12]). 
The metallic walls of the applicator were treated as perfect electric conductors (PEC's), so 
that the "diagonal split cell model" [8] could be used in a straightforward manner for the 
diverging metallic walls of the applicator which are oblique to the rectilinear mesh. This 
contour-path model is derived directly fi'om Faraday's law and is simple to implement 
compared to the confonnal modeling which had been used in other works for horn antcIUlas 
(13]. The simulations have shown that even this simple modification for the metallic walls 
gave better numerical results than the "staircasing" approach, which 'vas, however, retained 
for the Incite walls and the PVC cone. 
The excitation was modeled by a group of co-linear electric field components which 
connect the lower metal wall of the waveguide with the end of the feeding pin. A sinusoidal 
signal at 433MHz with a linear time-ramp was used for the excitation. The total simulation 
time was twenty periods of the source signal. The CPU time for a simulation on a compatible 
PC with a Pentium Il~ microprocessor at 450MHz and 512MB of RAM mel110lY was about 10 
hours. 
C. 111ermographic SAR measurements 
The SAR distributions were measured exp~rimeI1tally with an infrared camera (AGA 
Thermovision System 680/102B, Lidingo, Sweden) interfaced to a PC. The applicators were 
placed on top ofa semi-solid muscle equivalent phantom (50 x 50 x 10cm') [9]. Between the 
applicator and the phantom a waterbolus (a plastic bag filled with de-ionized water) was 
positioned. The phantom consists of I and 2cm layers for the first 5cm to allow the 
measurement of the SAR distribution at different depths from the phantom surface. The layers 
are made of the material enclosed in a 0.005cl11 thick PVC mylar which has no influence on 
the deposited electromagnetic energy. Because of the low sensitivity of the camera the 
phantom had to be heated for a maximum time of 1.5 n~inutes for the temperature to rise 
between 3-6°C. This time is slightly larger than the one specified in the ESHO quality 
assurance guidelines [3]. However, in [6] it is shown that the relative SAR distributions at 
lcm depth as measured with the thennographic camera for the semi-solid phantom and with 
the scanning dipole technique agree velY well, especially under the center of the aperture. The 
applicator, the waterbolus and the required phantom layers were removed after the power had 
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been tumed off. The temperature distribution on the top surface of the remaining phantom was 
measured within 155. The measured distribution of temperature rise cOlTesponds essentially to 
the SAR distribution, The method is explained in detail in [4]. The time which is necessary 
for the experimental assessment of a single SAR distribution is roughly I hour. After each 
measurement a period of 2-4 hours is necessary for the phantom to reach again thermal 
equilibrium. Therefore, it is less convenient to acquire by means of measurement the 3-D 
infol1nation on the SAR distribution, which is provided with a single computer simulation. 
III. RESULTS AND DISCUSSION 
Numetical calculations have been canied out for all three types of applicators of Fig. 1, 
i.e" the conventional applicator (CA), the hlCite applicator (LA) and the hlCite cone applicator 
(LeA). The discretized model which was used for the simulations is shown in Fig. 2. A finite-
size waterbolus of 18 x 18 x lcm3 similar to the one used during measurements was included 
in the model. 
(a) (b) 
Fig.2 Representation of the numerical model in (a) 2-D and (b) 3-D. In both models the 
"staircasing" effect is apparent. This requires that a contour-path approximation be 
employed for a more correct modeling. 
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Fig.3 SAR distributions (normalized to their maximum value) on the transversal cross-
section of a flat homogeneous muscle-equivalent phantom at a depth of lcm for a 
conventional applicator and a waterbolus of lcm thickness. 
(a) Measured distribution. (b) Predicted distribution, 
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Fig.4 SAR distributions (nonnalized to their maximum value) on the transversal cross-
section of a flat homogeneous muscle-equivalent phantom at a depth of lern for a 
Iucite applicator and a waterbolus of lcm thickness. 
(a) Measured distribution. (b) Predicted distribution. 
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Fig.S SAR distributions (normalized to their maximum value) on the transversal cross-section of a 
flat homogeneous muscle~equivalent phantom at a depth of lem for a lucite cone applicator 
and a watcrbolus of lem thickness. 
(a) Measured distribution. (b) Predicted distribution. 
On the cross-section of the muscle-equivalent phantom normal to the propagation direction 
the SAR distributions are compared at a depth of Icm. Figs. 3-5 show the predicted and the 
measured distributions for all three types of applicators. The values are llOlll1alized to the 
maximum value of each distribution. For clarity only iso-SAR values above 40% are plotted, 
It should be pointed out that Fig. 4a which depicts the measured SAR distribution of the hlCite 
applicator is of poor quality, due to the poor matching between the feeding line and the 
applicator. The reflected power for the measured ltlCite applicator was about 20%, whereas for 
the other two applicators the reflected power was about 3%. Consequently, the net output 
power from the Incite applicator was low and the maximum temperature rise achieved in the 
phantom was only 3°C. This resulted in a noisy measurement compared with the other two 
applicators for which the maximum temperature rise was 6°C. 
Additionally, a comparison of the predicted and measured SAR profiles along the main 
axes of the aperture for all three applicator types is presented in Figs. 6a-c for the axis parallel 
to the E-field direction and in Figs. 6d-f for the axis perpendicular to the E-field direction. The 
SAR distributions of Fig. 6 are nommlized to the maximum along each axis. 
It can be seen from Figs. 3-6 that there is a very good agreement between the predicted and 
measured distributions for all applicators. As was mentioned above, these results were 
obtained with a cell size ofO.2cm. Initially a coarser mesh with a cell size ofO.Scm was tested 
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for which the lucite cover was modeled in one case and was omitted in another. The 
electromagnetic field distributions inside the phantom were significantly different in the two 
cases. Therefore, the cell size had to be reduced to 0.2cm to allow the correct modeling of the 
lucite cover in front of the radiating aperture. Work is clUTcntly under way to implement a 
"thin sheet" approximation for this dielectric cover in order to examine the use of a coarser 
mesh in the numerical calculations. 
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Fig,6 The SAR distribution along the aperture axis of the applicators which is parallel (a-c) 
and perpendicular (d-f) to the electric field. The predicted (thick line), the measured 
(circle points) and the spline fit for the measured (thin line) distributions are given 
for the conventional (a,d), the lucite (b,e) and the lucite cone (c,f) applicators. 
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An important quantity for the characterization of superficial hyperthennia applicators is 
their effective field size (EFS). Table 2 summarizes the results with respect to the EFS. Beside 
the measured and predicted values at 1em depth, predicted values are given around this point 
to show the steepness with which the EFS decays, 
Table 2. Measured and predicted EFS for the three applicators. 
Measured at a Predicted at a depth of 
depth of Icm O.8cm lcm I.2cm 
Conventional applicator 32cm2 40.92cm2 40.16cm' 39.64cm2 
Lucite applicator 67cm2 54.64cm' 54.32cm' 54.08cm' 
Lucile cone applicator' 91cm2 85.92cm1 84.88cm2 83.40cm' 
aThe average measured value for six LeNs was 91±6cm2 (one standard deviation). 
The difference between predicted and measured results can be attributed to Cffors of both 
the numerical and the experimental methods. It must be noted that the resolution of the 
infrared camera is poor with a pixel size of roughly 4mm x 3 mm, Furthennore, heat diffusion 
during measurements can alter significantly the measured distributions [14], The 
detennination of the effect which heat conduction has on the measured distribution is under 
investigation, 
The results verify that the lucite cone applicator has an increased EFS compared to the 
other applicator types, This is achieved in the two steps which were considered for the 
development of the LeA: 
(I) It was shown in [15]lhat Ihe width of the H-plane within the applicator aperture can 
be increased by replacing the metal walls which are parallel to the electric field with lucite 
walls, 
(2) It is known that the partial loading of a rectangnlar applicator with slabs of high 
pemlittivity leads to a better unifonnity of the electric field across its aperture [16], [17]. The 
PVC cone which is inserted at the center of the aperture has a low pemlittivity compared to 
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de-ionized water, Thus, the water which surrounds it acts like a high permittivity slab, 
improving the ullifonllity of the electric fIeld. 
Along the direction of propagation it was not possible to measure the SAR distribution. 
The calculated SAR distributions on the H-field and the E-field planes show that there is little 
difference among the three applicator types for the energy deposition pattems inside the 
phantom as a function of depth. Nevertheless, the lucite cone applicator is still slightly 
supetior to the other two applicator types in terms of the penetration depth. Its penetration 
depth - calculated with an exponential fit of the numerical results - was found to be 3.6cm 
compared to 3.2cm for the cOllventional applicator and 3.1cm of the hlCite applicator. The 
penetration depth for plane wave exposure at this frequency is repOlied to be 3.56 cm [3],[9]. 
The efficiency of the applicators has also been calculated fi'om the ratio of the power 
absorbed in the muscle phantom to the power input to the applicator. It was found that the 
efficiency of all three applicators was about 48%. Table 3 contains infonnation about the 
calculated maximum 8AR which is achieved at the surface or the muscle phantom and at lcm 
depth in it per W of input power. It is assumed that the muscle-equivalent phantom has a 
density of =lOOOkg/m3 [18J. The maximum temperature rise per W of input power for a 
heating period of Imin can be estimated from the maximum SAR values3, assuming that the 
specific heat of the phantom is 3600J/kg/'C [I8]. 
Table 3. Capability of applicators to deliver power to the phantom. 
SARtlll~ T SAR""n T 
(WlkglW",) at ('C/min/W to) (WlkglW;,,) ('C/min/W;,o) 
surface at surface at lem at lcm 
Conventional applicator 5.25 0.0875 2.93 0.0488 
Lucite applicator 4.15 0.0692 2.15 0.0358 
Lucite cone applicator 2.81 0.0468 1.55 0.0258 
, U' 1 . ·'1' SAR· d! 1 . 1 h . . d' 1 'fi 1 sing t Ie equatIOn <:.l =: ---. W lere At IS t le eatll1g time an C IS t le speci Ie leat. 
c 
FDTD-lIlode/ling of the LeA 121 
IV. CONCLUSIONS 
A three-dimensional model based on the Finite-Difference Time-Domain (FDTD) method 
was developed for the study of superficial applicators. With this model it is feasible to further 
investigate the three applicator types considered. The results have verified that the lucite cone 
applicator (LeA) has a better perfonuance than the other two applicator types in tenus of 
EFS. The relevant numerical results agreed with the experimental ones, They both continned 
the expectations of the two-step design process of the LeA as described in the above section. 
Moreover, the numerical results presented in this work have shown that the penetration depth 
of the LeA is higher than for the other two applicators. This adds another advantage to the 
LeA. 
The approaches that had previously been attempted in modeling the applicators could offer 
limited infomlation on the resulting SAR distributions. Furthennore, they did not carry the 
potentia I for examining clinically significant factors, like the dimensions of the waterbolus 
and the complex patient anatomy, On the contralY) the developed numerical model allows a 
direct 3-D analysis of the treatment set-up, This will certainly facilitate the detenuination of 
clinically significant treatment factors and help improve treatment quality, Alt~lOUgh the 
model is based on a very fine mesh which is probably prohibitive for the simulation of 2 x 2 
applicator arrays work is already being carried out for the use of coarser models, 
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General discussion 
In the last two decades, progress has been made in hyperthcnuia in the fields of biology (Kong 
and Dewhirst, (1999», tumour physiology (Kanamori ef al. (1999», clinical applications and 
heating techniques (Dewhirst ef al. (1997); Dahl ef al. (1999». Especial1y in interstitial 
hyperthermia and deep regional hyperthcnuia have 3D-adjustable heating techniques, 3D patient-
orientated treatment plmming and their clinically related data have been made accessible through 
several studies. Different groups have contributed to these results through their specialised know-
how, based on either theoretical, technical or clinical research (Lagendijk, (1990); Sullivan et al. 
(1993); Sneed ef al. (1998); Tumer, (1998); Wust ef al. (1999); Paulsen ef al. (1999); Van der 
Zee ef al. (2000». 
A combination of these more recent results has led to the overall mechanisms of hyperthermia 
being better understood. Although at present several clinical applications of hyperthennia are 
either under investigation or are (already) considered as part of a standard treatment modality, no 
consensus appears to exist in treatment schemes1• There are also large differences of opinion as to 
what is considered to be the main issue that should be investigated in hypelthermia. 
In our group, the emphasis in the research done, was generally on the more practical sides of 
the clinical application of hyperthennia. We presented the clinical results of the treatment of 
recunent breast cancer which fonned the basis for this thesis (see chapter 2). It was clearly shown 
that the used tec1miques can have a great impact on the clinical outcome as was reported earlier 
I Inlhis discussion, the progress within the Asian hyperthennia conunuuity is not included for reasons of clarity. 
Research and development in Caucasian-related and Asian-related hyperthennia therapies have other teclll1ical and 
clinical accents. 11tis has an impact on certain hyperthermic treatment aspects, \vhich would complicate the 
discussion more than desirable. Asian hyperthermic research as an entity has, however, contributed significantly to 
the progress of hyperthemtia. 
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by Perez ef al. and Emami ef a/. (perez ef a/. (1989); Perez ef a/. (1991); Emami ef a/. (1996» 
and that hypelihennia can work providing a minimum quality is guaranteed. 
Quality of hype11hennia can be measured on different levels. One ideally should compare 
quality relative to the standard treatment scheme through CR rates, local control or sUll/ivaI rate. 
However, tlus set up is sometimes not feasible due to a limited influx of patients or the 
expectation of relatively small differences in clinical outcome between the two treatment 
schemes, Altematively, the hyperthennic quality can be expressed based on measured 
temperatures. However, in clinical practice, invasive thenllometry has its limitations (chapter 3) 
in providing data for thermal dose analyses. Also, accurate non-invasive measurement teclmiques 
are not yet available on a routine basis, More merits and demerits of the use of measured 
temperatures will be discussed further on in this chapter, 
The technical parameter of hyperthennic quality is SAR and its use is defined in the Quality 
Assurance (QA) guidelines of ESHO and RTOG (Hand ef a/. (1989); Dewhirst ef a/. (1990». 
However, the SAR requirements for hyperthemlic quality are not unequivocal when transferred 
from QA guidelines into clinical practice. Whether the QA guidelines-based 50% SAR coverage 
is the ultimate goal for clinical applications 9r the 25% SAR coverage that was found as 
prognostic factor for response (Myerson ef a/. (l990b); Lee ef a/. (1998)) or the homogeneity 
coefficient as defined by Gelvich ef a/. (1996) is as yet unclear. A validation of the 25% SAR 
con"elation with CR in combination with the use of different types of antennae will make clear 
whether this parameter, which can be measured or calculated relatively accurately, will hold its 
prognostic capabilities and thus its clinical relevance. 
For the remainder of this chapter, the discussion will be restricted to different aspects of 
thennal dosimetry in relation to the ultimate question, as described in the General Introduction: 
'Does technical impl'Ol'emellt ill (I "J'PeJ"hel'mic applicatioll actually result in a quantifiable 
illlprm'ement in the clinical hypertilel'mia treatment? 
The following items will be addressed: 
• Problems of confounding factors in thennal dosimetry 
• The use of the T90) TSO ) T20!IO or average temperature (Ta\') and measure for deviation. 
• The question of whether thennal dose-response studies should take place pdor to the 
conunencement of phase III studies. 
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The chapter concludes with future research possibilities for our Hype11hennia section of the 
Radiotherapy depaliment ofUHR-Daniel based on cUlTently presented results. 
10.1 Problems of confounding factors in thermal dosimetlY 
III vitro experiments have shown that higher temperatures generate more cell kill (Harisiadis et 
al. (1975); Dewey e/ al. (1977); Bhuyan, (1979» i.e. there exists a them1al dose-response 
relationship. One of the important lines in hypelihennic research is the translation from ill vitro 
thermal dosimetry into in vivo thennal dosimetry (Alfieri and Hahn, (1978); Perez and Sapareto, 
(1984». However, in vivo, the thennal dos-response correlations are influenced by confounding 
factors like the dynamic micro environment of the (tumour) cells i.e. tumour characteristics like 
oxygenation, nutrition and pH, thenno-tolerance or -resistance. Not only the biological cell 
mechanisms have to be taken into account but also the (varying) dose of the other treatment 
modality (i.e. radiotherapy or chemotherapy) plus pre-treatment (chemo, radiation therapy). Also, 
the fimction of temperature in time acts as a complicating factor. The total effect of the response 
to the combined treatments is a function of all variables including thennal dose. To distinguish 
the contribution of hyperthem1ia to the clinical response via a thennal dose parameter from this 
complex of variables is difficult but not impossible. First results on the possibility of delivering a 
prescribed thennal dose have been reported (Thrall e/ al.(1999)). 
When all variables with the exception of time-temperature are kept constant, a thennal 
measure for hyperthennic quality, not thenna! dose, of the hyperthennia treatment can be 
obtained. The intra-patient comparison of LCA- and WGA-related invasive temperatures (chapter 
8) is an example of such use of a thennal measure. In this comparison, it is not the absolute value 
of the average temperature per treatment (as a thennal dose parameter) which is important, but 
the difference between the two applied clinical set-ups. This parameter provides a measure for the 
evaluation of technical quality under clinical conditions based on a basic thelmal dose parameter. 
The development of thelmal dose-response relationship is seen as critical for progress in 
hyperthennia by the major North American hyperthennia researchers (Dewhirst e/ al. (1997». 
For this reason several definitions of thennal dose parameters have been tested (Oleson et al. 
(1993); Leopold e/ al. (1993); Kapp and Cox, (1995); Nishimura et al. (1995); Sherar et al. 
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(1997); Hand el al. (1997». Many groups have repOlted on retrospective thennal dose parameter 
studies and in par1icular reported on minimum temperature based parameters, which showed 
correlation with treatment outcome (Oleson el al. (1984); Cox and Kapp, (1992); Kapp and Cox, 
(1995); Hand el al. (1997); Overgaard el al. (1996». 
From these clinical findings and the biological support in literature, it is evident that a strong 
association exists between a time-temperature parameter and clinical response. However, due to 
the above-mentioned confounding factors, it is impossible to say that an unequivocal causal 
connection exists. I will ilIustrate this by two examples. 
Example I: Van del' Zee et al. (1992) found that the series average maximum tumour 
temperature at the coldest spot correlated with the number of intra tumour measurement sites 
(figure 10.1) and that the number of temperahlre measurements correlated with tumour size 
(personal communication). 
Also, Corry el al., Perez and Emami and Overgaard el al. (Corry el al. (1988); Perez and 
Emami, (1989); Overgaard el al. (1996» reported on a cOlTelation between number of 
temperature sites and a thenna1 dose parameter. Their findings were based on either a minimum 
temperature (Overgaard et al.), an average temperature (Cony et al.) or the number of probes 
reaching a maximum temperature above an index temperahlre (Perez and Emami). Overgaard el 
al. and Perez and Emami also found that the response was smaller for large tumours than for 
small tumours and since a large tumour can accommodate more temperature sites (on average), 
the correlation between thermal dose and response actually may be a non-hypelihennic 
correlation between hlmour size and response. Furthennore, the value of a thennal parameter may 
also be influenced by the temperature measurement tecllllique (Overgaard el al. (1996)). Hand el 
al. (1997) reported 110 correlation between number of temperature sites and minimum- or 
average-based thennal parameters. They argued that their number of thennometry sensors 
(median 10) was considerably greater than those used by Corry el {II. and Overgaard el al. (up to 
8 respectively median 4), Also, a conelation between the position of thennometry catheters and 
the radiation charactetistics of the used antennae can have an impact on the interdependence of 
temperature and number of sites, In short: the influences of tumour size and the quality of 
thenllometry on the thenna! dose concept are yet unclear. 
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figure 1 0.1: The treatment series average of the maximum temperature at the coldest spot 
as a function of invasive tumour sites. The numbers of sites are grouped; the numbers of 
observations are indicated as the data points. 
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Example II: It has been shown in the treatment of cervix cancer with radiotherapy that 
vascularity of the tUIllOur is a prognostic factor (Schlenger ef al. (1995); Cooper ef al. (1999)): 
cervix tumours with higher vascularity have less local control and survival probability. Suppose 
that: 
1. this patient group was treated with radiotherapy plus hyperthenllia, 
2. the grade of vascularity was unknown and 
3. vascularity is proportional to blood flow, 
then most probably the patient group with (unknown) high vascularity and thus high blood 
flow ,vill have a lower T90 and also an insufficient response to hyperthennia. However, as this 
group has already a lower chance onloeal control because of its vascularity-dependant effect of 
radiotherapy, this non-themlal tumour-related parameter would then influence the 
(retrospectively) obtained thennal dose-response correlation. 
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In conclusion, with the current available temperature data, results from retrospective thennal 
dose and thermal dose-response studies may be confounded by several pat11y unknown variables. 
Therefore, data from retrospective studies cannot be used to define optimal hyperthemlic 
treatment strategies. Defining quantitative measures for hyperthennia treatments (in combination 
with other treatment modalities) can only he done through prospective thennal dose studies. 
Should we concentrate first 011 defining clinically reliable thennal dose parameters that 
cOlTciate with response by addressing the problem of confounding factors in a controllable 
experimental set-up or temporarily settle for limited quantitative temperature-based analyses? 
10.2 The lise o/the T9(fr Ts() T2()/}() or average temperature (TaJ and measure/or de\liation 
Good correlations between minimum temperature-related parameters and clinical response 
regarding the effect of hyperthermia have been reported (Engin et a1. (1995); Kapp and Cox, 
(1995); Hand et al. (1997); Sherar et a1. (1997); Lee et al. (1998)). Oleson (1990) introduced the 
T90 (i.e. 10th percentile) as an alternative to the minimum temperature in order to reduce statistical 
noise. Likewise, the TJO and T20 were introduced as representatives of the maximum temperature 
in thennal dose analyses. 
A thennal dose parameter should: 
• Handle the temperature and time independently. In this way, thetmotolerance by step-
up and thennosensitivity by step-down heating can be incorporated in the thermal dose 
model. Also the duration of the treatment or fractionation of the hyperthennia treatment 
seties is then incorporated. 
• Function in optimisation routines during treatments and in between successive 
treatments. 
• COlTelate welJ with response and with local control. 
The clinically derived thennal dose parameter should ideally be independent of other 
patient/tissue-related properties such as treatment volume, perfusion and treatment history (e.g. 
fonner radiotherapy/chemotherapy/surgery). These requirements of independence are difficult if 
not impossible to meet. 
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The temperature data obtained from the clinical hyperthemlic applications gives a limited 
reflection of the actual overall temperature disttibution. With the currently available level of 
clinical thermometty we are confronted with clinical limitations: 
• The number of invasively located catheters in the treatment volume is limited due to 
patient~related constraints. 
• The number of invasive temperature sites per catheter is limited. 
• The spatial distribution of invasive thel1110metty is always a sum of local linear maps 
(multi-point temperature measurements in mainly straight catheters). 
With the assumption of lcm3 tissue temperature infonnation per invasive site, the order of 
coverage of the treatment volume is 1 %. These limitations can have an effect on the accuracy of 
the thermal dose parameters and influence correlation relationships. Some efforts have been made 
to overcome the first two limitations: e.g. the clinical use ofnon~invasive temperature techniques 
(Bertsch ef at. (1998); Delannoy ef at. (1991)) and con-ections in temperature distributions 
(Edelstein-Keshet ef at. (1989)) in spherically shaped tumours. However, these solutions are only 
applicable in specific cases. Therefore, the use of cUlTently available clinical themlOmetry in 
thermal dose calculations is of limited value and the search for the ultimate thennal dose 
parameter with the strongest association with response cannot be successful with the current 
quality of thennometry since the outcome of such analyses is still strongly data-dependent and 
dependent on the random fluctuations in the noise of each parameter. 
To investigate the usefulness of the more basic 'thennal dose' parameters like T9o,T5o and 
Tl0"20' calculations were perfonned using Stata2 on temperature data from a selection of patients 
treated with superficial hyperthennia in our section. Each treatment lasted 60 minutes. The data 
set contained temperature measurements from: 
• 176 patients; 
• 1137 treatments, 
• 6.5 treatments per treatment series (std: 2.1); 
• an average of20.2 temperature sites, (range 9 - 24), std: 3.3 of which 
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• 10.9 invasively (4.S in tumour) located sites and 
• an average of 53 readings per site per treatment (std: 22). 
In the calculations presented hereafter, the first 10 minutes of the treatments are excluded from 
the analyses to eliminate side effects from the wanlling-up period, 
Since the T90 and T IO.'20 are estimates of the minimum respectively maximum temperature, it is 
imp0l1ant to have an understanding of the shape of the temperature distribution. It is often the 
case that biological data follow the Nonnal distribution (Campbell and Machin, (1993)). The 
temperature data set is therefore analysed on its resemblance to the Normal distribution. To 
implement this, the quantile-Normal plot, which emphasizes the tails of the Nomml distribution, 
was used. The straight line in this plot represents the Nonnal distribution. Figure 10.2 shows 
quantile-Nonnal plots of the average temperature per invasive temperature site per treatment 
from nine randomly selected patient treatment series. 
The quantile-Nonnal plots of patient numbers 20S, 33S, 477 and 604 show significant 
deviations from the Nonnal distribution. In patient 723 the quality of invasive theml0metry is 
very poor. For five out of nine temperature distributions, the minimum or maximum temperature 
fa Us outside the Nonnal distribution. However, the T90 and T IO '20 in these distributions fall within 
the Normal distribution. but since these parameters do not represent the ultimate then1lal dose 
parameters, it is conceivable that other temperature based parameters like the Tso or Ta\' can be 
used instead. 
The interdependence of the T9o• Tso. average temperature Tal' and T20ilO is given in a matrix plot 
(figure 10.3). This plot clearly shows that the T" and T" are strongly con"elated which makes 
their use interchangeable in a comparison of different temperature analyses. This is also the case 
for the TIO and T2o' However, the qualitative correlation between the Tso and T90 is of more 
impOliance. The Tso (based on the average temperature per invasive site) follows the Nonnal 
distribution relatively well (figure 10.2). Ifwe take into account the T90- and T2ollO-dependence on 
statistically based fluctuations (e.g. the number of temperature sites), the Tso plus a measure for 
deviation are favoured from a statistical point of view and inform us equally well. 
2 Stata Corporation, 702 University Drive East, College station, TX 77840, USA 
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figure 10,2: Quantile-Normal plots of the Tso per site per treatment over all invasive sites. Nine 
randomly selected patient treatment series are plotted. 
The temperatures are handled in ten-fold to reduce PC memory usage. 
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figure 10.3: Interdependence matrix plot. Each dot represents a themmI dose parameter calculated 
per temperature site per treatment. The parameters are T90• Tso• Ta" T20 and T IO• 
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Although a con-elation between T90 and the number of intra-tumour temperature sites has been 
reported, this could not be confirmed in our current data set. A plausible reason for this could be 
the larger number of invasive temperature sites used. This amount was similar to that as reported 
by Hand el al. (1997) who did not find a correlation between Too and the number of sites. In the 
cun'cnt data set, WGA, LeA and eSA antcllllae have been used. The radiation characteristics of 
the LCA and CSA differ significantly from that of the WGA, this may have contributed to this 
non-reproducible result. 
Closing remarks With the current available quality of invasive thermometry, it has been 
possible to make basic clinical veri'fication of teclmical improvements (chapter 8). However, with 
the current level of treatment volumetric coverage it will be difficult to clinically confinn small 
technical differences as we showed in the technical comparison of SAR from the LCA and CSA 
(chapter 7). 
\Vith the current treatment planning tools it will be possible in the nlture to map modelled 
fine-meshed temperature distributions onto coar.se clinically measured temperature data. When 
this teclmique becomes available, higher quality thennal dosimetry can be made available. Also, 
the possibility of non-invasive thermomehy by MRI will boost know-how on the concept of 
thermal dose (Carter el al. (1998» and last but not least the functionality of hyperthennia in 
general. 
Concemillg the dependence of the thennal dose parameters with variables other than time and 
temperature, it is essential that further biological research, with clinical backup, should be done. 
Only then can more know-how be obtained on the influence of non-hyperthennia treatment-
related parameters on cell kill, which plays a significant rol~ in clinical thetmal dosimetry. 
10.3 The consideration a/whether thermal dose-response studies should take place prior to the 
commencement 0/ phase III studies 
The rationale to quantify the effect of hyperthennia is beyond discussion. Biological in vitro 
studies have clearly shown that hyperthennia is effective in cell kill. III vivo studies on 
hyperthemlia alone and radiation with or without hyperthenllia have demonstrated a thennal 
dose-response relationship (Dahl, (1982); Dewhirst el al. (1982); Dellll1an el al. (1991); 
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McChesney Gillette el al. (1992); Frew el al. (1995); Meijnders, (1998); Stubbs and Griffiths, 
(1999)), HO\vever, these ill vivo studies are based on non-human data and are somewhat limited 
as to direct human clinical relevance, We have already discussed that in clinical (human) 
hypelihelmia the question of quality is as yet impossible to define due to clinically limiting or 
confounding factors, However, if technical or clinical progress in hyperthennia is to be 
monitored, we need a hyperthennic parameter that is capable of dealing with known confounding 
factors. Human-based clinical prospective phase IIII hyperthennia studies may help in that 
respect if the confounding factors from clinical (invasive) thermometry can be dealt with. 
The importance of thermal dose-response studies In the Unites States of America, phase IIII 
studies on thennal dose-response prevail over the utilisation of the cun'ently available new 
hyperthennic technologies for phase III studies (Emami el al. (1991); Dewhirst ef al. (1997)). In 
general, clinicians are reluctant to start phase III studies. The main reason was the outcome of 
two American phase III trials (mIming from 1981 - 1987 respectively 1986 - 1992) that 
compared radiation alone to the combination of radiation plus hyperthennia (Perez"et al. (1989); 
Perez ef al. (1991); Emami el al. (1996)) and which failed to show a benefit from the addition of 
hypelihelmia. In their analyses, it was shown that the temperature targets were not met in the 
majority of the hyperthermia treatments. The equipment used apparently was not capable of 
producing adequate heat in the treatment volumes and they concluded that this failure was the 
main reason hyperthennia appeared not to be beneficial. If a sound concept for thennal dose can 
be defined, this parameter will automatically reflect the teclmical quality of the hyperthermic 
treatments. One of the main problems is that if a themal dose parameter has to be tested under 
clinical circumstances in phase IIII studies, one has to prescribe a (yet unknown) hyperthennic 
underclose to a subgroup of the cancer patients under study in order to correlate it with response 
over the whole clinical hyperthemlic dose range. From an ethical point of view this could be 
considered not to be a viable option. 
The justification of running phase III studies A different approach to estimate hyperthermic 
quality is by comparing patient- and treatment-related characteristics in different patient groups. 
If for a certain tumour type the addition of hypelihel1nia to the primary treatment results in an 
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improved CR rate and another tumour type has comparable initial CR rates after the primaty 
treatment, one can anticipate the same improved CR rate through the addition of hyperthenllia if 
at least the same technical quality for this type ofhyperthel111ic application is available. 
In the period 1980 - 1990, either new equipment became available or its limitations were 
better understood (Lagendijk, (1983); Tumer, (1984». Also promising results from superficial 
and interstitial hypelihennia studies were reported (Atistizabal and Oleson, (1984); Van der Zee 
el al. (1988); Van der Zee el at. (1992». This resulted in new phase III studies carried out using 
the efficacy of the new 'second generation' techniques in the treatment of specific tumour groups, 
The rationale to start the Dutch Phase III study on treatment of inoperable pelvic tumours by 
radiotherapy (RT) with or without deep regional hypelihellnia was: 
1. For patients with inoperable pelvic tumours, RT alone gives relative low CR rates. 
2. Our basic temperature analyses of superficial hyperthennia treatments of recurrent 
breast cancer show relatively low values (mean invasive temperature 40.9 °C). The CR 
rates for radiation alone are relative,ly low. The combined treatment of RT plus 
hyperthennia appears to be highly beneficial (Vemon el al. (1996». 
3. With radiative 'second generation' hyperthennia equipment Myerson et ai, (Myerson 
el al. (1990a); Myerson el al. (1996» measured temperatures comparable to our 
superficial hype11hennia treatment temperatures. 
4. Even if an adequate hyperthenllia treatment can be given to only a part of a patient 
group, improvement in CR can be expected for the whole group as we have seen in our 
study on treatment ofrecUlTent breast cancer with RT plus HT (chapter 2, this thesis). 
5. Solid proof was needed to establish a generally' approved position in regular health 
care. 
This study, and other recent phase III studies, using cun'ent state-of-the-art equipment, has 
shown a positive effect of hyperthermia in a combined treatment modality for both palliative and 
curative hypelihellllia treatment set ups (Overgaard el al. (1995); Sneed el al. (1998); Van der 
Zee el al. (1999)). In these second series of phase III studies, a critical altitude towards technical 
{im)possibilities was credit to their clinical success. Application of the Quality Assurance 
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guidelines from the European Society of Hyperthenuic Oncology (ESHO) (Hand e/ al. (1989)) 
and RTOG (Dewhirst e/ al. (1990)) made certain that a minimal technical quality was guaranteed. 
Pros and COilS o/phase 1111 and phase III stlldies The disappointing results from the first series 
of phase III studies have led to believe that the potential of hyperthennia can only be fully 
exploited if one can assure a certaiuminimal thennal dose, Le. thenna! quality. Some (American) 
groups believe that a second series of phase III studies ,vith a negative result for the addition of 
hyperthennia will result in a total halt of hyperthenllia research and they recommend that phase 
III studies are initiated only after methods are developed that allow for optimal treatment 
(Dewhirst, (1996)). Whilst from 1993 onwards the first positive results from the Dutch deep 
hypelihemlia Phase III study were made public (during the 13th Meeting of the North American 
Hyperthermic Society in Nashville 1994 and by (De Wit e/ al.(l994a,b); Van der Zee and 
Gonzalez Gonzalez, (1995); Van der Zee e/ al.(1996)), still in 1996 a negative attitude continued 
to exist towards the application of deep regional hyperthermia because of the apparently 
insufficient technical quality (Gibbs, Jr. (1996)) and the uncertainty in providing an optimal 
treatment (Seegenschmiedt and Feldmann, (1996)). 
If a clear proposal with well-founded (teclmicai and clinical) boundary conditions for the 
application of hyperthennia is made, progress can be made in the treatment of cancer with 
hypelihenllia, even in the cases whereby a beneficial contribution from hyperthennia is not 
found. The development of QA guidelines (Hand e/ al. (1989); Dewhirst e/ al. (1990)) were an 
indirect result of [omler (unsuccessful) experiences in applications of hypelihermia. If one can 
assure a minimal quality of a treatment modality by means of QA guidelines, the chance of a 
phase III failure is substantially diminished. On the one hand, the consequence of conducting a 
phase III study on specific cancer types, guided by yet insufficiently defined QA guidelines 
which could result in the conclusion that hyperthemlia is not beneficial, is far-reaching and could 
effect the applications of hyperthennia in other fields (due to mechanisms of non-scientific 
nature). On the other hand, if no phase III study is initiated at all, the scientific (and financial) 
suppori for hyperthermia could soon significantly diminish. 
The question of a) whether the more theoretically based (American) approach of assurance of a 
minimum thennal dose before applying hyperthennia clinically or b) the more pragmatic attitude 
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in the (European) approach in heating up to the maximum tolerance will result in a long term 
acceptance ofhYPclihemlia in the treatment of well-defined cases of cancer is still to be answered 
in the current decade. 
10.4 Future research possibilities based on current presented results 
This thesis describes a series of studies involving the development of superficial hyperthennia 
antcIUlae. These studies were perfonllcd as a result of funding by the Dutch Cancer Society 
project entitled 'Clinical verification and optimisation of the quality ofhYPclihemlic treatment of 
large superficial tumours ofthe chest wall' (grant DDHK 93-603). 
We encountered two recurring problems relating to the different studies: a) the lack of 
appropriate technical QA guidelines for evaluating alTays of antennae for superficial 
hYPcI1hennia and b) how to perfonn simple and adequate clinical studies to evaluate technical 
improvements. 
Recently, technical QA guidelines for deep regional hyperthennia have been fonnulated. 
However, the specific demands for deep regional hyperthelmia calUlot be transferred into the field 
of superficial hyperthermia. The current available superficial hyperthemlia QA guidelines do not 
cover the (RF~radiating) mu1ti~element non~coherent antenna array techniques. Reports on these 
systems show a wide variety of ideas in addressing the possibilities and restrictions (Auger et al. 
(1993); Diederich and Stauffer, (1993); Ryan et al. (1995); Rietveld et al. (1996); Gelvich et al. 
(1996); Rietveld et al. (1998); Tharp and Roemer, (1992); Stauffer et al. (1998)). An update of 
QA guidelines for superficial hypel1hennic equipment dealing with current available antennae 
techniques and modelling capabilities is badly needed on sho11 {enn. Only then can one properly 
exploit the possibilities of current and future state-of-the-art (superficial) hyperthermia 
teclmiques. 
The first results from the use of FDTD~based modelling of superficial LCAs, as shown in this 
thesis (chapter 9), are promising. Consequently, clinically relevant set~ups in superficial 
hyperthennic applications can be modelled. In particular, the cross coupling between the different 
antennae can be studied and optimisation routines can be developed that enhance non~interactive 
handling of antennae in an array. Also the effect on local SAR from a finite waterbolus or tissue 
inhomogeneities can be studied in detail. When FDTD~modeliing of smaller CSA becomes 
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available, more thorough analyses of the two superficial antenna types can be perfonned 
including modelled 3D-temperature distribution analyses. 
The next steps in quality quantification hyperthennia research are: 
• Incorporation of SARItemperature modelling in the process of optimisation during 
treatment. 
• The use of non-invasive MRI techniques in temperature monitoring which will validate 
CUlTent modelling results. 
Despite the fact that still many problems have to be solved, the current status of hyperthel111ia 
research justifies its role in regular public health service in Europe. 
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Summary 
In this thesis we have presented technical and clinical results from research in mainly 
superficial hyperthennia. 
The basis for this research project was fonned by the analyses of clinical superficial 
hyperthenllia data obtained from two different heating teclllliques (chapter 2). The main 
conclusion from this study was that reilTadiation with hyperthennia in recurrent breast cancer 
resulted in a worthwhile local palliation. The overall complete response (CR) rate was 58% 
for the original technique (2450 MHz) and 74% for the new teclmique, using waterHfilied 
waveguide applicators (WGAs) operated at 4,)3 MHz. A remarkable difference in CR was 
found as function of maximum tumour diameter (:::; 3 em or >3 em): for the small tumours the 
CR was ;'87%, for large tumours the CR was 31 % (2450 MHz) or 65% (433 MHz). We 
concluded that small tumours were properly heated, but even with the improved technical 
qualities of the 433:MHz system, the larger tumours responded less well. An additional 
technical improvement was needed. A research project proposal titled 'Clinical verification 
and optimisation of the quality of hyperthennic treatment of large superficial tumors of the 
chest wall' Was granted by the Dutch Cancer Society (grant DDHK 93-603) and fomled the 
backbone of this thesis. 
The basic method used to monitor clinical hyperthemlic quality is that of measuring the 
temperature during treatment. However, under clinical circumstances, practical limitations of 
invasive thennomehy exist. They are discllssed in chapter 3 and the value of invasive 
themlOmctry for optimisation of the treatment appeared limited. Due to the relatively low 
number of temperature sites over the treatment volume, the calculated thermal dose 
parameters are considered to be of limited value. The problem of validation of thennal dose 
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calculations is addressed morc extensively the General Discussion (chapter 10). To quantify 
ant mUla quality more accurately, a technical SAR-based evaluation of antenna charactedstics 
was carried out first. 
In chapter 4 we presented the first results fl."om a new type of 433 MHz antenna, the 
Lucite Cone Applicator (LCA). Quality was calculated from SAR distributions fi'om antellllae 
radiating in muscle-equivalent tissue. In an attempt to improve the quality of superficial 
hyperlhennia treatments of larger tumours, we modified a conventional waveguide antclma 
(apelture lOxia cm') which increased its effective field size (EFS) from 32 cm' to lOa cm'. 
This was obtained through replacement of the diverging metal sidewalls that are parallel with 
the dominant E-field by Lucite and inserting a PVC cone in the aperhuc. During experiments 
with different dimensions of waterboli, which couple the radiation to the patient, strong 
influences on the EFS were found. 
Based on this improvement, the SAR distributions from arrays of antennae were 
investigated by means of themlOgraphical (TG) imaging and Gaussian beam (GB) modelling 
(chapter 5). Firstly, the SAR profiles along the principal planes were measured with a small 
dipole and compared with TO-measured SAR values. These dipole data were used as input for 
the GB modelling. The GB modelling is capable of calculating SAR distributions from ID· 
layered structures, so its major drawback is the impossibility of modelling finite shaped water 
layers (i.e. waterboli). Using a large waterbolus in the TO-measured SAR distribution gave a 
proper match with the GB·predicted SAR distribution from a single LCA. Secondly, SAR 
distributions at 1 cm depth in muscle-equivalent tissue from 2x 1 atTays of LCA were TG-
measured, GB-predicted and compared. For clinical settings the differences between TG-
measured and GB-predicted SAR distributions were acceptable although we measured some 
interaction between the LCAs in the atTay. 
In chapter 6, we investigated 2x2 arrays of LCAs in different E·field orientated 
configurations. The GB model was used to predict SAR distributions from incoherently 
equally powered antennae. In the case of a clockwise-orientated E-field configuration, the 
maximum EFS was found that covered almost the entire apelture. Also the problem of 
antenna interaction was addressed. TG-measured SAR distributions showed that adjacent 
antennae moved the local maximum SAR towards the outer itlCite aperture boundaries. The 
GB model does not take mutual interactions into account. However, the difference between 
TO-measured and GB-predicted SAR distributions was less equal than 15% on average and 
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dropped to 12% when an additional spacing of 2 cm was added to decrease antelUla 
interactions. Especially in the more important EFS area, the difference decreased to 9% after 
implementing the 2 cm interspace in the clockwise-orientated E-field configured 2x2 LCA-
array. From these (GB-modelled) results we concluded that the LCA was a technical better 
antenna than the WGA. 
A second important item in the project was to find out the relevance of high spatial 
resolution in power control in optimising treatment quality. This can decrease penetration 
depth (PD). The CUlTent Sheet Applicator (CSA) was developed into a clinical applicable 
antenna (aperture 6.6x7.5 cm') and technically compared with the LCA (chapter 7). The CSA 
represented the small antelUla capable of relative high spatial adaptation of power at the cost 
of 2 nun GB-predicted PD compared that of the LCA. Further teclmical comparison was 
based on field sizes (FS) of 50% (Le. EFS), 75% and 25% SAR at either I cm depth in 
muscle-equivalent tissue or over a 3 cm deep volume covering the atTay aperture. For a single 
LCA and CSA, the EFS measured 69% respectively 57%. The SAR homogeneity coefficient 
(HC~FS2/FS25) for both single antelmae was about equal. The comparison based on 2t2 LCA 
anay and 3x3 CSA an'ay GB predicted SAR distributions showed an increase ofEFS to 75% 
respectively 72% and an increase of HC frOlil 0.2 to 0.3. This indicated that a Sllnm13tion of 
single SAR distributions in an array application of both LCA and CSA resulted in 
constructively better SAR distribution. We concluded that the LCA and CSA performed 
teelmical equally well. 
Based on the results from the GB-predicted SAR distributions from 2x2 LCA arrays, a 
clinical intra-patient study was set up in which the LCA was compared with the \VGA to find 
out to what extent the technical improvements would be reflected in the power and 
temperature distributions. Although the EFS was about 3 times larger for the LeA compared 
to that of the WGA, the average power per LCA only iticreased by about 30%. The invasively 
measured temperatures increased by 0.27 °C on average. Since the main SAR difference 
between the two systems was found in the periphery of the antenna aperture, we analysed the 
temperature difference between the centre and the periphery of the aperture. For the WGA the 
average temperature in the centre of the aperture was 0.43 °C higher than in the petiphery, 
while for the LCA this difference was -0.05 °C. This meant that the LCAs heated more 
unifonllly than the WGAs. The minimum temperatures remained unchanged. From these 
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results we concluded that the LCA was clinically superior to the WGA. The LCA became 
therefore our new standard antenna for superficial hyperthemlia. 
From basic GB modelling of the LeA and basic temperature analyses of clinical data 
from LeA and WGA treatments we concluded that the LeA was superior. However, there are 
still questions to he answered: what is the optimal waterbolus size for clinical applications 
with the LeA, which problems generate mutual antenna interactions under clinical 
circumstances and why is the increase in temperature relatively small compared to the clinical 
results using the WGA? Since TG measurements ofSAR are cumbersome and relatively slow 
when dealing with array applications of antennae, we statied research on more sophisticated 
SAR modelling by means of Finite-Difference Time-Domain (FDTD) calculus. Chapter 9 
presents the first results of modelling the LCA with FDTD. Special attention was paid to 
modelling the diverging metal sidewalls. The 'diagonally split cell model' was implemented 
on these side\valls. Furthennore, it was found that modelling the Lucite cover in front of the 
antenna plays an important role for the calculations. Taking these two points into 
consideration, the FDTD-predicted SAR distribution of the LCA at I cm depth in a flat, 
homogeneous, muscle-equivalent phantom became comparable to that of the TG-measured 
SAR disttibutions. 
The first FDTD results encouraged us to set up additional research in FDTD-
calculations in the near future, which will include a thorough parameter study. Firstly, this 
study will be concemed with waterbolns size effects on the SAR distribution and typical side 
effects (e.g. mutual interaction) in array applications of the LCA and secondly it will 
concentrate more on clinically-orientated situations involving an'ay applications on (curved) 
3D tissue geometries. We expect that this study will push the quality of superficial 
hyperthennia treatments of especially the larger chest wall recurrences of breast cancer to a 
higher level and eventually will result in an improved CR rate comparable to that found for 
smaller lesions that are treated with low dose radiotherapy plus hyperthelmia. 
Samenvatting 
In dit proefschrift worden technische en klinische resultaten gepresenteerd van onderzoek gedaan in 
voomamelijk oppen'Jakkige hyperthennie. 
De basis voor dit onderzoek werd gevomld door de analyse van gegevens van oppervJakkige 
hyperthenniebehandelingen waarin twee verschillende verwanllingstec1111ieken werden vcrgeleken 
(hoofdstuk 2), De belangrijkste conc1usie van dat onderzoek was dut de combinatie van een lage dasis 
bestraling en hyperthennie bij de behandeling van tenlgkomende borstkanker leidde tot waardevolle 
klachtenvenninderingen. De gecombineerde behandcling sloeg aan (d,w.z. gafeen complete respolls (CR» 
bij 58% van de patientcl1 indien de Ollde tcchniek werd gebmikt (frequentie 2450 MHz) en bij 74% indien 
de nieuwe tcchniek werd gebnlikt van Watergevulde GolfpijpAntenlles (WGAs, frequentie 433 MHz). Een 
opmerkelijk verschil in CR werd gevonden als functie van de tulllordiallleter (kleiner geJijk dan 3 cm of 
groter dan 3 cm); voor de kleille tumorell was de CR 87%, voor de grote tumorcn was de CR 31 % (2450 
MHz) of65% (433 MHz). We concludeerdell dat de kleille tullloren goed konden worden verwannd maar 
dat zelfs met de verbeterde techllische kwaliteiten van het 433 MHz systeem, de grotere tUll10ren slechter 
reageerden op de gecombilleerde behalldeling dan de kleine tumoren. Een aanvullende technische 
verbetering was gewenst. Eell onderzoeksproject getiteld "Klinische verificatie en optimalisatie van de 
kwaliteit van hyperthenne behandelingen van grote oppervlakkige tumoren van de borstkast" werd 
finallcieel gehonoreerd door de Nederlandse Kankerbestrijding-Koningin Wilhelmina Fonds (project 
DDHK 93-603). Dit project vomide de n1ggengraat van dit proefschrift. 
De eenvoudigste methode om de kwaliteit van de hyperthenniebehandeling te bekijken, is door 
lemperaturcn te meten tijdens de behandeling. Er zijn echter klinische omstandigheden die tot praktische 
beperkingen leiden bij illwendige temperatuunnetingen. We behandelen deze beperkingen in hoofdstuk 3. 
De waarde van inwendige temperatuurmetillgen voor hel optimaliseren van de behandeling bleken beperkt. 
Door het rclatief lage aantal meelplll1ten in het behandelingsgebied, zijn de berekende hyperthermie 
dosisgetallen van beperkte waarde. Dit probleem wordt verder uitgewerkt in hoofdstu)< 10. Om hel gemis 
in kwaliteit van temperatuunnetingen in de kliniek te olllzeilen, is gekozen am eerst een basale teclmische 
evaluatie van aanpassingen in de appiicatie nit te voeren. 
In hoofdstuk 4 hebbcn we de eerste resultaten .gepresenteerd van een nieuw type 433 MHz antenne, 
de Lucite Cone Applicator (LCA) met een alltenncopening van lO*lOcm2• De kwaliteit van deze antenne 
werd berekend van SAR-verdelingen in materiaal met spierequivalente eigenschappen. In eell paging de 
kwaliteit van opperviakkige hyperthenniebehandelingen van grote tumoren Ie verbeteren, hcbben we de 
WGA aangepast wat leidde tot een verhoging van de effectieve veldgrootte (EFS) van 32 cm2 tot 100 cm2• 
Dit werd bereikt door de l1lelalen divergerende zijwanden welke parallel lopen aan het dominante 
elektrische veld te vervallgen door perspex. Tevens werd cen PVC kegel in de anlenneopening gepiaatst. 
Tijdens experimenten waarbij verschillende grootte waterbolussen werden gebmikt, die voor een koppeling 
zorgell van antenne naar patient, bleek dat deze varialics slerke invloed hadden op de EFS. 
Oebaseerd op deze verbeteringen, werden thennografische (TG) gemelen en Gaussian beam (OB) 
berekellde SAR distributies onderzocht (hoofdstuk 5). Berst werden de SAR-profielen in de hoofdvlakken 
gemeten met een kleine dipoolanlenlle en de~e waarden werden vergelekell met TG-gemeten SAR-
waarden. De dipoolgemeten data diende als invoer voor de GB-berekeningen. GB-berekeningen kunnen 
infonllatie gevell over SAR-verdelingen van I -dimensionaal gelaagde stntcturen. De grootste tekortkoming 
van het OB-model is het gebrek om het effect van een eindige ·waterlaag (d.w.z. een waterbolus) in hel 
model op Ie !lemen. Door het gebmik van een grote waterbolus in de TG-gcmeten SAR-verdelingen, werd 
cell goede overeenkomst gevondell met de GB-berekende SAR-vcrdeling. Vervolgens werden de SAR-
verdelingen op 1 COl diepte in spierequivalent weefsel gemeten (TG) en berekcnd (GB). Deze verdelingen 
werden vervolgcns vergeleken. Onder klinische voorwaarden waren de verschillen russen de TG- en GB-
SAR-verdelingen acceptabel. Bij de TG-gemeten SAR verdelingen werd een interactie tussen de twee 
LCAs gevonden die de verdelillg beIllvloedde. 
In hoofdstuk 6 hebben we de eigenschappen onderzocht van een 2x2 array van LeAs die in 
ol1derlillg verschillende B-veld orienlalies waren geconfigureerd. Het OB-model werd gebntikt om SAR 
distributies te berekenen van incoherente aallgesluurde antennes mel een geJijke vemlOgensinstelling. 
Indien de kloksgewijze E-veldconfiguratie werd loegepast, werd de maximale EFS voor een 2x2 array van 
LCAs gevonden. Dil effectieve veld bedekte bijna de gehele oppervlakte van de array. Ook werd het 
probleem van de onderlinge antennewisseiwerking bestudeerd. TG-gemeten SAR verdelingen lielen zien 
dat bij aangrenzende antennes de lokale SAR maxima werden verschovell naar de perspexbuitellzijde van 
de antelUleopening. Hoewel het GB-model geen rekellillg houdt met onderlillge alltennewisselwerkingen, 
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was het vcrschil hlssen de TG-gemeten en GB-herekende SAR verdelingen gemiddeld kleiner dan 15%. 
He! verschil veoninderde tot 12% als een 2 em grote tussenruimte tussen de antennes in de array weed 
toegevoegd am de wisselwerkillg Ie venninderen. In het SAR domcin van de EFS werd het verschil 9% na 
de implementatie van de 2 em tussenruimle voor de kloksgewijze E-veld cOllfiguratie van de 2x2 LeA 
array. Gebaseerd op deze resultaten concludeerdcn we dat de LeA technisch bctcr was dan de \YGA. 
Een twcede ol1derdeel binnen het project was he! uitzoeken van het belallg van een hoge ntimtelijke 
resolulie in vennogenssturing bij het optimaiiseren van de behandeling. Dit gaal mogelijk tcn koste van 
illdringdiepte (PD) van de straling. De 'kleine' Current Sheet Applicator (CSA) werd geschikt gemaakt 
voor gebruik in de kliniek (antenneopening 6.6*7.5 cm2) en vcrgeleken mel de 'grote' LCA (hoofdstuk 7). 
De GB-berekende PD van de CSA bedroeg 2 l11111111inder dan die van de LCA. De technisehe vergeJijking 
van de twee antennetypes was gebasecrd op veldgroottes (rS) van 50% SAR (EFS), 75% en 25% SAR op 
of wei I em diepte in spierequivalent weefsel of wei over een volume van 3 cm diep opgespannen door de 
array. Voor een LCA en CSA bedroeg de EFS respeclievelijk 69% en 57%. De SAR 
homogeniteilcoefficient (HC=rS7/FS15) was voor beide antennes nagenoeg gelijk. De vergelijkingen 
gebaseerd op GB-berekeningen van een 2x2 LCA-array en een 3x3 CSA-array toonden een verhoging in 
de EFS tot 75% respectievelijk 72% en een verhoging in de HC van 0.2 lot 0.3. Dit geeft aan dat een 
sommatie van individuele SAR distribllties in een array-applicalie voor zowel de LCA als de CSA leidde 
101 een constmctief verbeterde SAR verdeling. We concludeerden dat de LCA en eSA teclmisch 
gelijkwaardige antennes zijn. 
Gebaseerd op de resultalen van de GB-herekende SAR verdelingen van 2x2 LCA arrays, werd een 
kliniseh intra-patienten onderzoek opgezet waarbij de LCA werd vcrgeleken met de WGA (hoofdstuk 8). 
Hiemit moest duidelijk worden in hoeverre een technische verbetering zou leiden tot gewijzigde 
vennogens- en temperatulIrverdelingen. Hoewel de EFS van de LCA ongeveer 3 maal zo groat is als die 
vall de WGA, nam het gemiddelde vemlOgen per LCA slechts toe met ongeveer 30%. De gemiddelde 
invasief gemeten temperatuur werd 0.27°C hoger. Omdal het versehil in de SAR-vcrdeling van de twee 
systemen voomamelijk in de buitenrand van de antelmeopening zit, hebben we het temperatuurverschil 
russen centnnu en periferie onder de antenneopening geanalyseerd. Voor de WGA was de gemiddelde 
temperatuur in het eentnun 0.43°C hager dan in de periferie terwijl voor de LCA het temperah.lUrverschil -
O.05°C bedroeg. Dit betekent dat de LCAs meer unifonn verwannen dan de WGAs. De minimum 
temperatuur bleef echter ongewijzigd. Een statistische analyse van deze gegevens resulteerde in een 
significant verschil dus de LCA was klinisch superieur aan de WGA. De LCA werd dan ook tot 
standaardantelme gekozen voor oppervlakkige hyperthermie. 
Middels eenvoudige GB-modelberekeningell aan de LCA en middels temperatuuranalyses van 
klinische data verkregen met LCAs of WGAs, hebben we geconcludeerd dat de LCA beler was dan de 
WGA. Er zijn echter nog een aanlal vragen die moeten ,vorden beantwoord: wat is de optimale afmeting 
van de waterbolus bij gebmik van de LCA, welke problemen in de kliniek worden veroorzaakt door 
onderlinge wisselwerkingen tussen de antennes en waarom is de verhoging van de gemiddelde invasief 
gemeten temperatuur bij gebmik van de LCAs relatiefklein t.o.v. de WGAs? Omdat TG-metingen van de 
SAR relatief moeilijk zijn en langzaam gaan illdien klinische applicaties worden gesimuleerd, hebben we 
onderzoek gestart naar het gebrl.lik van cell meer geavanceerd SAR-bepalcnd rekerunodel, de Finite-
Difference Time-Domain (FDTD) methodiek. In hoofdstuk 9 presenteren we de eerste resultaten voor de 
LCA van deze berekeningsteehniek. Er werd speciale aal1dacht besteed aan het correct modelleren van de 
divergerende metalen wanden. Het 'diagonally split cell model' werd toegepast Olll een optimale 
representatie te krijgen. Ook bleek dat de perspex plaat in de anlenneopening eell grote invloed had op de 
berekende SAR distributie. Rekeninghoudend mel deze twee specifieke problemen, bleken de FDTD-
berekende SAR distributies op 1 cm diepte in spierequivalent fanloom van een LCA goed overeen Ie 
komen met de TG-gcmeten SAR distributies. 
De eerste FDTD-resultaten hebben ons bemoedigend om het FDTD-onderzoek verder uit te werken 
in de nabije toekoillst in de richting van een gedetailleerd ollderzoek. In deze studie zullen we OilS eerst 
richten op het effect van de waterbolus op de SAR verdeling als functie van de afmetingen, de onderlinge 
antennewisselwerkingen in een array applicatie van de LCA en vervolgens zuBen we ons cOl1centreren op 
meer klinisch-relevante situaties waarin de antenne arrays stralen op (gekromde) 3D-weefseldistributies. 
We verwachten dat deze studie de kwalileit zal verhogen van oppervlakkige hyperthennische applicaties 
van grotere lemgkomellde borstkanker op de borstwand. Mogelijk kan dit leiden lot cen verbeterde 
complete respons welke vergelijkbaar is met die van kleinere horstkankertumoren die behandeld worden 
met een lage dosis radiotherapie en hyperthemlie. 
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